<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- RRD ActiveDisclosure(SM) XBRL Instance Document - http://www.financial.rrd.com/ -->
<!-- Creation Date      : 2014-05-06T16:17:25.3878099+00:00 -->
<!-- Version            : 1.8.3.0 -->
<!-- Package ID         : BE4A5ED11FCF54C04749D658B3B90F6C-0000879407-001403 -->
<!-- Copyright (c) 2014 R. R. Donnelley & Sons Company. All Rights Reserved. -->
<xbrl xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns="http://www.xbrl.org/2003/instance" xmlns:arwr="http://www.arrowheadresearch.com/20140331" xmlns:xbrll="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:us-gaap="http://fasb.org/us-gaap/2013-01-31" xmlns:us-types="http://fasb.org/us-types/2013-01-31" xmlns:country="http://xbrl.sec.gov/country/2013-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2012-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2013-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2013-01-31" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2011-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2011-01-31">
  <xbrll:schemaRef xlink:type="simple" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xlink:href="arwr-20140331.xsd" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrll="http://www.xbrl.org/2003/linkbase" />
  <unit id="U_shares">
    <measure>shares</measure>
  </unit>
  <unit id="U_iso4217USD">
    <measure>iso4217:USD</measure>
  </unit>
  <unit id="U_iso4217USD_shares">
    <divide>
      <unitNumerator>
        <measure>iso4217:USD</measure>
      </unitNumerator>
      <unitDenominator>
        <measure>shares</measure>
      </unitDenominator>
    </divide>
  </unit>
  <unit id="U_pure">
    <measure>pure</measure>
  </unit>
  <unit id="U_iso4217USD_arwrWarrant">
    <divide>
      <unitNumerator>
        <measure>iso4217:USD</measure>
      </unitNumerator>
      <unitDenominator>
        <measure>arwr:Warrant</measure>
      </unitDenominator>
    </divide>
  </unit>
  <context id="C_0000879407_20131001_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <startDate>2013-10-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_20140501">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <instant>2014-05-01</instant>
    </period>
  </context>
  <context id="C_0000879407_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <instant>2014-03-31</instant>
    </period>
  </context>
  <context id="C_0000879407_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <instant>2013-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_20140101_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_20130101_20130331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-03-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_20121001_20130331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-03-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_20030501_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <startDate>2003-05-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20020930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2002-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20020930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:PreferredStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2002-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20020930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2002-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20020930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:SubscriptionsReceivableMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2002-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20020930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2002-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20020930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:NoncontrollingInterestMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2002-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_20020930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <instant>2002-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtZeroPointZeroOneDollarsPerUnitMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20021001_20030930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedForCashAtZeroPointZeroOneDollarsPerUnitMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2002-10-01</startDate>
      <endDate>2003-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtZeroPointZeroOneDollarsPerUnitMember_20021001_20030930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedForCashAtZeroPointZeroOneDollarsPerUnitMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2002-10-01</startDate>
      <endDate>2003-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtTenDollarPerUnitMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20021001_20030930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedForCashAtTenDollarPerUnitMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2002-10-01</startDate>
      <endDate>2003-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtTenDollarPerUnitMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20021001_20030930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedForCashAtTenDollarPerUnitMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2002-10-01</startDate>
      <endDate>2003-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtTenDollarPerUnitMember_20021001_20030930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedForCashAtTenDollarPerUnitMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2002-10-01</startDate>
      <endDate>2003-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrStockIssuanceCostChargedToAdditionalPaidInCapitalMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20021001_20030930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:StockIssuanceCostChargedToAdditionalPaidInCapitalMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2002-10-01</startDate>
      <endDate>2003-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrStockIssuanceCostChargedToAdditionalPaidInCapitalMember_20021001_20030930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:StockIssuanceCostChargedToAdditionalPaidInCapitalMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2002-10-01</startDate>
      <endDate>2003-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20021001_20030930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2002-10-01</startDate>
      <endDate>2003-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_20021001_20030930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <startDate>2002-10-01</startDate>
      <endDate>2003-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20030930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2003-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20030930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2003-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20030930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2003-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_20030930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <instant>2003-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtTenDollarPerUnitMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedForCashAtTenDollarPerUnitMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtTenDollarPerUnitMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedForCashAtTenDollarPerUnitMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtTenDollarPerUnitMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedForCashAtTenDollarPerUnitMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForMarketableSecuritiesAtTenDollarPerUnitMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedForMarketableSecuritiesAtTenDollarPerUnitMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForMarketableSecuritiesAtTenDollarPerUnitMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedForMarketableSecuritiesAtTenDollarPerUnitMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForMarketableSecuritiesAtTenDollarPerUnitMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedForMarketableSecuritiesAtTenDollarPerUnitMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrStockIssuanceCostChargedToAdditionalPaidInCapitalMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:StockIssuanceCostChargedToAdditionalPaidInCapitalMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrStockIssuanceCostChargedToAdditionalPaidInCapitalMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:StockIssuanceCostChargedToAdditionalPaidInCapitalMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtFifteenDollarPerUnitMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedForCashAtFifteenDollarPerUnitMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtFifteenDollarPerUnitMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedForCashAtFifteenDollarPerUnitMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtFifteenDollarPerUnitMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedForCashAtFifteenDollarPerUnitMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_us-gaapEquityIssuedInBusinessCombinationMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:EquityIssuedInBusinessCombinationMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_us-gaapEquityIssuedInBusinessCombinationMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:EquityIssuedInBusinessCombinationMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_us-gaapEquityIssuedInBusinessCombinationMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:EquityIssuedInBusinessCombinationMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAsGiftForTenDollarAndNinetyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAsGiftForTenDollarAndNinetyCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAsGiftForTenDollarAndNinetyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAsGiftForTenDollarAndNinetyCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAsGiftForTenDollarAndNinetyCentsPerShareMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAsGiftForTenDollarAndNinetyCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAsStockIssuanceCostAtFifteenDollarPerUnitMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAsStockIssuanceCostAtFifteenDollarPerUnitMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAsStockIssuanceCostAtFifteenDollarPerUnitMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAsStockIssuanceCostAtFifteenDollarPerUnitMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAsStockIssuanceCostAtFifteenDollarPerUnitMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAsStockIssuanceCostAtFifteenDollarPerUnitMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtTwoDollarPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:ExercisedAtTwoDollarPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtTwoDollarPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:ExercisedAtTwoDollarPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtTwoDollarPerShareMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:ExercisedAtTwoDollarPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtTenDollarPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:ExercisedAtTenDollarPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtTenDollarPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:ExercisedAtTenDollarPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtTenDollarPerShareMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:ExercisedAtTenDollarPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:NoncontrollingInterestMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2004-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2004-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2004-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:NoncontrollingInterestMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2004-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <instant>2004-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20041001_20050930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2004-10-01</startDate>
      <endDate>2005-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtFifteenDollarPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20041001_20050930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:ExercisedAtFifteenDollarPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2004-10-01</startDate>
      <endDate>2005-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtFifteenDollarPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20041001_20050930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:ExercisedAtFifteenDollarPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2004-10-01</startDate>
      <endDate>2005-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtFifteenDollarPerShareMember_20041001_20050930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:ExercisedAtFifteenDollarPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2004-10-01</startDate>
      <endDate>2005-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtTenDollarPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20041001_20050930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:ExercisedAtTenDollarPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2004-10-01</startDate>
      <endDate>2005-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtTenDollarPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20041001_20050930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:ExercisedAtTenDollarPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2004-10-01</startDate>
      <endDate>2005-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtTenDollarPerShareMember_20041001_20050930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:ExercisedAtTenDollarPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2004-10-01</startDate>
      <endDate>2005-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToPurchaseInsertTherapeuticsShareAtThirtyNineDollarsAndEightyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20041001_20050930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedToPurchaseInsertTherapeuticsShareAtThirtyNineDollarsAndEightyCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2004-10-01</startDate>
      <endDate>2005-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToPurchaseInsertTherapeuticsShareAtThirtyNineDollarsAndEightyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20041001_20050930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedToPurchaseInsertTherapeuticsShareAtThirtyNineDollarsAndEightyCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2004-10-01</startDate>
      <endDate>2005-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToPurchaseInsertTherapeuticsShareAtThirtyNineDollarsAndEightyCentsPerShareMember_20041001_20050930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedToPurchaseInsertTherapeuticsShareAtThirtyNineDollarsAndEightyCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2004-10-01</startDate>
      <endDate>2005-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20041001_20050930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2004-10-01</startDate>
      <endDate>2005-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_20041001_20050930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <startDate>2004-10-01</startDate>
      <endDate>2005-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20041001_20050930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2004-10-01</startDate>
      <endDate>2005-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20041001_20050930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:NoncontrollingInterestMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2004-10-01</startDate>
      <endDate>2005-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20050930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2005-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20050930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2005-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20050930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2005-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20050930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:NoncontrollingInterestMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2005-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_20050930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <instant>2005-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20051001_20060930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20051001_20060930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_20051001_20060930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFortyEightDollarsAndEightyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20051001_20060930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtFortyEightDollarsAndEightyCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFortyEightDollarsAndEightyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20051001_20060930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtFortyEightDollarsAndEightyCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFortyEightDollarsAndEightyCentsPerShareMember_20051001_20060930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtFortyEightDollarsAndEightyCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThirtyEightDollarsAndFortyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20051001_20060930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtThirtyEightDollarsAndFortyCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThirtyEightDollarsAndFortyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20051001_20060930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtThirtyEightDollarsAndFortyCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThirtyEightDollarsAndFortyCentsPerShareMember_20051001_20060930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtThirtyEightDollarsAndFortyCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThirtyFiveDollarsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20051001_20060930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtThirtyFiveDollarsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThirtyFiveDollarsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20051001_20060930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtThirtyFiveDollarsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThirtyFiveDollarsPerShareMember_20051001_20060930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtThirtyFiveDollarsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiftyNineDollarsAndTenCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20051001_20060930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtFiftyNineDollarsAndTenCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiftyNineDollarsAndTenCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20051001_20060930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtFiftyNineDollarsAndTenCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiftyNineDollarsAndTenCentsPerShareMember_20051001_20060930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtFiftyNineDollarsAndTenCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToPurchaseCalandoPharmaceuticalsIncAtFiftyOneDollarsAndSeventyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20051001_20060930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedToPurchaseCalandoPharmaceuticalsIncAtFiftyOneDollarsAndSeventyCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToPurchaseCalandoPharmaceuticalsIncAtFiftyOneDollarsAndSeventyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20051001_20060930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedToPurchaseCalandoPharmaceuticalsIncAtFiftyOneDollarsAndSeventyCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToPurchaseCalandoPharmaceuticalsIncAtFiftyOneDollarsAndSeventyCentsPerShareMember_20051001_20060930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedToPurchaseCalandoPharmaceuticalsIncAtFiftyOneDollarsAndSeventyCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20051001_20060930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20051001_20060930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:NoncontrollingInterestMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20060930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2006-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20060930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2006-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20060930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2006-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20060930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:NoncontrollingInterestMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2006-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_20060930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <instant>2006-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20061001_20070930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2006-10-01</startDate>
      <endDate>2007-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20061001_20070930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2006-10-01</startDate>
      <endDate>2007-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_20061001_20070930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <startDate>2006-10-01</startDate>
      <endDate>2007-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiftySevenDollarsAndEightyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20061001_20070930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtFiftySevenDollarsAndEightyCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2006-10-01</startDate>
      <endDate>2007-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiftySevenDollarsAndEightyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20061001_20070930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtFiftySevenDollarsAndEightyCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2006-10-01</startDate>
      <endDate>2007-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiftySevenDollarsAndEightyCentsPerShareMember_20061001_20070930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtFiftySevenDollarsAndEightyCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2006-10-01</startDate>
      <endDate>2007-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForPurchaseOfCarbonNanotechnologiesIncAtThirtySevenDollarsAndSeventyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20061001_20070930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedForPurchaseOfCarbonNanotechnologiesIncAtThirtySevenDollarsAndSeventyCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2006-10-01</startDate>
      <endDate>2007-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForPurchaseOfCarbonNanotechnologiesIncAtThirtySevenDollarsAndSeventyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20061001_20070930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedForPurchaseOfCarbonNanotechnologiesIncAtThirtySevenDollarsAndSeventyCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2006-10-01</startDate>
      <endDate>2007-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForPurchaseOfCarbonNanotechnologiesIncAtThirtySevenDollarsAndSeventyCentsPerShareMember_20061001_20070930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedForPurchaseOfCarbonNanotechnologiesIncAtThirtySevenDollarsAndSeventyCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2006-10-01</startDate>
      <endDate>2007-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20061001_20070930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2006-10-01</startDate>
      <endDate>2007-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20061001_20070930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:NoncontrollingInterestMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2006-10-01</startDate>
      <endDate>2007-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20070930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2007-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20070930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2007-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20070930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2007-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20070930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:NoncontrollingInterestMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2007-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_20070930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <instant>2007-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20071001_20080930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20071001_20080930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_20071001_20080930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtApproximatelyEighteenDollarPerShareNetMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20071001_20080930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtApproximatelyEighteenDollarPerShareNetMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtApproximatelyEighteenDollarPerShareNetMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20071001_20080930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtApproximatelyEighteenDollarPerShareNetMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtApproximatelyEighteenDollarPerShareNetMember_20071001_20080930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtApproximatelyEighteenDollarPerShareNetMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentySevenDollarsAndTwentyCentsPerShareToRiceUniversityMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20071001_20080930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtTwentySevenDollarsAndTwentyCentsPerShareToRiceUniversityMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentySevenDollarsAndTwentyCentsPerShareToRiceUniversityMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20071001_20080930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtTwentySevenDollarsAndTwentyCentsPerShareToRiceUniversityMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentySevenDollarsAndTwentyCentsPerShareToRiceUniversityMember_20071001_20080930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtTwentySevenDollarsAndTwentyCentsPerShareToRiceUniversityMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyEightDollarsAndThirtyCentsPerShareToPurchaseSharesOfUnidymIncMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20071001_20080930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtTwentyEightDollarsAndThirtyCentsPerShareToPurchaseSharesOfUnidymIncMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyEightDollarsAndThirtyCentsPerShareToPurchaseSharesOfUnidymIncMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20071001_20080930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtTwentyEightDollarsAndThirtyCentsPerShareToPurchaseSharesOfUnidymIncMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyEightDollarsAndThirtyCentsPerShareToPurchaseSharesOfUnidymIncMember_20071001_20080930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtTwentyEightDollarsAndThirtyCentsPerShareToPurchaseSharesOfUnidymIncMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyNineDollarsAndFiftyCentsPerShareToPurchaseMasaEnergyLlcMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20071001_20080930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtTwentyNineDollarsAndFiftyCentsPerShareToPurchaseMasaEnergyLlcMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyNineDollarsAndFiftyCentsPerShareToPurchaseMasaEnergyLlcMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20071001_20080930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtTwentyNineDollarsAndFiftyCentsPerShareToPurchaseMasaEnergyLlcMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyNineDollarsAndFiftyCentsPerShareToPurchaseMasaEnergyLlcMember_20071001_20080930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtTwentyNineDollarsAndFiftyCentsPerShareToPurchaseMasaEnergyLlcMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyOneDollarsAndNinetyCentsPerShareToUnidymForAcquisitionOfNanoconductionMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20071001_20080930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtTwentyOneDollarsAndNinetyCentsPerShareToUnidymForAcquisitionOfNanoconductionMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyOneDollarsAndNinetyCentsPerShareToUnidymForAcquisitionOfNanoconductionMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20071001_20080930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtTwentyOneDollarsAndNinetyCentsPerShareToUnidymForAcquisitionOfNanoconductionMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyOneDollarsAndNinetyCentsPerShareToUnidymForAcquisitionOfNanoconductionMember_20071001_20080930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtTwentyOneDollarsAndNinetyCentsPerShareToUnidymForAcquisitionOfNanoconductionMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyOneDollarsAndEightyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20071001_20080930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtTwentyOneDollarsAndEightyCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyOneDollarsAndEightyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20071001_20080930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtTwentyOneDollarsAndEightyCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyOneDollarsAndEightyCentsPerShareMember_20071001_20080930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtTwentyOneDollarsAndEightyCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20071001_20080930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20071001_20080930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:NoncontrollingInterestMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20080930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2008-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20080930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2008-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20080930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2008-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_20080930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <instant>2008-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiveDollarsAndFiftyCentsPerShareToUnidymStockholderInExchangeForUnidymSSharesMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20081001_20090930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtFiveDollarsAndFiftyCentsPerShareToUnidymStockholderInExchangeForUnidymSSharesMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-10-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiveDollarsAndFiftyCentsPerShareToUnidymStockholderInExchangeForUnidymSSharesMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20081001_20090930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtFiveDollarsAndFiftyCentsPerShareToUnidymStockholderInExchangeForUnidymSSharesMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-10-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiveDollarsAndFiftyCentsPerShareToUnidymStockholderInExchangeForUnidymSSharesMember_20081001_20090930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtFiveDollarsAndFiftyCentsPerShareToUnidymStockholderInExchangeForUnidymSSharesMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-10-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiveDollarsAndTwentyCentsPerShareToTelVenturesInExchangeForUnidymSSharesMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20081001_20090930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtFiveDollarsAndTwentyCentsPerShareToTelVenturesInExchangeForUnidymSSharesMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-10-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiveDollarsAndTwentyCentsPerShareToTelVenturesInExchangeForUnidymSSharesMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20081001_20090930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtFiveDollarsAndTwentyCentsPerShareToTelVenturesInExchangeForUnidymSSharesMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-10-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiveDollarsAndTwentyCentsPerShareToTelVenturesInExchangeForUnidymSSharesMember_20081001_20090930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtFiveDollarsAndTwentyCentsPerShareToTelVenturesInExchangeForUnidymSSharesMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-10-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20081001_20090930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-10-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_20081001_20090930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <startDate>2008-10-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrArrowheadsIncreaseInProportionateShareOfCalandosEquityMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20081001_20090930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:ArrowheadsIncreaseInProportionateShareOfCalandosEquityMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-10-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrArrowheadsIncreaseInProportionateShareOfCalandosEquityMember_20081001_20090930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:ArrowheadsIncreaseInProportionateShareOfCalandosEquityMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-10-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThreeDollarsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20081001_20090930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtThreeDollarsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-10-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThreeDollarsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20081001_20090930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtThreeDollarsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-10-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThreeDollarsPerShareMember_20081001_20090930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtThreeDollarsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-10-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToUnidymStockholdersInExchangeForUnidymsSharesMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20081001_20090930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedToUnidymStockholdersInExchangeForUnidymsSharesMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-10-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToUnidymStockholdersInExchangeForUnidymsSharesMember_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20081001_20090930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:SubscriptionsReceivableMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedToUnidymStockholdersInExchangeForUnidymsSharesMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-10-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20081001_20090930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-10-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20090930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2009-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20090930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2009-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20090930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:SubscriptionsReceivableMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2009-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20090930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2009-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_20090930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <instant>2009-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20091001_20100930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-10-01</startDate>
      <endDate>2010-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20091001_20100930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-10-01</startDate>
      <endDate>2010-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_20091001_20100930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <startDate>2009-10-01</startDate>
      <endDate>2010-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20091001_20100930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:SubscriptionsReceivableMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-10-01</startDate>
      <endDate>2010-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20091001_20100930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:NoncontrollingInterestMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-10-01</startDate>
      <endDate>2010-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtSixDollarsAndThirtyFourCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20091001_20100930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtSixDollarsAndThirtyFourCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-10-01</startDate>
      <endDate>2010-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtSixDollarsAndThirtyFourCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20091001_20100930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtSixDollarsAndThirtyFourCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-10-01</startDate>
      <endDate>2010-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtSixDollarsAndThirtyFourCentsPerShareMember_20091001_20100930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtSixDollarsAndThirtyFourCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-10-01</startDate>
      <endDate>2010-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThirteenDollarsAndTwelveCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20091001_20100930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtThirteenDollarsAndTwelveCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-10-01</startDate>
      <endDate>2010-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThirteenDollarsAndTwelveCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20091001_20100930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtThirteenDollarsAndTwelveCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-10-01</startDate>
      <endDate>2010-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThirteenDollarsAndTwelveCentsPerShareMember_20091001_20100930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtThirteenDollarsAndTwelveCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-10-01</startDate>
      <endDate>2010-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToCalandoStockholdersInExchangeForCalandoSSharesMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20091001_20100930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedToCalandoStockholdersInExchangeForCalandoSSharesMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-10-01</startDate>
      <endDate>2010-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToCalandoStockholdersInExchangeForCalandoSSharesMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20091001_20100930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedToCalandoStockholdersInExchangeForCalandoSSharesMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-10-01</startDate>
      <endDate>2010-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToCalandoStockholdersInExchangeForCalandoSSharesMember_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20091001_20100930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:NoncontrollingInterestMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedToCalandoStockholdersInExchangeForCalandoSSharesMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-10-01</startDate>
      <endDate>2010-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToUnidymStockholdersInExchangeForUnidymsSharesMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20091001_20100930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedToUnidymStockholdersInExchangeForUnidymsSharesMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-10-01</startDate>
      <endDate>2010-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToUnidymStockholdersInExchangeForUnidymsSharesMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20091001_20100930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedToUnidymStockholdersInExchangeForUnidymsSharesMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-10-01</startDate>
      <endDate>2010-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToUnidymStockholdersInExchangeForUnidymsSharesMember_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20091001_20100930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:NoncontrollingInterestMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedToUnidymStockholdersInExchangeForUnidymsSharesMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-10-01</startDate>
      <endDate>2010-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20091001_20100930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-10-01</startDate>
      <endDate>2010-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20100930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2010-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20100930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2010-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20100930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2010-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20100930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:NoncontrollingInterestMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2010-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_20100930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <instant>2010-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20101001_20110930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-10-01</startDate>
      <endDate>2011-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20101001_20110930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-10-01</startDate>
      <endDate>2011-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_20101001_20110930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <startDate>2010-10-01</startDate>
      <endDate>2011-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20101001_20110930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:NoncontrollingInterestMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-10-01</startDate>
      <endDate>2011-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThreeDollarsAndEightyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20101001_20110930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtThreeDollarsAndEightyCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-10-01</startDate>
      <endDate>2011-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThreeDollarsAndEightyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20101001_20110930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtThreeDollarsAndEightyCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-10-01</startDate>
      <endDate>2011-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThreeDollarsAndEightyCentsPerShareMember_20101001_20110930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtThreeDollarsAndEightyCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-10-01</startDate>
      <endDate>2011-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuanceOfCommonStockForSubscriptionMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20101001_20110930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuanceOfCommonStockForSubscriptionMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-10-01</startDate>
      <endDate>2011-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuanceOfCommonStockForSubscriptionMember_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20101001_20110930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:SubscriptionsReceivableMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuanceOfCommonStockForSubscriptionMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-10-01</startDate>
      <endDate>2011-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20101001_20110930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-10-01</startDate>
      <endDate>2011-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20110930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20110930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20110930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:SubscriptionsReceivableMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20110930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20110930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:NoncontrollingInterestMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_20110930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <instant>2011-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThreeDollarsAndEightyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtThreeDollarsAndEightyCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThreeDollarsAndEightyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtThreeDollarsAndEightyCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThreeDollarsAndEightyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:SubscriptionsReceivableMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtThreeDollarsAndEightyCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThreeDollarsAndEightyCentsPerShareMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtThreeDollarsAndEightyCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThreeDollarsAndSeventyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtThreeDollarsAndSeventyCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThreeDollarsAndSeventyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtThreeDollarsAndSeventyCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThreeDollarsAndSeventyCentsPerShareMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtThreeDollarsAndSeventyCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFourDollarsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtFourDollarsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFourDollarsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtFourDollarsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFourDollarsPerShareMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtFourDollarsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtSixDollarsAndTwentyThreeCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtSixDollarsAndTwentyThreeCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtSixDollarsAndTwentyThreeCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtSixDollarsAndTwentyThreeCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtSixDollarsAndTwentyThreeCentsPerShareMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtSixDollarsAndTwentyThreeCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiveDollarsAndElevenCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtFiveDollarsAndElevenCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiveDollarsAndElevenCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtFiveDollarsAndElevenCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiveDollarsAndElevenCentsPerShareMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtFiveDollarsAndElevenCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwoDollarsAndSeventySixCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtTwoDollarsAndSeventySixCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwoDollarsAndSeventySixCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtTwoDollarsAndSeventySixCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwoDollarsAndSeventySixCentsPerShareMember_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:SubscriptionsReceivableMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtTwoDollarsAndSeventySixCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwoDollarsAndSeventySixCentsPerShareMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtTwoDollarsAndSeventySixCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedUnderCommittedCapitalAgreementMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedUnderCommittedCapitalAgreementMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedUnderCommittedCapitalAgreementMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedUnderCommittedCapitalAgreementMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_us-gaapEquityIssuedInBusinessCombinationMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:EquityIssuedInBusinessCombinationMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_us-gaapEquityIssuedInBusinessCombinationMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:EquityIssuedInBusinessCombinationMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_us-gaapEquityIssuedInBusinessCombinationMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:EquityIssuedInBusinessCombinationMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrPreferredStockIssuedAtThousandDollarsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:PreferredStockMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:PreferredStockIssuedAtThousandDollarsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrPreferredStockIssuedAtThousandDollarsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:PreferredStockIssuedAtThousandDollarsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrPreferredStockIssuedAtThousandDollarsPerShareMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:PreferredStockIssuedAtThousandDollarsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:PreferredStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToCalandoStockholdersInExchangeForCalandoSSharesMember_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:NoncontrollingInterestMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedToCalandoStockholdersInExchangeForCalandoSSharesMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToCalandoStockholdersInExchangeForCalandoSSharesMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedToCalandoStockholdersInExchangeForCalandoSSharesMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:NoncontrollingInterestMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:SubscriptionsReceivableMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:NoncontrollingInterestMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <instant>2012-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:SubscriptionsReceivableMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFourDollarsAndFortyNineCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtFourDollarsAndFortyNineCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFourDollarsAndFortyNineCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtFourDollarsAndFortyNineCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFourDollarsAndFortyNineCentsPerShareMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtFourDollarsAndFortyNineCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwoDollarsAndTwentySixCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtTwoDollarsAndTwentySixCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwoDollarsAndTwentySixCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtTwoDollarsAndTwentySixCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwoDollarsAndTwentySixCentsPerShareMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtTwoDollarsAndTwentySixCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwoDollarsAndTwelveCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtTwoDollarsAndTwelveCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwoDollarsAndTwelveCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtTwoDollarsAndTwelveCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwoDollarsAndTwelveCentsPerShareMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtTwoDollarsAndTwelveCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtOneDollarAndEightyThreeCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtOneDollarAndEightyThreeCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtOneDollarAndEightyThreeCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtOneDollarAndEightyThreeCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtOneDollarAndEightyThreeCentsPerShareMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtOneDollarAndEightyThreeCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrPreferredStockIssuedAtThousandDollarsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:PreferredStockMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:PreferredStockIssuedAtThousandDollarsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrPreferredStockIssuedAtThousandDollarsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:PreferredStockIssuedAtThousandDollarsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrPreferredStockIssuedAtThousandDollarsPerShareMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:PreferredStockIssuedAtThousandDollarsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:NoncontrollingInterestMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:PreferredStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:NoncontrollingInterestMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20131001_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-10-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20131001_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-10-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiveDollarsAndEightySixCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20131001_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtFiveDollarsAndEightySixCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-10-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiveDollarsAndEightySixCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20131001_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtFiveDollarsAndEightySixCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-10-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiveDollarsAndEightySixCentsPerShareMember_20131001_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtFiveDollarsAndEightySixCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-10-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtEighteenDollarAndNinetyFiveCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20131001_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtEighteenDollarAndNinetyFiveCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-10-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtEighteenDollarAndNinetyFiveCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20131001_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtEighteenDollarAndNinetyFiveCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-10-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtEighteenDollarAndNinetyFiveCentsPerShareMember_20131001_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtEighteenDollarAndNinetyFiveCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-10-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrPreferredStockIssuedAtThousandDollarsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20131001_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:PreferredStockMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:PreferredStockIssuedAtThousandDollarsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-10-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrPreferredStockIssuedAtThousandDollarsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20131001_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:PreferredStockIssuedAtThousandDollarsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-10-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrPreferredStockIssuedAtThousandDollarsPerShareMember_20131001_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:PreferredStockIssuedAtThousandDollarsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-10-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToGallowayMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20131001_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedToGallowayMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-10-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToGallowayMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20131001_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedToGallowayMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-10-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToGallowayMember_20131001_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedToGallowayMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-10-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20131001_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:PreferredStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-10-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20131001_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-10-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20131001_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:NoncontrollingInterestMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-10-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-03-31</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:PreferredStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-03-31</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-03-31</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-03-31</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:NoncontrollingInterestMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-03-31</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtZeroPointZeroOneDollarsPerUnitMember_20030930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedForCashAtZeroPointZeroOneDollarsPerUnitMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2003-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtTenDollarPerUnitMember_20030930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedForCashAtTenDollarPerUnitMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2003-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtTenDollarPerUnitMember_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedForCashAtTenDollarPerUnitMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2004-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForMarketableSecuritiesAtTenDollarPerUnitMember_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedForMarketableSecuritiesAtTenDollarPerUnitMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2004-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtFifteenDollarPerUnitMember_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedForCashAtFifteenDollarPerUnitMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2004-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAsGiftForTenDollarAndNinetyCentsPerShareMember_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAsGiftForTenDollarAndNinetyCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2004-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAsStockIssuanceCostAtFifteenDollarPerUnitMember_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAsStockIssuanceCostAtFifteenDollarPerUnitMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2004-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtTwoDollarPerShareMember_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:ExercisedAtTwoDollarPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2004-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtTenDollarPerShareMember_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:ExercisedAtTenDollarPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2004-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtFifteenDollarPerShareMember_20050930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:ExercisedAtFifteenDollarPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2005-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtTenDollarPerShareMember_20050930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:ExercisedAtTenDollarPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2005-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToPurchaseInsertTherapeuticsShareAtThirtyNineDollarsAndEightyCentsPerShareMember_20050930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedToPurchaseInsertTherapeuticsShareAtThirtyNineDollarsAndEightyCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2005-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFortyEightDollarsAndEightyCentsPerShareMember_20060930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtFortyEightDollarsAndEightyCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2006-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThirtyEightDollarsAndFortyCentsPerShareMember_20060930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtThirtyEightDollarsAndFortyCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2006-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThirtyFiveDollarsPerShareMember_20060930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtThirtyFiveDollarsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2006-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiftyNineDollarsAndTenCentsPerShareMember_20060930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtFiftyNineDollarsAndTenCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2006-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToPurchaseCalandoPharmaceuticalsIncAtFiftyOneDollarsAndSeventyCentsPerShareMember_20060930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedToPurchaseCalandoPharmaceuticalsIncAtFiftyOneDollarsAndSeventyCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2006-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiftySevenDollarsAndEightyCentsPerShareMember_20070930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtFiftySevenDollarsAndEightyCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2007-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForPurchaseOfCarbonNanotechnologiesIncAtThirtySevenDollarsAndSeventyCentsPerShareMember_20070930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedForPurchaseOfCarbonNanotechnologiesIncAtThirtySevenDollarsAndSeventyCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2007-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtApproximatelyEighteenDollarPerShareNetMember_20080930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtApproximatelyEighteenDollarPerShareNetMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2008-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentySevenDollarsAndTwentyCentsPerShareToRiceUniversityMember_20080930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtTwentySevenDollarsAndTwentyCentsPerShareToRiceUniversityMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2008-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyEightDollarsAndThirtyCentsPerShareToPurchaseSharesOfUnidymIncMember_20080930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtTwentyEightDollarsAndThirtyCentsPerShareToPurchaseSharesOfUnidymIncMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2008-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyNineDollarsAndFiftyCentsPerShareToPurchaseMasaEnergyLlcMember_20080930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtTwentyNineDollarsAndFiftyCentsPerShareToPurchaseMasaEnergyLlcMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2008-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyOneDollarsAndNinetyCentsPerShareToUnidymForAcquisitionOfNanoconductionMember_20080930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtTwentyOneDollarsAndNinetyCentsPerShareToUnidymForAcquisitionOfNanoconductionMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2008-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyOneDollarsAndEightyCentsPerShareMember_20080930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtTwentyOneDollarsAndEightyCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2008-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiveDollarsAndFiftyCentsPerShareToUnidymStockholderInExchangeForUnidymSSharesMember_20090930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtFiveDollarsAndFiftyCentsPerShareToUnidymStockholderInExchangeForUnidymSSharesMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2009-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiveDollarsAndTwentyCentsPerShareToTelVenturesInExchangeForUnidymSSharesMember_20090930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtFiveDollarsAndTwentyCentsPerShareToTelVenturesInExchangeForUnidymSSharesMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2009-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThreeDollarsPerShareMember_20090930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtThreeDollarsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2009-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtSixDollarsAndThirtyFourCentsPerShareMember_20100930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtSixDollarsAndThirtyFourCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2010-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThirteenDollarsAndTwelveCentsPerShareMember_20100930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtThirteenDollarsAndTwelveCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2010-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThreeDollarsAndEightyCentsPerShareMember_20110930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtThreeDollarsAndEightyCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThreeDollarsAndEightyCentsPerShareMember_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtThreeDollarsAndEightyCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThreeDollarsAndSeventyCentsPerShareMember_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtThreeDollarsAndSeventyCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFourDollarsPerShareMember_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtFourDollarsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtSixDollarsAndTwentyThreeCentsPerShareMember_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtSixDollarsAndTwentyThreeCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiveDollarsAndElevenCentsPerShareMember_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtFiveDollarsAndElevenCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwoDollarsAndSeventySixCentsPerShareMember_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtTwoDollarsAndSeventySixCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrPreferredStockIssuedAtThousandDollarsPerShareMember_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:PreferredStockIssuedAtThousandDollarsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFourDollarsAndFortyNineCentsPerShareMember_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtFourDollarsAndFortyNineCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwoDollarsAndTwentySixCentsPerShareMember_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtTwoDollarsAndTwentySixCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwoDollarsAndTwelveCentsPerShareMember_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtTwoDollarsAndTwelveCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtOneDollarAndEightyThreeCentsPerShareMember_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtOneDollarAndEightyThreeCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrPreferredStockIssuedAtThousandDollarsPerShareMember_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:PreferredStockIssuedAtThousandDollarsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiveDollarsAndEightySixCentsPerShareMember_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtFiveDollarsAndEightySixCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-03-31</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtEighteenDollarAndNinetyFiveCentsPerShareMember_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedAtEighteenDollarAndNinetyFiveCentsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-03-31</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrPreferredStockIssuedAtThousandDollarsPerShareMember_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:PreferredStockIssuedAtThousandDollarsPerShareMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-03-31</instant>
    </period>
  </context>
  <context id="C_0000879407_20130331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <instant>2013-03-31</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToGallowayMember_20140218">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:IssuedToGallowayMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-02-18</instant>
    </period>
  </context>
  <context id="C_0000879407_deiLegalEntityAxis_arwrInsertTherapeuticsIncMember_20050323">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="dei:LegalEntityAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:InsertTherapeuticsIncMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2005-03-23</instant>
    </period>
  </context>
  <context id="C_0000879407_deiLegalEntityAxis_arwrCalandoPharmaceuticalsIncMember_20060331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="dei:LegalEntityAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:CalandoPharmaceuticalsIncMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2006-03-31</instant>
    </period>
  </context>
  <context id="C_0000879407_deiLegalEntityAxis_arwrCarbonNanotechnologiesIncMember_us-gaapStatementClassOfStockAxis_us-gaapSeriesEPreferredStockMember_20070420">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="dei:LegalEntityAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:CarbonNanotechnologiesIncMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:SeriesEPreferredStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2007-04-20</instant>
    </period>
  </context>
  <context id="C_0000879407_deiLegalEntityAxis_arwrUnidymIncMember_20080423">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="dei:LegalEntityAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:UnidymIncMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2008-04-23</instant>
    </period>
  </context>
  <context id="C_0000879407_deiLegalEntityAxis_arwrMsEnergyLlcMember_20080429">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="dei:LegalEntityAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:MsEnergyLlcMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2008-04-29</instant>
    </period>
  </context>
  <context id="C_0000879407_deiLegalEntityAxis_arwrUnidymIncMember_20080808">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="dei:LegalEntityAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:UnidymIncMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2008-08-08</instant>
    </period>
  </context>
  <context id="C_0000879407_deiLegalEntityAxis_arwrUnidymIncMember_us-gaapStatementClassOfStockAxis_us-gaapSeriesAPreferredStockMember_20090611">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="dei:LegalEntityAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:UnidymIncMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:SeriesAPreferredStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2009-06-11</instant>
    </period>
  </context>
  <context id="C_0000879407_deiLegalEntityAxis_arwrUnidymIncMember_us-gaapStatementClassOfStockAxis_us-gaapSeriesCPreferredStockMember_20090625">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="dei:LegalEntityAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:UnidymIncMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:SeriesCPreferredStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2009-06-25</instant>
    </period>
  </context>
  <context id="C_0000879407_deiLegalEntityAxis_arwrUnidymIncMember_us-gaapStatementClassOfStockAxis_us-gaapSeriesAPreferredStockMember_20090922">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="dei:LegalEntityAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:UnidymIncMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:SeriesAPreferredStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2009-09-22</instant>
    </period>
  </context>
  <context id="C_0000879407_deiLegalEntityAxis_arwrUnidymIncMember_20090928">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="dei:LegalEntityAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:UnidymIncMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2009-09-28</instant>
    </period>
  </context>
  <context id="C_0000879407_deiLegalEntityAxis_arwrUnidymIncMember_us-gaapStatementClassOfStockAxis_us-gaapSeriesAPreferredStockMember_20090928">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="dei:LegalEntityAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:UnidymIncMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:SeriesAPreferredStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2009-09-28</instant>
    </period>
  </context>
  <context id="C_0000879407_deiLegalEntityAxis_arwrUnidymIncMember_us-gaapStatementClassOfStockAxis_us-gaapSeriesCPreferredStockMember_20090928">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="dei:LegalEntityAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:UnidymIncMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:SeriesCPreferredStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2009-09-28</instant>
    </period>
  </context>
  <context id="C_0000879407_deiLegalEntityAxis_arwrUnidymIncMember_us-gaapStatementClassOfStockAxis_arwrSeriesCOnePreferredStockMember_20090930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="dei:LegalEntityAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:UnidymIncMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:SeriesCOnePreferredStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2009-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_deiLegalEntityAxis_arwrUnidymIncMember_us-gaapStatementClassOfStockAxis_us-gaapSeriesCPreferredStockMember_20091130">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="dei:LegalEntityAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:UnidymIncMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:SeriesCPreferredStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2009-11-30</instant>
    </period>
  </context>
  <context id="C_0000879407_deiLegalEntityAxis_arwrCalandoPharmaceuticalsIncMember_20091130">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="dei:LegalEntityAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:CalandoPharmaceuticalsIncMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2009-11-30</instant>
    </period>
  </context>
  <context id="C_0000879407_deiLegalEntityAxis_arwrCalandoPharmaceuticalsIncMember_20100228">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="dei:LegalEntityAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:CalandoPharmaceuticalsIncMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2010-02-28</instant>
    </period>
  </context>
  <context id="C_0000879407_20100331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <instant>2010-03-31</instant>
    </period>
  </context>
  <context id="C_0000879407_deiLegalEntityAxis_arwrCalandoPharmaceuticalsIncMember_us-gaapStatementClassOfStockAxis_us-gaapSeriesAPreferredStockMember_20100930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="dei:LegalEntityAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:CalandoPharmaceuticalsIncMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:SeriesAPreferredStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2010-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_deiLegalEntityAxis_arwrRocheMadisonMember_20111021">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="dei:LegalEntityAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:RocheMadisonMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-10-21</instant>
    </period>
  </context>
  <context id="C_0000879407_deiLegalEntityAxis_arwrAlvosTherapeuticsMember_20120405">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="dei:LegalEntityAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:AlvosTherapeuticsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-04-05</instant>
    </period>
  </context>
  <context id="C_0000879407_deiLegalEntityAxis_arwrRocheMadisonMember_20121021">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="dei:LegalEntityAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:RocheMadisonMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-10-21</instant>
    </period>
  </context>
  <context id="C_0000879407_20121020_20121021">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <startDate>2012-10-20</startDate>
      <endDate>2012-10-21</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapFairValueByLiabilityClassAxis_us-gaapWarrantMember_20131001_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:WarrantMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-10-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrExchangeRightsMember_20131001_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:ExchangeRightsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-10-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapSummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesByTypeAxis_us-gaapBondsMember_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesByTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:BondsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-03-31</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementScenarioAxis_arwrWarrantsIssuedMember_20131001_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementScenarioAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:WarrantsIssuedMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-10-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapSummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesByTypeAxis_us-gaapBondsMember_20131001_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesByTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:BondsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-10-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapRangeAxis_us-gaapMinimumMember_20131001_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:RangeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:MinimumMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-10-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapRangeAxis_us-gaapMaximumMember_20131001_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:RangeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:MaximumMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-10-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapMajorTypesOfDebtAndEquitySecuritiesAxis_arwrCommercialNotesDueWithinOneYearMember_20131001_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:CommercialNotesDueWithinOneYearMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-10-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapMajorTypesOfDebtAndEquitySecuritiesAxis_arwrCommercialNotesDueAfterOneYearThroughTwoYearsMember_20131001_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:CommercialNotesDueAfterOneYearThroughTwoYearsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-10-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapMajorTypesOfDebtAndEquitySecuritiesAxis_arwrCommercialNotesDueWithinOneYearMember_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:CommercialNotesDueWithinOneYearMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-03-31</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapMajorTypesOfDebtAndEquitySecuritiesAxis_arwrCommercialNotesDueAfterOneYearThroughTwoYearsMember_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:CommercialNotesDueAfterOneYearThroughTwoYearsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-03-31</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapMajorTypesOfDebtAndEquitySecuritiesAxis_arwrCommercialNotesDueWithinOneYearMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:CommercialNotesDueWithinOneYearMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapMajorTypesOfDebtAndEquitySecuritiesAxis_arwrCommercialNotesDueAfterOneYearThroughTwoYearsMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:CommercialNotesDueAfterOneYearThroughTwoYearsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapMajorTypesOfDebtAndEquitySecuritiesAxis_arwrCommercialNotesDueWithinOneYearMember_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:CommercialNotesDueWithinOneYearMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapMajorTypesOfDebtAndEquitySecuritiesAxis_arwrCommercialNotesDueAfterOneYearThroughTwoYearsMember_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:CommercialNotesDueAfterOneYearThroughTwoYearsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapBusinessAcquisitionAxis_arwrRocheMadisonMember_20111021">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:BusinessAcquisitionAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:RocheMadisonMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-10-21</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapBusinessAcquisitionAxis_arwrRocheMadisonMember_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:BusinessAcquisitionAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:RocheMadisonMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-03-31</instant>
    </period>
  </context>
  <context id="C_0000879407_20111001_20111021">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2011-10-21</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapLicensingAgreementsMember_20131001_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:LicensingAgreementsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-10-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapPatentsMember_us-gaapRangeAxis_us-gaapMinimumMember_20131001_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:RangeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:MinimumMember</explicitMember>
        <explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:PatentsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-10-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapPatentsMember_us-gaapRangeAxis_us-gaapMaximumMember_20131001_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:RangeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:MaximumMember</explicitMember>
        <explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:PatentsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-10-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapBusinessAcquisitionAxis_arwrRocheMadisonMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:BusinessAcquisitionAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:RocheMadisonMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapBusinessAcquisitionAxis_arwrAlvosTherapeuticsMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:BusinessAcquisitionAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:AlvosTherapeuticsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_deiLegalEntityAxis_arwrCalandoPharmaceuticalsIncMember_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="dei:LegalEntityAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:CalandoPharmaceuticalsIncMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-03-31</instant>
    </period>
  </context>
  <context id="C_0000879407_deiLegalEntityAxis_arwrAblarisTherapeuticsMember_20101001_20110930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="dei:LegalEntityAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:AblarisTherapeuticsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-10-01</startDate>
      <endDate>2011-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_deiLegalEntityAxis_arwrAblarisTherapeuticsMember_20110930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="dei:LegalEntityAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:AblarisTherapeuticsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_deiLegalEntityAxis_arwrAblarisTherapeuticsMember_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="dei:LegalEntityAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:AblarisTherapeuticsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-03-31</instant>
    </period>
  </context>
  <context id="C_0000879407_20081126">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <instant>2008-11-26</instant>
    </period>
  </context>
  <context id="C_0000879407_deiLegalEntityAxis_arwrCalandoMember_us-gaapStatementClassOfStockAxis_us-gaapSeriesAPreferredStockMember_20131001_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:SeriesAPreferredStockMember</explicitMember>
        <explicitMember dimension="dei:LegalEntityAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:CalandoMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-10-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapPlanNameAxis_arwrTwoThousandFourEquityIncentivePlanTwoThousandStockOptionPlanAndInducementGrantsMember_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:PlanNameAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:TwoThousandFourEquityIncentivePlanTwoThousandStockOptionPlanAndInducementGrantsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-03-31</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_us-gaapLimitedLiabilityCompanyMember_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:LimitedLiabilityCompanyMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-03-31</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_us-gaapLimitedLiabilityCompanyMember_20140101_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:LimitedLiabilityCompanyMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_us-gaapSeriesAPreferredStockMember_20120229">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:SeriesAPreferredStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-02-29</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_us-gaapSeriesAPreferredStockMember_20111021">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:SeriesAPreferredStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-10-21</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_us-gaapSeriesAPreferredStockMember_20111001_20111031">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:SeriesAPreferredStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2011-10-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_us-gaapSeriesAPreferredStockMember_us-gaapStatementScenarioAxis_arwrSubscriptionAgreementMember_20111001_20111031">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementScenarioAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:SubscriptionAgreementMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:SeriesAPreferredStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2011-10-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_us-gaapSeriesAPreferredStockMember_20120201_20120229">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:SeriesAPreferredStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-02-01</startDate>
      <endDate>2012-02-29</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementScenarioAxis_arwrSubscriptionAgreementMember_20111031">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementScenarioAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:SubscriptionAgreementMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-10-31</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementScenarioAxis_arwrSubscriptionAgreementMember_20111001_20111031">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementScenarioAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:SubscriptionAgreementMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2011-10-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_20120809_20120810">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <startDate>2012-08-09</startDate>
      <endDate>2012-08-10</endDate>
    </period>
  </context>
  <context id="C_0000879407_20120810">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <instant>2012-08-10</instant>
    </period>
  </context>
  <context id="C_0000879407_20121201_20121231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <startDate>2012-12-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_20121231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="C_0000879407_20130131">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <instant>2013-01-31</instant>
    </period>
  </context>
  <context id="C_0000879407_20130101_20130131">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-01-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20130531">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-05-31</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrConvertiblePreferredStockSeriesBMember_20130531">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:ConvertiblePreferredStockSeriesBMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-05-31</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20130501_20130531">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-05-01</startDate>
      <endDate>2013-05-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrConvertiblePreferredStockSeriesBMember_20130501_20130531">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:ConvertiblePreferredStockSeriesBMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-05-01</startDate>
      <endDate>2013-05-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_20130531">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <instant>2013-05-31</instant>
    </period>
  </context>
  <context id="C_0000879407_20130501_20130531">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <startDate>2013-05-01</startDate>
      <endDate>2013-05-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_20131011">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <instant>2013-10-11</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_us-gaapSeriesCPreferredStockMember_20131011">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:SeriesCPreferredStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-10-11</instant>
    </period>
  </context>
  <context id="C_0000879407_20131010_20131011">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <startDate>2013-10-10</startDate>
      <endDate>2013-10-11</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_us-gaapSeriesCPreferredStockMember_20131010_20131011">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:SeriesCPreferredStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-10-10</startDate>
      <endDate>2013-10-11</endDate>
    </period>
  </context>
  <context id="C_0000879407_20140223_20140224">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <startDate>2014-02-23</startDate>
      <endDate>2014-02-24</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantOneMember_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:WarrantOneMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-03-31</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantTwoMember_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:WarrantTwoMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-03-31</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantThreeMember_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:WarrantThreeMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-03-31</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantFourMember_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:WarrantFourMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-03-31</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantFiveMember_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:WarrantFiveMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-03-31</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantSixMember_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:WarrantSixMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-03-31</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantSevenMember_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:WarrantSevenMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-03-31</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantEightMember_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:WarrantEightMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-03-31</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantOneMember_20140101_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:WarrantOneMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantTwoMember_20140101_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:WarrantTwoMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantThreeMember_20140101_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:WarrantThreeMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantFourMember_20140101_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:WarrantFourMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantFiveMember_20140101_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:WarrantFiveMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantSixMember_20140101_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:WarrantSixMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantSevenMember_20140101_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:WarrantSevenMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantEightMember_20140101_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:WarrantEightMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapPropertySubjectToOrAvailableForOperatingLeaseAxis_arwrCorporateHeadquartersInPasadenaMember_20131001_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:CorporateHeadquartersInPasadenaMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-10-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapPropertySubjectToOrAvailableForOperatingLeaseAxis_arwrResearchFacilityInMadisonMember_20131001_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:ResearchFacilityInMadisonMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-10-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapPropertySubjectToOrAvailableForOperatingLeaseAxis_us-gaapAssetsHeldUnderCapitalLeasesMember_20131001_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AssetsHeldUnderCapitalLeasesMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-10-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapPlanNameAxis_arwrTwoThousandsStockOptionPlanMember_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:PlanNameAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:TwoThousandsStockOptionPlanMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-03-31</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapPlanNameAxis_arwrTwoThousandsFourEquityIncentivePlanMember_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:PlanNameAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:TwoThousandsFourEquityIncentivePlanMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-03-31</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapPlanNameAxis_arwrTwoThousandsThirteenIncentivePlanMember_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:PlanNameAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:TwoThousandsThirteenIncentivePlanMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-03-31</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapPlanNameAxis_arwrTwoThousandsFourEquityIncentivePlanMember_20131001_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:PlanNameAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:TwoThousandsFourEquityIncentivePlanMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-10-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapPlanNameAxis_arwrTwoThousandsThirteenIncentivePlanMember_20131001_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:PlanNameAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:TwoThousandsThirteenIncentivePlanMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-10-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_arwrArrowheadMember_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:ArrowheadMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-03-31</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_arwrArrowheadMember_20140101_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:ArrowheadMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapRangeAxis_us-gaapMinimumMember_20121001_20130331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:RangeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:MinimumMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-03-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapRangeAxis_us-gaapMaximumMember_20121001_20130331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:RangeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:MaximumMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-03-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:AwardTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:RestrictedStockUnitsRSUMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-03-31</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:AwardTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:RestrictedStockUnitsRSUMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20131001_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:AwardTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:RestrictedStockUnitsRSUMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-10-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20121001_20130331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:AwardTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:RestrictedStockUnitsRSUMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-03-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:FairValueMeasurementsRecurringMember</explicitMember>
        <explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:FairValueInputsLevel1Member</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-03-31</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:FairValueMeasurementsRecurringMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-03-31</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:FairValueMeasurementsRecurringMember</explicitMember>
        <explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:FairValueInputsLevel2Member</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-03-31</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:FairValueMeasurementsRecurringMember</explicitMember>
        <explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:FairValueInputsLevel3Member</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-03-31</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:FairValueMeasurementsRecurringMember</explicitMember>
        <explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:FairValueInputsLevel1Member</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:FairValueMeasurementsRecurringMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:FairValueMeasurementsRecurringMember</explicitMember>
        <explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:FairValueInputsLevel2Member</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:FairValueMeasurementsRecurringMember</explicitMember>
        <explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:FairValueInputsLevel3Member</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_arwrUnidymIncMember_20110101_20110131">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:UnidymIncMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-01-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_arwrUnidymIncMember_20110131">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:UnidymIncMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-01-31</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapFairValueByAssetClassAxis_us-gaapDerivativeFinancialInstrumentsAssetsMember_20131001_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:FairValueByAssetClassAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:DerivativeFinancialInstrumentsAssetsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-10-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapFairValueByAssetClassAxis_us-gaapDerivativeFinancialInstrumentsAssetsMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:FairValueByAssetClassAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:DerivativeFinancialInstrumentsAssetsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapFairValueByAssetClassAxis_us-gaapDerivativeFinancialInstrumentsAssetsMember_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:FairValueByAssetClassAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:DerivativeFinancialInstrumentsAssetsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapFairValueByAssetClassAxis_us-gaapDerivativeFinancialInstrumentsAssetsMember_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:FairValueByAssetClassAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:DerivativeFinancialInstrumentsAssetsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapFairValueByAssetClassAxis_us-gaapDerivativeFinancialInstrumentsAssetsMember_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:FairValueByAssetClassAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:DerivativeFinancialInstrumentsAssetsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-03-31</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrTwoThousandTenWarrantsMember_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:TwoThousandTenWarrantsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-03-31</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrTwoThousandsTwelveWarrantsMember_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:TwoThousandsTwelveWarrantsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-03-31</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrTwoThousandThirteenWarrantsMember_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:TwoThousandThirteenWarrantsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-03-31</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrTwoThousandTenWarrantsMember_20131001_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:TwoThousandTenWarrantsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-10-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrTwoThousandTenWarrantsMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:TwoThousandTenWarrantsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrTwoThousandsTwelveWarrantsMember_20131001_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:TwoThousandsTwelveWarrantsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-10-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrTwoThousandsTwelveWarrantsMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:TwoThousandsTwelveWarrantsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrTwoThousandThirteenWarrantsMember_20131001_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:TwoThousandThirteenWarrantsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-10-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrTwoThousandThirteenWarrantsMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:TwoThousandThirteenWarrantsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapFairValueByLiabilityClassAxis_us-gaapWarrantMember_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:WarrantMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapFairValueByLiabilityClassAxis_us-gaapWarrantMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:WarrantMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapFairValueByLiabilityClassAxis_us-gaapWarrantMember_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:WarrantMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapFairValueByLiabilityClassAxis_us-gaapWarrantMember_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:WarrantMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-03-31</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_arwrAblarisTherapeuticsMember_20131001_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:AblarisTherapeuticsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-10-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrExchangeRightsMember_20140101_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:ExchangeRightsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrExchangeRightsMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:ExchangeRightsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrExchangeRightsMember_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:ExchangeRightsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrExchangeRightsMember_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:ExchangeRightsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrExchangeRightsMember_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis" xmlns="http://xbrl.org/2006/xbrldi">arwr:ExchangeRightsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-03-31</instant>
    </period>
  </context>
  <dei:DocumentType id="F_000000" contextRef="C_0000879407_20131001_20140331">10-Q</dei:DocumentType>
  <dei:AmendmentFlag id="F_000001" contextRef="C_0000879407_20131001_20140331">false</dei:AmendmentFlag>
  <dei:DocumentPeriodEndDate id="F_000002" contextRef="C_0000879407_20131001_20140331">2014-03-31</dei:DocumentPeriodEndDate>
  <dei:DocumentFiscalYearFocus id="F_000003" contextRef="C_0000879407_20131001_20140331">2014</dei:DocumentFiscalYearFocus>
  <dei:DocumentFiscalPeriodFocus id="F_000004" contextRef="C_0000879407_20131001_20140331">Q2</dei:DocumentFiscalPeriodFocus>
  <dei:TradingSymbol id="F_000005" contextRef="C_0000879407_20131001_20140331">ARWR</dei:TradingSymbol>
  <dei:EntityRegistrantName id="F_000006" contextRef="C_0000879407_20131001_20140331">ARROWHEAD RESEARCH CORP</dei:EntityRegistrantName>
  <dei:EntityCentralIndexKey id="F_000007" contextRef="C_0000879407_20131001_20140331">0000879407</dei:EntityCentralIndexKey>
  <dei:CurrentFiscalYearEndDate id="F_000008" contextRef="C_0000879407_20131001_20140331">--09-30</dei:CurrentFiscalYearEndDate>
  <dei:EntityFilerCategory id="F_000009" contextRef="C_0000879407_20131001_20140331">Smaller Reporting Company</dei:EntityFilerCategory>
  <dei:EntityCommonStockSharesOutstanding id="F_000010" contextRef="C_0000879407_20140501" decimals="INF" unitRef="U_shares">51872371</dei:EntityCommonStockSharesOutstanding>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue id="F_000011" contextRef="C_0000879407_20140331" decimals="0" unitRef="U_iso4217USD">142847860</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue id="F_000012" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">19114444</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:AccountsReceivableNetCurrent id="F_000013" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">75000</us-gaap:AccountsReceivableNetCurrent>
  <us-gaap:PrepaidExpenseCurrent id="F_000014" contextRef="C_0000879407_20140331" decimals="0" unitRef="U_iso4217USD">643023</us-gaap:PrepaidExpenseCurrent>
  <us-gaap:PrepaidExpenseCurrent id="F_000015" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">532354</us-gaap:PrepaidExpenseCurrent>
  <us-gaap:OtherAssetsCurrent id="F_000016" contextRef="C_0000879407_20140331" decimals="0" unitRef="U_iso4217USD">633807</us-gaap:OtherAssetsCurrent>
  <us-gaap:OtherAssetsCurrent id="F_000017" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">91660</us-gaap:OtherAssetsCurrent>
  <us-gaap:MarketableSecuritiesCurrent id="F_000018" contextRef="C_0000879407_20140331" decimals="0" unitRef="U_iso4217USD">17798475</us-gaap:MarketableSecuritiesCurrent>
  <us-gaap:MarketableSecuritiesCurrent id="F_000019" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">9030261</us-gaap:MarketableSecuritiesCurrent>
  <us-gaap:AssetsCurrent id="F_000020" contextRef="C_0000879407_20140331" decimals="0" unitRef="U_iso4217USD">161923165</us-gaap:AssetsCurrent>
  <us-gaap:AssetsCurrent id="F_000021" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">28843719</us-gaap:AssetsCurrent>
  <us-gaap:PropertyPlantAndEquipmentNet id="F_000022" contextRef="C_0000879407_20140331" decimals="0" unitRef="U_iso4217USD">3290270</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:PropertyPlantAndEquipmentNet id="F_000023" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">3513235</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:FiniteLivedIntangibleAssetsGross id="F_000024" contextRef="C_0000879407_20140331" decimals="0" unitRef="U_iso4217USD">3213186</us-gaap:FiniteLivedIntangibleAssetsGross>
  <us-gaap:FiniteLivedIntangibleAssetsGross id="F_000025" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">3240513</us-gaap:FiniteLivedIntangibleAssetsGross>
  <us-gaap:InvestmentOwnedAtCost id="F_000026" contextRef="C_0000879407_20140331" decimals="0" unitRef="U_iso4217USD">34048359</us-gaap:InvestmentOwnedAtCost>
  <us-gaap:InvestmentOwnedAtCost id="F_000027" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">1702153</us-gaap:InvestmentOwnedAtCost>
  <us-gaap:OtherAssetsMiscellaneousNoncurrent id="F_000028" contextRef="C_0000879407_20140331" decimals="0" unitRef="U_iso4217USD">166414</us-gaap:OtherAssetsMiscellaneousNoncurrent>
  <us-gaap:OtherAssetsMiscellaneousNoncurrent id="F_000029" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">30011</us-gaap:OtherAssetsMiscellaneousNoncurrent>
  <us-gaap:Assets id="F_000030" contextRef="C_0000879407_20140331" decimals="0" unitRef="U_iso4217USD">202641394</us-gaap:Assets>
  <us-gaap:Assets id="F_000031" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">37329631</us-gaap:Assets>
  <us-gaap:AccountsPayableCurrent id="F_000032" contextRef="C_0000879407_20140331" decimals="0" unitRef="U_iso4217USD">2511572</us-gaap:AccountsPayableCurrent>
  <us-gaap:AccountsPayableCurrent id="F_000033" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">1199632</us-gaap:AccountsPayableCurrent>
  <us-gaap:AccruedLiabilitiesCurrent id="F_000034" contextRef="C_0000879407_20140331" decimals="0" unitRef="U_iso4217USD">913856</us-gaap:AccruedLiabilitiesCurrent>
  <us-gaap:AccruedLiabilitiesCurrent id="F_000035" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">638884</us-gaap:AccruedLiabilitiesCurrent>
  <us-gaap:EmployeeRelatedLiabilitiesCurrent id="F_000036" contextRef="C_0000879407_20140331" decimals="0" unitRef="U_iso4217USD">732131</us-gaap:EmployeeRelatedLiabilitiesCurrent>
  <us-gaap:EmployeeRelatedLiabilitiesCurrent id="F_000037" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">905771</us-gaap:EmployeeRelatedLiabilitiesCurrent>
  <us-gaap:DeferredRevenueCurrent id="F_000038" contextRef="C_0000879407_20140331" decimals="0" unitRef="U_iso4217USD">65625</us-gaap:DeferredRevenueCurrent>
  <us-gaap:DeferredRevenueCurrent id="F_000039" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">103125</us-gaap:DeferredRevenueCurrent>
  <us-gaap:DerivativeLiabilitiesCurrent id="F_000040" contextRef="C_0000879407_20140331" decimals="0" unitRef="U_iso4217USD">4936530</us-gaap:DerivativeLiabilitiesCurrent>
  <us-gaap:DerivativeLiabilitiesCurrent id="F_000041" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">4096363</us-gaap:DerivativeLiabilitiesCurrent>
  <us-gaap:CapitalLeaseObligationsCurrent id="F_000042" contextRef="C_0000879407_20140331" decimals="0" unitRef="U_iso4217USD">212234</us-gaap:CapitalLeaseObligationsCurrent>
  <us-gaap:CapitalLeaseObligationsCurrent id="F_000043" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">221345</us-gaap:CapitalLeaseObligationsCurrent>
  <us-gaap:NotesPayableCurrent id="F_000044" contextRef="C_0000879407_20140331" decimals="0" unitRef="U_iso4217USD">1050000</us-gaap:NotesPayableCurrent>
  <us-gaap:NotesPayableCurrent id="F_000045" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">971557</us-gaap:NotesPayableCurrent>
  <us-gaap:OtherLiabilitiesCurrent id="F_000046" contextRef="C_0000879407_20140331" decimals="0" unitRef="U_iso4217USD">60592</us-gaap:OtherLiabilitiesCurrent>
  <us-gaap:OtherLiabilitiesCurrent id="F_000047" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">588343</us-gaap:OtherLiabilitiesCurrent>
  <us-gaap:LiabilitiesCurrent id="F_000048" contextRef="C_0000879407_20140331" decimals="0" unitRef="U_iso4217USD">10482540</us-gaap:LiabilitiesCurrent>
  <us-gaap:LiabilitiesCurrent id="F_000049" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">8725020</us-gaap:LiabilitiesCurrent>
  <us-gaap:LongTermNotesPayable id="F_000050" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">50000</us-gaap:LongTermNotesPayable>
  <us-gaap:CapitalLeaseObligationsNoncurrent id="F_000051" contextRef="C_0000879407_20140331" decimals="0" unitRef="U_iso4217USD">865777</us-gaap:CapitalLeaseObligationsNoncurrent>
  <us-gaap:CapitalLeaseObligationsNoncurrent id="F_000052" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">1061113</us-gaap:CapitalLeaseObligationsNoncurrent>
  <us-gaap:OtherLiabilitiesNoncurrent id="F_000053" contextRef="C_0000879407_20140331" decimals="0" unitRef="U_iso4217USD">1755520</us-gaap:OtherLiabilitiesNoncurrent>
  <us-gaap:OtherLiabilitiesNoncurrent id="F_000054" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">1758709</us-gaap:OtherLiabilitiesNoncurrent>
  <us-gaap:LiabilitiesNoncurrent id="F_000055" contextRef="C_0000879407_20140331" decimals="0" unitRef="U_iso4217USD">2621297</us-gaap:LiabilitiesNoncurrent>
  <us-gaap:LiabilitiesNoncurrent id="F_000056" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">2869822</us-gaap:LiabilitiesNoncurrent>
  <us-gaap:CommitmentsAndContingencies id="F_000057" xsi:nil="true" contextRef="C_0000879407_20140331" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:CommitmentsAndContingencies id="F_000058" xsi:nil="true" contextRef="C_0000879407_20130930" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:PreferredStockValue id="F_000059" contextRef="C_0000879407_20140331" decimals="0" unitRef="U_iso4217USD">21</us-gaap:PreferredStockValue>
  <us-gaap:PreferredStockValue id="F_000060" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">10</us-gaap:PreferredStockValue>
  <us-gaap:CommonStockValue id="F_000061" contextRef="C_0000879407_20140331" decimals="0" unitRef="U_iso4217USD">144237</us-gaap:CommonStockValue>
  <us-gaap:CommonStockValue id="F_000062" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">124859</us-gaap:CommonStockValue>
  <us-gaap:AdditionalPaidInCapitalCommonStock id="F_000063" contextRef="C_0000879407_20140331" decimals="0" unitRef="U_iso4217USD">381966576</us-gaap:AdditionalPaidInCapitalCommonStock>
  <us-gaap:AdditionalPaidInCapitalCommonStock id="F_000064" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">193514766</us-gaap:AdditionalPaidInCapitalCommonStock>
  <us-gaap:RetainedEarningsAccumulatedDeficit id="F_000065" contextRef="C_0000879407_20140331" decimals="0" unitRef="U_iso4217USD">-190711800</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:RetainedEarningsAccumulatedDeficit id="F_000066" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">-166140969</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:StockholdersEquity id="F_000067" contextRef="C_0000879407_20140331" decimals="0" unitRef="U_iso4217USD">191399034</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="F_000068" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">27498666</us-gaap:StockholdersEquity>
  <us-gaap:MinorityInterest id="F_000069" contextRef="C_0000879407_20140331" decimals="0" unitRef="U_iso4217USD">-1861477</us-gaap:MinorityInterest>
  <us-gaap:MinorityInterest id="F_000070" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">-1763877</us-gaap:MinorityInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000071" contextRef="C_0000879407_20140331" decimals="0" unitRef="U_iso4217USD">189537557</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000072" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">25734789</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:LiabilitiesAndStockholdersEquity id="F_000073" contextRef="C_0000879407_20140331" decimals="0" unitRef="U_iso4217USD">202641394</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:LiabilitiesAndStockholdersEquity id="F_000074" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">37329631</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:PreferredStockParOrStatedValuePerShare id="F_000075" contextRef="C_0000879407_20140331" decimals="INF" unitRef="U_iso4217USD_shares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockParOrStatedValuePerShare id="F_000076" contextRef="C_0000879407_20130930" decimals="INF" unitRef="U_iso4217USD_shares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockSharesAuthorized id="F_000077" contextRef="C_0000879407_20140331" decimals="INF" unitRef="U_shares">5000000</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:PreferredStockSharesAuthorized id="F_000078" contextRef="C_0000879407_20130930" decimals="INF" unitRef="U_shares">5000000</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:PreferredStockSharesIssued id="F_000079" contextRef="C_0000879407_20140331" decimals="INF" unitRef="U_shares">21291</us-gaap:PreferredStockSharesIssued>
  <us-gaap:PreferredStockSharesIssued id="F_000080" contextRef="C_0000879407_20130930" decimals="INF" unitRef="U_shares">9900</us-gaap:PreferredStockSharesIssued>
  <us-gaap:PreferredStockSharesOutstanding id="F_000081" contextRef="C_0000879407_20140331" decimals="INF" unitRef="U_shares">21291</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:PreferredStockSharesOutstanding id="F_000082" contextRef="C_0000879407_20130930" decimals="INF" unitRef="U_shares">9900</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:CommonStockParOrStatedValuePerShare id="F_000083" contextRef="C_0000879407_20140331" decimals="INF" unitRef="U_iso4217USD_shares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockParOrStatedValuePerShare id="F_000084" contextRef="C_0000879407_20130930" decimals="INF" unitRef="U_iso4217USD_shares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockSharesAuthorized id="F_000085" contextRef="C_0000879407_20140331" decimals="INF" unitRef="U_shares">145000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockSharesAuthorized id="F_000086" contextRef="C_0000879407_20130930" decimals="INF" unitRef="U_shares">145000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockSharesIssued id="F_000087" contextRef="C_0000879407_20140331" decimals="INF" unitRef="U_shares">51867071</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesIssued id="F_000088" contextRef="C_0000879407_20130930" decimals="INF" unitRef="U_shares">32489444</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesOutstanding id="F_000089" contextRef="C_0000879407_20140331" decimals="INF" unitRef="U_shares">51867071</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:CommonStockSharesOutstanding id="F_000090" contextRef="C_0000879407_20130930" decimals="INF" unitRef="U_shares">32489444</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:Revenues id="F_000091" contextRef="C_0000879407_20140101_20140331" decimals="0" unitRef="U_iso4217USD">43750</us-gaap:Revenues>
  <us-gaap:Revenues id="F_000092" contextRef="C_0000879407_20130101_20130331" decimals="0" unitRef="U_iso4217USD">43750</us-gaap:Revenues>
  <us-gaap:Revenues id="F_000093" contextRef="C_0000879407_20131001_20140331" decimals="0" unitRef="U_iso4217USD">87500</us-gaap:Revenues>
  <us-gaap:Revenues id="F_000094" contextRef="C_0000879407_20121001_20130331" decimals="0" unitRef="U_iso4217USD">202766</us-gaap:Revenues>
  <us-gaap:Revenues id="F_000095" contextRef="C_0000879407_20030501_20140331" decimals="0" unitRef="U_iso4217USD">4516600</us-gaap:Revenues>
  <us-gaap:LaborAndRelatedExpense id="F_000096" contextRef="C_0000879407_20140101_20140331" decimals="0" unitRef="U_iso4217USD">3097902</us-gaap:LaborAndRelatedExpense>
  <us-gaap:LaborAndRelatedExpense id="F_000097" contextRef="C_0000879407_20130101_20130331" decimals="0" unitRef="U_iso4217USD">1725176</us-gaap:LaborAndRelatedExpense>
  <us-gaap:LaborAndRelatedExpense id="F_000098" contextRef="C_0000879407_20131001_20140331" decimals="0" unitRef="U_iso4217USD">5179693</us-gaap:LaborAndRelatedExpense>
  <us-gaap:LaborAndRelatedExpense id="F_000099" contextRef="C_0000879407_20121001_20130331" decimals="0" unitRef="U_iso4217USD">3354599</us-gaap:LaborAndRelatedExpense>
  <us-gaap:LaborAndRelatedExpense id="F_000100" contextRef="C_0000879407_20030501_20140331" decimals="0" unitRef="U_iso4217USD">38239492</us-gaap:LaborAndRelatedExpense>
  <us-gaap:GeneralAndAdministrativeExpense id="F_000101" contextRef="C_0000879407_20140101_20140331" decimals="0" unitRef="U_iso4217USD">1347677</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:GeneralAndAdministrativeExpense id="F_000102" contextRef="C_0000879407_20130101_20130331" decimals="0" unitRef="U_iso4217USD">779970</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:GeneralAndAdministrativeExpense id="F_000103" contextRef="C_0000879407_20131001_20140331" decimals="0" unitRef="U_iso4217USD">2261461</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:GeneralAndAdministrativeExpense id="F_000104" contextRef="C_0000879407_20121001_20130331" decimals="0" unitRef="U_iso4217USD">1697646</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:GeneralAndAdministrativeExpense id="F_000105" contextRef="C_0000879407_20030501_20140331" decimals="0" unitRef="U_iso4217USD">37103540</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:ResearchAndDevelopmentExpense id="F_000106" contextRef="C_0000879407_20140101_20140331" decimals="0" unitRef="U_iso4217USD">5216446</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:ResearchAndDevelopmentExpense id="F_000107" contextRef="C_0000879407_20130101_20130331" decimals="0" unitRef="U_iso4217USD">2125019</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:ResearchAndDevelopmentExpense id="F_000108" contextRef="C_0000879407_20131001_20140331" decimals="0" unitRef="U_iso4217USD">8349460</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:ResearchAndDevelopmentExpense id="F_000109" contextRef="C_0000879407_20121001_20130331" decimals="0" unitRef="U_iso4217USD">3701685</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:ResearchAndDevelopmentExpense id="F_000110" contextRef="C_0000879407_20030501_20140331" decimals="0" unitRef="U_iso4217USD">59673835</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:ShareBasedCompensation id="F_000111" contextRef="C_0000879407_20140101_20140331" decimals="0" unitRef="U_iso4217USD">1198444</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation id="F_000112" contextRef="C_0000879407_20130101_20130331" decimals="0" unitRef="U_iso4217USD">355108</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation id="F_000113" contextRef="C_0000879407_20131001_20140331" decimals="0" unitRef="U_iso4217USD">1719582</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation id="F_000114" contextRef="C_0000879407_20121001_20130331" decimals="0" unitRef="U_iso4217USD">750782</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation id="F_000115" contextRef="C_0000879407_20030501_20140331" decimals="0" unitRef="U_iso4217USD">16837321</us-gaap:ShareBasedCompensation>
  <us-gaap:DepreciationDepletionAndAmortization id="F_000116" contextRef="C_0000879407_20140101_20140331" decimals="0" unitRef="U_iso4217USD">395779</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:DepreciationDepletionAndAmortization id="F_000117" contextRef="C_0000879407_20130101_20130331" decimals="0" unitRef="U_iso4217USD">448765</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:DepreciationDepletionAndAmortization id="F_000118" contextRef="C_0000879407_20131001_20140331" decimals="0" unitRef="U_iso4217USD">799184</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:DepreciationDepletionAndAmortization id="F_000119" contextRef="C_0000879407_20121001_20130331" decimals="0" unitRef="U_iso4217USD">898362</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:DepreciationDepletionAndAmortization id="F_000120" contextRef="C_0000879407_20030501_20140331" decimals="0" unitRef="U_iso4217USD">9959882</us-gaap:DepreciationDepletionAndAmortization>
  <arwr:ImpairmentOfIntangibleAssets id="F_000121" contextRef="C_0000879407_20030501_20140331" decimals="0" unitRef="U_iso4217USD">1308047</arwr:ImpairmentOfIntangibleAssets>
  <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 id="F_000122" contextRef="C_0000879407_20030501_20140331" decimals="0" unitRef="U_iso4217USD">1421652</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
  <us-gaap:OperatingExpenses id="F_000123" contextRef="C_0000879407_20140101_20140331" decimals="0" unitRef="U_iso4217USD">11256248</us-gaap:OperatingExpenses>
  <us-gaap:OperatingExpenses id="F_000124" contextRef="C_0000879407_20130101_20130331" decimals="0" unitRef="U_iso4217USD">5434038</us-gaap:OperatingExpenses>
  <us-gaap:OperatingExpenses id="F_000125" contextRef="C_0000879407_20131001_20140331" decimals="0" unitRef="U_iso4217USD">18309380</us-gaap:OperatingExpenses>
  <us-gaap:OperatingExpenses id="F_000126" contextRef="C_0000879407_20121001_20130331" decimals="0" unitRef="U_iso4217USD">10403074</us-gaap:OperatingExpenses>
  <us-gaap:OperatingExpenses id="F_000127" contextRef="C_0000879407_20030501_20140331" decimals="0" unitRef="U_iso4217USD">164543769</us-gaap:OperatingExpenses>
  <us-gaap:OperatingIncomeLoss id="F_000128" contextRef="C_0000879407_20140101_20140331" decimals="0" unitRef="U_iso4217USD">-11212498</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss id="F_000129" contextRef="C_0000879407_20130101_20130331" decimals="0" unitRef="U_iso4217USD">-5390288</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss id="F_000130" contextRef="C_0000879407_20131001_20140331" decimals="0" unitRef="U_iso4217USD">-18221880</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss id="F_000131" contextRef="C_0000879407_20121001_20130331" decimals="0" unitRef="U_iso4217USD">-10200308</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss id="F_000132" contextRef="C_0000879407_20030501_20140331" decimals="0" unitRef="U_iso4217USD">-160027169</us-gaap:OperatingIncomeLoss>
  <us-gaap:IncomeLossFromEquityMethodInvestments id="F_000133" contextRef="C_0000879407_20140101_20140331" decimals="0" unitRef="U_iso4217USD">-9597</us-gaap:IncomeLossFromEquityMethodInvestments>
  <us-gaap:IncomeLossFromEquityMethodInvestments id="F_000134" contextRef="C_0000879407_20130101_20130331" decimals="0" unitRef="U_iso4217USD">-157612</us-gaap:IncomeLossFromEquityMethodInvestments>
  <us-gaap:IncomeLossFromEquityMethodInvestments id="F_000135" contextRef="C_0000879407_20131001_20140331" decimals="0" unitRef="U_iso4217USD">-148053</us-gaap:IncomeLossFromEquityMethodInvestments>
  <us-gaap:IncomeLossFromEquityMethodInvestments id="F_000136" contextRef="C_0000879407_20121001_20130331" decimals="0" unitRef="U_iso4217USD">-221169</us-gaap:IncomeLossFromEquityMethodInvestments>
  <us-gaap:IncomeLossFromEquityMethodInvestments id="F_000137" contextRef="C_0000879407_20030501_20140331" decimals="0" unitRef="U_iso4217USD">-1752601</us-gaap:IncomeLossFromEquityMethodInvestments>
  <us-gaap:ImpairmentOfInvestments id="F_000138" contextRef="C_0000879407_20030501_20140331" decimals="0" unitRef="U_iso4217USD">1642775</us-gaap:ImpairmentOfInvestments>
  <arwr:GainOnAcquisition id="F_000139" contextRef="C_0000879407_20030501_20140331" decimals="0" unitRef="U_iso4217USD">1576107</arwr:GainOnAcquisition>
  <us-gaap:GainLossOnSaleOfPropertyPlantEquipment id="F_000140" contextRef="C_0000879407_20140101_20140331" decimals="0" unitRef="U_iso4217USD">-5316</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
  <us-gaap:GainLossOnSaleOfPropertyPlantEquipment id="F_000141" contextRef="C_0000879407_20130101_20130331" decimals="0" unitRef="U_iso4217USD">-54932</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
  <us-gaap:GainLossOnSaleOfPropertyPlantEquipment id="F_000142" contextRef="C_0000879407_20131001_20140331" decimals="0" unitRef="U_iso4217USD">-58878</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
  <us-gaap:GainLossOnSaleOfPropertyPlantEquipment id="F_000143" contextRef="C_0000879407_20121001_20130331" decimals="0" unitRef="U_iso4217USD">-36440</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
  <us-gaap:GainLossOnSaleOfPropertyPlantEquipment id="F_000144" contextRef="C_0000879407_20030501_20140331" decimals="0" unitRef="U_iso4217USD">-1341731</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
  <us-gaap:MarketableSecuritiesGainLoss id="F_000145" contextRef="C_0000879407_20030501_20140331" decimals="0" unitRef="U_iso4217USD">62954</us-gaap:MarketableSecuritiesGainLoss>
  <us-gaap:InterestIncomeExpenseNet id="F_000146" contextRef="C_0000879407_20140101_20140331" decimals="0" unitRef="U_iso4217USD">119390</us-gaap:InterestIncomeExpenseNet>
  <us-gaap:InterestIncomeExpenseNet id="F_000147" contextRef="C_0000879407_20130101_20130331" decimals="0" unitRef="U_iso4217USD">-27567</us-gaap:InterestIncomeExpenseNet>
  <us-gaap:InterestIncomeExpenseNet id="F_000148" contextRef="C_0000879407_20131001_20140331" decimals="0" unitRef="U_iso4217USD">159968</us-gaap:InterestIncomeExpenseNet>
  <us-gaap:InterestIncomeExpenseNet id="F_000149" contextRef="C_0000879407_20121001_20130331" decimals="0" unitRef="U_iso4217USD">-20151</us-gaap:InterestIncomeExpenseNet>
  <us-gaap:InterestIncomeExpenseNet id="F_000150" contextRef="C_0000879407_20030501_20140331" decimals="0" unitRef="U_iso4217USD">2812502</us-gaap:InterestIncomeExpenseNet>
  <us-gaap:UnrealizedGainLossOnDerivatives id="F_000151" contextRef="C_0000879407_20140101_20140331" decimals="0" unitRef="U_iso4217USD">-2951225</us-gaap:UnrealizedGainLossOnDerivatives>
  <us-gaap:UnrealizedGainLossOnDerivatives id="F_000152" contextRef="C_0000879407_20130101_20130331" decimals="0" unitRef="U_iso4217USD">-29403</us-gaap:UnrealizedGainLossOnDerivatives>
  <us-gaap:UnrealizedGainLossOnDerivatives id="F_000153" contextRef="C_0000879407_20131001_20140331" decimals="0" unitRef="U_iso4217USD">-6470803</us-gaap:UnrealizedGainLossOnDerivatives>
  <us-gaap:UnrealizedGainLossOnDerivatives id="F_000154" contextRef="C_0000879407_20121001_20130331" decimals="0" unitRef="U_iso4217USD">14873</us-gaap:UnrealizedGainLossOnDerivatives>
  <us-gaap:UnrealizedGainLossOnDerivatives id="F_000155" contextRef="C_0000879407_20030501_20140331" decimals="0" unitRef="U_iso4217USD">-8489788</us-gaap:UnrealizedGainLossOnDerivatives>
  <arwr:GainLossOnSaleOfStockInSubsidiary id="F_000156" contextRef="C_0000879407_20030501_20140331" decimals="0" unitRef="U_iso4217USD">2292800</arwr:GainLossOnSaleOfStockInSubsidiary>
  <us-gaap:OtherNonoperatingIncomeExpense id="F_000157" contextRef="C_0000879407_20140101_20140331" decimals="0" unitRef="U_iso4217USD">76546</us-gaap:OtherNonoperatingIncomeExpense>
  <us-gaap:OtherNonoperatingIncomeExpense id="F_000158" contextRef="C_0000879407_20130101_20130331" decimals="0" unitRef="U_iso4217USD">-1279881</us-gaap:OtherNonoperatingIncomeExpense>
  <us-gaap:OtherNonoperatingIncomeExpense id="F_000159" contextRef="C_0000879407_20131001_20140331" decimals="0" unitRef="U_iso4217USD">71215</us-gaap:OtherNonoperatingIncomeExpense>
  <us-gaap:OtherNonoperatingIncomeExpense id="F_000160" contextRef="C_0000879407_20121001_20130331" decimals="0" unitRef="U_iso4217USD">-1257196</us-gaap:OtherNonoperatingIncomeExpense>
  <us-gaap:OtherNonoperatingIncomeExpense id="F_000161" contextRef="C_0000879407_20030501_20140331" decimals="0" unitRef="U_iso4217USD">-676760</us-gaap:OtherNonoperatingIncomeExpense>
  <us-gaap:NonoperatingIncomeExpense id="F_000162" contextRef="C_0000879407_20140101_20140331" decimals="0" unitRef="U_iso4217USD">-2770202</us-gaap:NonoperatingIncomeExpense>
  <us-gaap:NonoperatingIncomeExpense id="F_000163" contextRef="C_0000879407_20130101_20130331" decimals="0" unitRef="U_iso4217USD">-1549395</us-gaap:NonoperatingIncomeExpense>
  <us-gaap:NonoperatingIncomeExpense id="F_000164" contextRef="C_0000879407_20131001_20140331" decimals="0" unitRef="U_iso4217USD">-6446551</us-gaap:NonoperatingIncomeExpense>
  <us-gaap:NonoperatingIncomeExpense id="F_000165" contextRef="C_0000879407_20121001_20130331" decimals="0" unitRef="U_iso4217USD">-1520083</us-gaap:NonoperatingIncomeExpense>
  <us-gaap:NonoperatingIncomeExpense id="F_000166" contextRef="C_0000879407_20030501_20140331" decimals="0" unitRef="U_iso4217USD">-7159292</us-gaap:NonoperatingIncomeExpense>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest id="F_000167" contextRef="C_0000879407_20140101_20140331" decimals="0" unitRef="U_iso4217USD">-13982700</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest id="F_000168" contextRef="C_0000879407_20130101_20130331" decimals="0" unitRef="U_iso4217USD">-6939683</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest id="F_000169" contextRef="C_0000879407_20131001_20140331" decimals="0" unitRef="U_iso4217USD">-24668431</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest id="F_000170" contextRef="C_0000879407_20121001_20130331" decimals="0" unitRef="U_iso4217USD">-11720391</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest id="F_000171" contextRef="C_0000879407_20030501_20140331" decimals="0" unitRef="U_iso4217USD">-167186461</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
  <us-gaap:IncomeTaxExpenseBenefit id="F_000172" xsi:nil="true" contextRef="C_0000879407_20140101_20140331" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:IncomeTaxExpenseBenefit id="F_000173" xsi:nil="true" contextRef="C_0000879407_20130101_20130331" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:IncomeTaxExpenseBenefit id="F_000174" xsi:nil="true" contextRef="C_0000879407_20131001_20140331" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:IncomeTaxExpenseBenefit id="F_000175" xsi:nil="true" contextRef="C_0000879407_20121001_20130331" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:IncomeTaxExpenseBenefit id="F_000176" xsi:nil="true" contextRef="C_0000879407_20030501_20140331" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest id="F_000177" contextRef="C_0000879407_20140101_20140331" decimals="0" unitRef="U_iso4217USD">-13982700</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest id="F_000178" contextRef="C_0000879407_20130101_20130331" decimals="0" unitRef="U_iso4217USD">-6939683</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest id="F_000179" contextRef="C_0000879407_20131001_20140331" decimals="0" unitRef="U_iso4217USD">-24668431</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest id="F_000180" contextRef="C_0000879407_20121001_20130331" decimals="0" unitRef="U_iso4217USD">-11720391</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest id="F_000181" contextRef="C_0000879407_20030501_20140331" decimals="0" unitRef="U_iso4217USD">-167186461</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax id="F_000182" contextRef="C_0000879407_20130101_20130331" decimals="0" unitRef="U_iso4217USD">-336</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax>
  <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax id="F_000183" contextRef="C_0000879407_20121001_20130331" decimals="0" unitRef="U_iso4217USD">-354</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax>
  <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax id="F_000184" contextRef="C_0000879407_20030501_20140331" decimals="0" unitRef="U_iso4217USD">-47546996</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax>
  <us-gaap:DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax id="F_000185" contextRef="C_0000879407_20030501_20140331" decimals="0" unitRef="U_iso4217USD">4708588</us-gaap:DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax>
  <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax id="F_000186" contextRef="C_0000879407_20130101_20130331" decimals="0" unitRef="U_iso4217USD">-336</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
  <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax id="F_000187" contextRef="C_0000879407_20121001_20130331" decimals="0" unitRef="U_iso4217USD">-354</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
  <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax id="F_000188" contextRef="C_0000879407_20030501_20140331" decimals="0" unitRef="U_iso4217USD">-42838408</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
  <us-gaap:ProfitLoss id="F_000189" contextRef="C_0000879407_20140101_20140331" decimals="0" unitRef="U_iso4217USD">-13982700</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss id="F_000190" contextRef="C_0000879407_20130101_20130331" decimals="0" unitRef="U_iso4217USD">-6940019</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss id="F_000191" contextRef="C_0000879407_20131001_20140331" decimals="0" unitRef="U_iso4217USD">-24668431</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss id="F_000192" contextRef="C_0000879407_20121001_20130331" decimals="0" unitRef="U_iso4217USD">-11720745</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss id="F_000193" contextRef="C_0000879407_20030501_20140331" decimals="0" unitRef="U_iso4217USD">-210024869</us-gaap:ProfitLoss>
  <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest id="F_000194" contextRef="C_0000879407_20140101_20140331" decimals="0" unitRef="U_iso4217USD">-40179</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
  <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest id="F_000195" contextRef="C_0000879407_20130101_20130331" decimals="0" unitRef="U_iso4217USD">-182082</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
  <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest id="F_000196" contextRef="C_0000879407_20131001_20140331" decimals="0" unitRef="U_iso4217USD">-97600</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
  <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest id="F_000197" contextRef="C_0000879407_20121001_20130331" decimals="0" unitRef="U_iso4217USD">-348650</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
  <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest id="F_000198" contextRef="C_0000879407_20030501_20140331" decimals="0" unitRef="U_iso4217USD">-19477029</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
  <us-gaap:NetIncomeLoss id="F_000199" contextRef="C_0000879407_20140101_20140331" decimals="0" unitRef="U_iso4217USD">-13942521</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss id="F_000200" contextRef="C_0000879407_20130101_20130331" decimals="0" unitRef="U_iso4217USD">-6757937</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss id="F_000201" contextRef="C_0000879407_20131001_20140331" decimals="0" unitRef="U_iso4217USD">-24570831</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss id="F_000202" contextRef="C_0000879407_20121001_20130331" decimals="0" unitRef="U_iso4217USD">-11372095</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss id="F_000203" contextRef="C_0000879407_20030501_20140331" decimals="0" unitRef="U_iso4217USD">-190547840</us-gaap:NetIncomeLoss>
  <us-gaap:EarningsPerShareBasicAndDiluted id="F_000204" contextRef="C_0000879407_20140101_20140331" decimals="2" unitRef="U_iso4217USD_shares">-0.31</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:EarningsPerShareBasicAndDiluted id="F_000205" contextRef="C_0000879407_20130101_20130331" decimals="2" unitRef="U_iso4217USD_shares">-0.41</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:EarningsPerShareBasicAndDiluted id="F_000206" contextRef="C_0000879407_20131001_20140331" decimals="2" unitRef="U_iso4217USD_shares">-0.60</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:EarningsPerShareBasicAndDiluted id="F_000207" contextRef="C_0000879407_20121001_20130331" decimals="2" unitRef="U_iso4217USD_shares">-0.74</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted id="F_000208" contextRef="C_0000879407_20140101_20140331" decimals="0" unitRef="U_shares">44321847</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted id="F_000209" contextRef="C_0000879407_20130101_20130331" decimals="0" unitRef="U_shares">16461693</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted id="F_000210" contextRef="C_0000879407_20131001_20140331" decimals="0" unitRef="U_shares">40941903</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted id="F_000211" contextRef="C_0000879407_20121001_20130331" decimals="0" unitRef="U_shares">15272703</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000212" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20020930" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000213" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20020930" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000214" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20020930" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000215" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20020930" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000216" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20020930" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000217" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20020930" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000218" xsi:nil="true" contextRef="C_0000879407_20020930" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000219" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtZeroPointZeroOneDollarsPerUnitMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20021001_20030930" decimals="INF" unitRef="U_shares">300000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000220" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtZeroPointZeroOneDollarsPerUnitMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20021001_20030930" decimals="0" unitRef="U_iso4217USD">3000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000221" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtZeroPointZeroOneDollarsPerUnitMember_20021001_20030930" decimals="0" unitRef="U_iso4217USD">3000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000222" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtTenDollarPerUnitMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20021001_20030930" decimals="INF" unitRef="U_shares">168000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000223" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtTenDollarPerUnitMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20021001_20030930" decimals="0" unitRef="U_iso4217USD">1680</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000224" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtTenDollarPerUnitMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20021001_20030930" decimals="0" unitRef="U_iso4217USD">1678320</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000225" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtTenDollarPerUnitMember_20021001_20030930" decimals="0" unitRef="U_iso4217USD">1680000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts id="F_000226" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrStockIssuanceCostChargedToAdditionalPaidInCapitalMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20021001_20030930" decimals="0" unitRef="U_iso4217USD">168000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts id="F_000227" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrStockIssuanceCostChargedToAdditionalPaidInCapitalMember_20021001_20030930" decimals="0" unitRef="U_iso4217USD">168000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
  <us-gaap:ProfitLoss id="F_000228" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20021001_20030930" decimals="0" unitRef="U_iso4217USD">-95238</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss id="F_000229" contextRef="C_0000879407_20021001_20030930" decimals="0" unitRef="U_iso4217USD">-95238</us-gaap:ProfitLoss>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000230" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20030930" decimals="0" unitRef="U_iso4217USD">4680</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000231" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20030930" decimals="0" unitRef="U_iso4217USD">1510320</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000232" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20030930" decimals="0" unitRef="U_iso4217USD">-95238</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000233" contextRef="C_0000879407_20030930" decimals="0" unitRef="U_iso4217USD">1419762</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:SharesIssued id="F_000234" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20030930" decimals="INF" unitRef="U_shares">468000</us-gaap:SharesIssued>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised id="F_000235" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20031001_20040930" decimals="INF" unitRef="U_shares">7500</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000236" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20031001_20040930" decimals="0" unitRef="U_iso4217USD">75</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000237" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20031001_20040930" decimals="0" unitRef="U_iso4217USD">14925</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000238" contextRef="C_0000879407_20031001_20040930" decimals="0" unitRef="U_iso4217USD">15000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000239" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtTenDollarPerUnitMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20031001_20040930" decimals="INF" unitRef="U_shares">47500</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000240" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtTenDollarPerUnitMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20031001_20040930" decimals="0" unitRef="U_iso4217USD">475</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000241" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtTenDollarPerUnitMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20031001_20040930" decimals="0" unitRef="U_iso4217USD">474525</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000242" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtTenDollarPerUnitMember_20031001_20040930" decimals="0" unitRef="U_iso4217USD">475000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000243" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForMarketableSecuritiesAtTenDollarPerUnitMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20031001_20040930" decimals="INF" unitRef="U_shares">50000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000244" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForMarketableSecuritiesAtTenDollarPerUnitMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20031001_20040930" decimals="0" unitRef="U_iso4217USD">500</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000245" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForMarketableSecuritiesAtTenDollarPerUnitMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20031001_20040930" decimals="0" unitRef="U_iso4217USD">499500</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000246" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForMarketableSecuritiesAtTenDollarPerUnitMember_20031001_20040930" decimals="0" unitRef="U_iso4217USD">500000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts id="F_000247" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrStockIssuanceCostChargedToAdditionalPaidInCapitalMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20031001_20040930" decimals="0" unitRef="U_iso4217USD">96500</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts id="F_000248" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrStockIssuanceCostChargedToAdditionalPaidInCapitalMember_20031001_20040930" decimals="0" unitRef="U_iso4217USD">96500</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000249" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtFifteenDollarPerUnitMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20031001_20040930" decimals="INF" unitRef="U_shares">660879</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000250" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtFifteenDollarPerUnitMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20031001_20040930" decimals="0" unitRef="U_iso4217USD">6609</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000251" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtFifteenDollarPerUnitMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20031001_20040930" decimals="0" unitRef="U_iso4217USD">9906573</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000252" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtFifteenDollarPerUnitMember_20031001_20040930" decimals="0" unitRef="U_iso4217USD">9913182</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000253" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_us-gaapEquityIssuedInBusinessCombinationMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20031001_20040930" decimals="INF" unitRef="U_shares">70553</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000254" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_us-gaapEquityIssuedInBusinessCombinationMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20031001_20040930" decimals="0" unitRef="U_iso4217USD">706</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000255" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_us-gaapEquityIssuedInBusinessCombinationMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20031001_20040930" decimals="0" unitRef="U_iso4217USD">-151175</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000256" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_us-gaapEquityIssuedInBusinessCombinationMember_20031001_20040930" decimals="0" unitRef="U_iso4217USD">-150469</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000257" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAsGiftForTenDollarAndNinetyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20031001_20040930" decimals="INF" unitRef="U_shares">15000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000258" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAsGiftForTenDollarAndNinetyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20031001_20040930" decimals="0" unitRef="U_iso4217USD">163</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000259" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAsGiftForTenDollarAndNinetyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20031001_20040930" decimals="0" unitRef="U_iso4217USD">162587</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000260" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAsGiftForTenDollarAndNinetyCentsPerShareMember_20031001_20040930" decimals="0" unitRef="U_iso4217USD">162750</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000261" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAsStockIssuanceCostAtFifteenDollarPerUnitMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20031001_20040930" decimals="INF" unitRef="U_shares">35623</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000262" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAsStockIssuanceCostAtFifteenDollarPerUnitMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20031001_20040930" decimals="0" unitRef="U_iso4217USD">356</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000263" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAsStockIssuanceCostAtFifteenDollarPerUnitMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20031001_20040930" decimals="0" unitRef="U_iso4217USD">533988</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000264" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAsStockIssuanceCostAtFifteenDollarPerUnitMember_20031001_20040930" decimals="0" unitRef="U_iso4217USD">534344</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts id="F_000265" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20031001_20040930" decimals="0" unitRef="U_iso4217USD">991318</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts id="F_000266" contextRef="C_0000879407_20031001_20040930" decimals="0" unitRef="U_iso4217USD">991318</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised id="F_000267" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtTwoDollarPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20031001_20040930" decimals="INF" unitRef="U_shares">7500</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000268" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtTwoDollarPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20031001_20040930" decimals="0" unitRef="U_iso4217USD">75</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000269" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtTwoDollarPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20031001_20040930" decimals="0" unitRef="U_iso4217USD">14925</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000270" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtTwoDollarPerShareMember_20031001_20040930" decimals="0" unitRef="U_iso4217USD">15000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised id="F_000271" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtTenDollarPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20031001_20040930" decimals="INF" unitRef="U_shares">600</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000272" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtTenDollarPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20031001_20040930" decimals="0" unitRef="U_iso4217USD">6</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000273" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtTenDollarPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20031001_20040930" decimals="0" unitRef="U_iso4217USD">5994</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000274" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtTenDollarPerShareMember_20031001_20040930" decimals="0" unitRef="U_iso4217USD">6000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="F_000275" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20031001_20040930" decimals="0" unitRef="U_iso4217USD">175653</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="F_000276" contextRef="C_0000879407_20031001_20040930" decimals="0" unitRef="U_iso4217USD">175653</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:ProfitLoss id="F_000277" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20031001_20040930" decimals="0" unitRef="U_iso4217USD">-2528954</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss id="F_000278" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20031001_20040930" decimals="0" unitRef="U_iso4217USD">1777699</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss id="F_000279" contextRef="C_0000879407_20031001_20040930" decimals="0" unitRef="U_iso4217USD">-751255</us-gaap:ProfitLoss>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000280" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20040930" decimals="0" unitRef="U_iso4217USD">13645</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000281" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20040930" decimals="0" unitRef="U_iso4217USD">12059997</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000282" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20040930" decimals="0" unitRef="U_iso4217USD">-2624192</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000283" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20040930" decimals="0" unitRef="U_iso4217USD">1777699</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000284" contextRef="C_0000879407_20040930" decimals="0" unitRef="U_iso4217USD">11227149</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:SharesIssued id="F_000285" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20040930" decimals="INF" unitRef="U_shares">1363155</us-gaap:SharesIssued>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised id="F_000286" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20041001_20050930" decimals="INF" unitRef="U_shares">1381289</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000287" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtFifteenDollarPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20041001_20050930" decimals="0" unitRef="U_iso4217USD">13813</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000288" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtFifteenDollarPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20041001_20050930" decimals="0" unitRef="U_iso4217USD">20705522</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000289" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtFifteenDollarPerShareMember_20041001_20050930" decimals="0" unitRef="U_iso4217USD">20719335</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised id="F_000290" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtFifteenDollarPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20041001_20050930" decimals="INF" unitRef="U_shares">2500</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000291" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtTenDollarPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20041001_20050930" decimals="0" unitRef="U_iso4217USD">25</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000292" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtTenDollarPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20041001_20050930" decimals="0" unitRef="U_iso4217USD">24975</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000293" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtTenDollarPerShareMember_20041001_20050930" decimals="0" unitRef="U_iso4217USD">25000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000294" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtTenDollarPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20041001_20050930" decimals="INF" unitRef="U_shares">50226</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000295" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToPurchaseInsertTherapeuticsShareAtThirtyNineDollarsAndEightyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20041001_20050930" decimals="0" unitRef="U_iso4217USD">502</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000296" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToPurchaseInsertTherapeuticsShareAtThirtyNineDollarsAndEightyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20041001_20050930" decimals="0" unitRef="U_iso4217USD">1999498</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000297" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToPurchaseInsertTherapeuticsShareAtThirtyNineDollarsAndEightyCentsPerShareMember_20041001_20050930" decimals="0" unitRef="U_iso4217USD">2000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000298" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToPurchaseInsertTherapeuticsShareAtThirtyNineDollarsAndEightyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20041001_20050930" decimals="INF" unitRef="U_shares">1250</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000299" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20041001_20050930" decimals="0" unitRef="U_iso4217USD">12</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000300" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20041001_20050930" decimals="0" unitRef="U_iso4217USD">49988</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000301" contextRef="C_0000879407_20041001_20050930" decimals="0" unitRef="U_iso4217USD">50000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="F_000302" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20041001_20050930" decimals="0" unitRef="U_iso4217USD">508513</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="F_000303" contextRef="C_0000879407_20041001_20050930" decimals="0" unitRef="U_iso4217USD">508513</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance id="F_000304" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20041001_20050930" decimals="0" unitRef="U_iso4217USD">230087</us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance>
  <us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance id="F_000305" contextRef="C_0000879407_20041001_20050930" decimals="0" unitRef="U_iso4217USD">230087</us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance>
  <us-gaap:ProfitLoss id="F_000306" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20041001_20050930" decimals="0" unitRef="U_iso4217USD">-6854918</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss id="F_000307" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20041001_20050930" decimals="0" unitRef="U_iso4217USD">121491</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss id="F_000308" contextRef="C_0000879407_20041001_20050930" decimals="0" unitRef="U_iso4217USD">-6733427</us-gaap:ProfitLoss>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000309" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20050930" decimals="0" unitRef="U_iso4217USD">27997</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000310" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20050930" decimals="0" unitRef="U_iso4217USD">35578580</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000311" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20050930" decimals="0" unitRef="U_iso4217USD">-9479110</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000312" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20050930" decimals="0" unitRef="U_iso4217USD">1899190</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000313" contextRef="C_0000879407_20050930" decimals="0" unitRef="U_iso4217USD">28026657</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:SharesIssued id="F_000314" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20050930" decimals="INF" unitRef="U_shares">2798419</us-gaap:SharesIssued>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised id="F_000315" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20051001_20060930" decimals="INF" unitRef="U_shares">11579</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000316" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20051001_20060930" decimals="0" unitRef="U_iso4217USD">116</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000317" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20051001_20060930" decimals="0" unitRef="U_iso4217USD">341421</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000318" contextRef="C_0000879407_20051001_20060930" decimals="0" unitRef="U_iso4217USD">341537</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000319" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFortyEightDollarsAndEightyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20051001_20060930" decimals="INF" unitRef="U_shares">20485</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000320" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFortyEightDollarsAndEightyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20051001_20060930" decimals="0" unitRef="U_iso4217USD">205</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000321" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFortyEightDollarsAndEightyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20051001_20060930" decimals="0" unitRef="U_iso4217USD">999795</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000322" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFortyEightDollarsAndEightyCentsPerShareMember_20051001_20060930" decimals="0" unitRef="U_iso4217USD">1000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000323" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThirtyEightDollarsAndFortyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20051001_20060930" decimals="INF" unitRef="U_shares">1500</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000324" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThirtyEightDollarsAndFortyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20051001_20060930" decimals="0" unitRef="U_iso4217USD">15</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000325" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThirtyEightDollarsAndFortyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20051001_20060930" decimals="0" unitRef="U_iso4217USD">57585</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000326" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThirtyEightDollarsAndFortyCentsPerShareMember_20051001_20060930" decimals="0" unitRef="U_iso4217USD">57600</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000327" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThirtyFiveDollarsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20051001_20060930" decimals="INF" unitRef="U_shares">559000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000328" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThirtyFiveDollarsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20051001_20060930" decimals="0" unitRef="U_iso4217USD">5590</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000329" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThirtyFiveDollarsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20051001_20060930" decimals="0" unitRef="U_iso4217USD">19539410</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000330" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThirtyFiveDollarsPerShareMember_20051001_20060930" decimals="0" unitRef="U_iso4217USD">19545000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000331" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiftyNineDollarsAndTenCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20051001_20060930" decimals="INF" unitRef="U_shares">2536</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000332" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiftyNineDollarsAndTenCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20051001_20060930" decimals="0" unitRef="U_iso4217USD">25</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000333" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiftyNineDollarsAndTenCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20051001_20060930" decimals="0" unitRef="U_iso4217USD">149975</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000334" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiftyNineDollarsAndTenCentsPerShareMember_20051001_20060930" decimals="0" unitRef="U_iso4217USD">150000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000335" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToPurchaseCalandoPharmaceuticalsIncAtFiftyOneDollarsAndSeventyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20051001_20060930" decimals="INF" unitRef="U_shares">20838</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000336" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToPurchaseCalandoPharmaceuticalsIncAtFiftyOneDollarsAndSeventyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20051001_20060930" decimals="0" unitRef="U_iso4217USD">208</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000337" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToPurchaseCalandoPharmaceuticalsIncAtFiftyOneDollarsAndSeventyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20051001_20060930" decimals="0" unitRef="U_iso4217USD">1077125</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000338" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToPurchaseCalandoPharmaceuticalsIncAtFiftyOneDollarsAndSeventyCentsPerShareMember_20051001_20060930" decimals="0" unitRef="U_iso4217USD">1077333</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="F_000339" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20051001_20060930" decimals="0" unitRef="U_iso4217USD">1369478</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="F_000340" contextRef="C_0000879407_20051001_20060930" decimals="0" unitRef="U_iso4217USD">1369478</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:ProfitLoss id="F_000341" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20051001_20060930" decimals="0" unitRef="U_iso4217USD">-18997209</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss id="F_000342" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20051001_20060930" decimals="0" unitRef="U_iso4217USD">-964752</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss id="F_000343" contextRef="C_0000879407_20051001_20060930" decimals="0" unitRef="U_iso4217USD">-19961961</us-gaap:ProfitLoss>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000344" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20060930" decimals="0" unitRef="U_iso4217USD">34156</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000345" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20060930" decimals="0" unitRef="U_iso4217USD">59113369</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000346" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20060930" decimals="0" unitRef="U_iso4217USD">-28476319</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000347" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20060930" decimals="0" unitRef="U_iso4217USD">934438</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000348" contextRef="C_0000879407_20060930" decimals="0" unitRef="U_iso4217USD">31605644</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:SharesIssued id="F_000349" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20060930" decimals="INF" unitRef="U_shares">3414359</us-gaap:SharesIssued>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised id="F_000350" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20061001_20070930" decimals="INF" unitRef="U_shares">18616</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000351" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20061001_20070930" decimals="0" unitRef="U_iso4217USD">186</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000352" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20061001_20070930" decimals="0" unitRef="U_iso4217USD">434541</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000353" contextRef="C_0000879407_20061001_20070930" decimals="0" unitRef="U_iso4217USD">434727</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000354" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiftySevenDollarsAndEightyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20061001_20070930" decimals="INF" unitRef="U_shares">284945</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000355" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiftySevenDollarsAndEightyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20061001_20070930" decimals="0" unitRef="U_iso4217USD">2849</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000356" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiftySevenDollarsAndEightyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20061001_20070930" decimals="0" unitRef="U_iso4217USD">15149366</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000357" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiftySevenDollarsAndEightyCentsPerShareMember_20061001_20070930" decimals="0" unitRef="U_iso4217USD">15152215</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance id="F_000358" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20061001_20070930" decimals="0" unitRef="U_iso4217USD">2401394</us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance>
  <us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance id="F_000359" contextRef="C_0000879407_20061001_20070930" decimals="0" unitRef="U_iso4217USD">2401394</us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000360" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForPurchaseOfCarbonNanotechnologiesIncAtThirtySevenDollarsAndSeventyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20061001_20070930" decimals="INF" unitRef="U_shares">143122</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000361" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForPurchaseOfCarbonNanotechnologiesIncAtThirtySevenDollarsAndSeventyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20061001_20070930" decimals="0" unitRef="U_iso4217USD">1431</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000362" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForPurchaseOfCarbonNanotechnologiesIncAtThirtySevenDollarsAndSeventyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20061001_20070930" decimals="0" unitRef="U_iso4217USD">5398569</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000363" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForPurchaseOfCarbonNanotechnologiesIncAtThirtySevenDollarsAndSeventyCentsPerShareMember_20061001_20070930" decimals="0" unitRef="U_iso4217USD">5400000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="F_000364" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20061001_20070930" decimals="0" unitRef="U_iso4217USD">2175544</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="F_000365" contextRef="C_0000879407_20061001_20070930" decimals="0" unitRef="U_iso4217USD">2175544</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:ProfitLoss id="F_000366" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20061001_20070930" decimals="0" unitRef="U_iso4217USD">-29931118</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss id="F_000367" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20061001_20070930" decimals="0" unitRef="U_iso4217USD">-781829</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss id="F_000368" contextRef="C_0000879407_20061001_20070930" decimals="0" unitRef="U_iso4217USD">-30712947</us-gaap:ProfitLoss>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000369" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20070930" decimals="0" unitRef="U_iso4217USD">38622</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000370" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20070930" decimals="0" unitRef="U_iso4217USD">84672783</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000371" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20070930" decimals="0" unitRef="U_iso4217USD">-58407437</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000372" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20070930" decimals="0" unitRef="U_iso4217USD">152609</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000373" contextRef="C_0000879407_20070930" decimals="0" unitRef="U_iso4217USD">26456577</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:SharesIssued id="F_000374" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20070930" decimals="INF" unitRef="U_shares">3861042</us-gaap:SharesIssued>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised id="F_000375" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20071001_20080930" decimals="INF" unitRef="U_shares">10536</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000376" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20071001_20080930" decimals="0" unitRef="U_iso4217USD">106</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000377" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20071001_20080930" decimals="0" unitRef="U_iso4217USD">289921</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000378" contextRef="C_0000879407_20071001_20080930" decimals="0" unitRef="U_iso4217USD">290027</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000379" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtApproximatelyEighteenDollarPerShareNetMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20071001_20080930" decimals="INF" unitRef="U_shares">386399</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000380" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtApproximatelyEighteenDollarPerShareNetMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20071001_20080930" decimals="0" unitRef="U_iso4217USD">3867</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000381" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtApproximatelyEighteenDollarPerShareNetMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20071001_20080930" decimals="0" unitRef="U_iso4217USD">6956718</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000382" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtApproximatelyEighteenDollarPerShareNetMember_20071001_20080930" decimals="0" unitRef="U_iso4217USD">6960585</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance id="F_000383" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20071001_20080930" decimals="0" unitRef="U_iso4217USD">1720962</us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance>
  <us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance id="F_000384" contextRef="C_0000879407_20071001_20080930" decimals="0" unitRef="U_iso4217USD">1720962</us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000385" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentySevenDollarsAndTwentyCentsPerShareToRiceUniversityMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20071001_20080930" decimals="INF" unitRef="U_shares">5000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000386" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentySevenDollarsAndTwentyCentsPerShareToRiceUniversityMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20071001_20080930" decimals="0" unitRef="U_iso4217USD">50</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000387" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentySevenDollarsAndTwentyCentsPerShareToRiceUniversityMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20071001_20080930" decimals="0" unitRef="U_iso4217USD">135950</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000388" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentySevenDollarsAndTwentyCentsPerShareToRiceUniversityMember_20071001_20080930" decimals="0" unitRef="U_iso4217USD">136000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000389" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyEightDollarsAndThirtyCentsPerShareToPurchaseSharesOfUnidymIncMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20071001_20080930" decimals="INF" unitRef="U_shares">7055</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000390" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyEightDollarsAndThirtyCentsPerShareToPurchaseSharesOfUnidymIncMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20071001_20080930" decimals="0" unitRef="U_iso4217USD">71</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000391" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyEightDollarsAndThirtyCentsPerShareToPurchaseSharesOfUnidymIncMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20071001_20080930" decimals="0" unitRef="U_iso4217USD">199929</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000392" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyEightDollarsAndThirtyCentsPerShareToPurchaseSharesOfUnidymIncMember_20071001_20080930" decimals="0" unitRef="U_iso4217USD">200000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000393" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyNineDollarsAndFiftyCentsPerShareToPurchaseMasaEnergyLlcMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20071001_20080930" decimals="INF" unitRef="U_shares">10505</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000394" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyNineDollarsAndFiftyCentsPerShareToPurchaseMasaEnergyLlcMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20071001_20080930" decimals="0" unitRef="U_iso4217USD">105</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000395" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyNineDollarsAndFiftyCentsPerShareToPurchaseMasaEnergyLlcMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20071001_20080930" decimals="0" unitRef="U_iso4217USD">309895</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000396" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyNineDollarsAndFiftyCentsPerShareToPurchaseMasaEnergyLlcMember_20071001_20080930" decimals="0" unitRef="U_iso4217USD">310000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000397" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyOneDollarsAndNinetyCentsPerShareToUnidymForAcquisitionOfNanoconductionMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20071001_20080930" decimals="INF" unitRef="U_shares">11416</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000398" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyOneDollarsAndNinetyCentsPerShareToUnidymForAcquisitionOfNanoconductionMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20071001_20080930" decimals="0" unitRef="U_iso4217USD">114</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000399" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyOneDollarsAndNinetyCentsPerShareToUnidymForAcquisitionOfNanoconductionMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20071001_20080930" decimals="0" unitRef="U_iso4217USD">249886</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000400" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyOneDollarsAndNinetyCentsPerShareToUnidymForAcquisitionOfNanoconductionMember_20071001_20080930" decimals="0" unitRef="U_iso4217USD">250000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000401" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyOneDollarsAndEightyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20071001_20080930" decimals="INF" unitRef="U_shares">1500</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000402" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyOneDollarsAndEightyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20071001_20080930" decimals="0" unitRef="U_iso4217USD">15</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000403" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyOneDollarsAndEightyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20071001_20080930" decimals="0" unitRef="U_iso4217USD">32685</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000404" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyOneDollarsAndEightyCentsPerShareMember_20071001_20080930" decimals="0" unitRef="U_iso4217USD">32700</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="F_000405" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20071001_20080930" decimals="0" unitRef="U_iso4217USD">3187397</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="F_000406" contextRef="C_0000879407_20071001_20080930" decimals="0" unitRef="U_iso4217USD">3187397</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:ProfitLoss id="F_000407" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20071001_20080930" decimals="0" unitRef="U_iso4217USD">-27089030</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss id="F_000408" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20071001_20080930" decimals="0" unitRef="U_iso4217USD">-152609</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss id="F_000409" contextRef="C_0000879407_20071001_20080930" decimals="0" unitRef="U_iso4217USD">-27241639</us-gaap:ProfitLoss>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000410" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20080930" decimals="0" unitRef="U_iso4217USD">42950</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000411" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20080930" decimals="0" unitRef="U_iso4217USD">97756126</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000412" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20080930" decimals="0" unitRef="U_iso4217USD">-85496467</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000413" contextRef="C_0000879407_20080930" decimals="0" unitRef="U_iso4217USD">12302609</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:SharesIssued id="F_000414" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20080930" decimals="INF" unitRef="U_shares">4293452</us-gaap:SharesIssued>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000415" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiveDollarsAndFiftyCentsPerShareToUnidymStockholderInExchangeForUnidymSSharesMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20081001_20090930" decimals="INF" unitRef="U_shares">205839</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000416" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiveDollarsAndFiftyCentsPerShareToUnidymStockholderInExchangeForUnidymSSharesMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20081001_20090930" decimals="0" unitRef="U_iso4217USD">2059</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000417" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiveDollarsAndFiftyCentsPerShareToUnidymStockholderInExchangeForUnidymSSharesMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20081001_20090930" decimals="0" unitRef="U_iso4217USD">1131617</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000418" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiveDollarsAndFiftyCentsPerShareToUnidymStockholderInExchangeForUnidymSSharesMember_20081001_20090930" decimals="0" unitRef="U_iso4217USD">1133676</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000419" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiveDollarsAndTwentyCentsPerShareToTelVenturesInExchangeForUnidymSSharesMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20081001_20090930" decimals="INF" unitRef="U_shares">222222</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000420" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiveDollarsAndTwentyCentsPerShareToTelVenturesInExchangeForUnidymSSharesMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20081001_20090930" decimals="0" unitRef="U_iso4217USD">2222</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000421" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiveDollarsAndTwentyCentsPerShareToTelVenturesInExchangeForUnidymSSharesMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20081001_20090930" decimals="0" unitRef="U_iso4217USD">1156111</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000422" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiveDollarsAndTwentyCentsPerShareToTelVenturesInExchangeForUnidymSSharesMember_20081001_20090930" decimals="0" unitRef="U_iso4217USD">1158333</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt id="F_000423" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20081001_20090930" decimals="0" unitRef="U_iso4217USD">2000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt id="F_000424" contextRef="C_0000879407_20081001_20090930" decimals="0" unitRef="U_iso4217USD">2000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
  <us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance id="F_000425" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrArrowheadsIncreaseInProportionateShareOfCalandosEquityMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20081001_20090930" decimals="0" unitRef="U_iso4217USD">2120250</us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance>
  <us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance id="F_000426" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrArrowheadsIncreaseInProportionateShareOfCalandosEquityMember_20081001_20090930" decimals="0" unitRef="U_iso4217USD">2120250</us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000427" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThreeDollarsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20081001_20090930" decimals="INF" unitRef="U_shares">919664</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000428" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThreeDollarsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20081001_20090930" decimals="0" unitRef="U_iso4217USD">9197</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000429" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThreeDollarsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20081001_20090930" decimals="0" unitRef="U_iso4217USD">2749796</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000430" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThreeDollarsPerShareMember_20081001_20090930" decimals="0" unitRef="U_iso4217USD">2758993</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance id="F_000431" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20081001_20090930" decimals="0" unitRef="U_iso4217USD">16297</us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance>
  <us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance id="F_000432" contextRef="C_0000879407_20081001_20090930" decimals="0" unitRef="U_iso4217USD">16297</us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="F_000433" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20081001_20090930" decimals="0" unitRef="U_iso4217USD">2676170</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="F_000434" contextRef="C_0000879407_20081001_20090930" decimals="0" unitRef="U_iso4217USD">2676170</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock id="F_000435" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToUnidymStockholdersInExchangeForUnidymsSharesMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20081001_20090930" decimals="0" unitRef="U_iso4217USD">300000</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
  <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock id="F_000436" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToUnidymStockholdersInExchangeForUnidymsSharesMember_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20081001_20090930" decimals="0" unitRef="U_iso4217USD">-300000</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature id="F_000437" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20081001_20090930" decimals="0" unitRef="U_iso4217USD">163960</us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature id="F_000438" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20081001_20090930" decimals="0" unitRef="U_iso4217USD">-163960</us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature>
  <us-gaap:ProfitLoss id="F_000439" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20081001_20090930" decimals="0" unitRef="U_iso4217USD">-19308392</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss id="F_000440" contextRef="C_0000879407_20081001_20090930" decimals="0" unitRef="U_iso4217USD">-19308392</us-gaap:ProfitLoss>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000441" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20090930" decimals="0" unitRef="U_iso4217USD">56428</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000442" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20090930" decimals="0" unitRef="U_iso4217USD">110070327</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000443" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20090930" decimals="2" unitRef="U_iso4217USD">-300000.00</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000444" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20090930" decimals="0" unitRef="U_iso4217USD">-104968819</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000445" contextRef="C_0000879407_20090930" decimals="0" unitRef="U_iso4217USD">4857936</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:SharesIssued id="F_000446" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20090930" decimals="INF" unitRef="U_shares">5641177</us-gaap:SharesIssued>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised id="F_000447" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20091001_20100930" decimals="INF" unitRef="U_shares">688</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000448" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20091001_20100930" decimals="0" unitRef="U_iso4217USD">7</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000449" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20091001_20100930" decimals="0" unitRef="U_iso4217USD">7624</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000450" contextRef="C_0000879407_20091001_20100930" decimals="0" unitRef="U_iso4217USD">7631</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock id="F_000451" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20091001_20100930" decimals="0" unitRef="U_iso4217USD">300000</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
  <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock id="F_000452" contextRef="C_0000879407_20091001_20100930" decimals="0" unitRef="U_iso4217USD">300000</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
  <us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest id="F_000453" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20091001_20100930" decimals="0" unitRef="U_iso4217USD">245345</us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest>
  <us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest id="F_000454" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20091001_20100930" decimals="0" unitRef="U_iso4217USD">54655</us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest>
  <us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest id="F_000455" contextRef="C_0000879407_20091001_20100930" decimals="0" unitRef="U_iso4217USD">300000</us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000456" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtSixDollarsAndThirtyFourCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20091001_20100930" decimals="INF" unitRef="U_shares">508343</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000457" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtSixDollarsAndThirtyFourCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20091001_20100930" decimals="0" unitRef="U_iso4217USD">5083</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000458" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtSixDollarsAndThirtyFourCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20091001_20100930" decimals="0" unitRef="U_iso4217USD">3217813</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000459" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtSixDollarsAndThirtyFourCentsPerShareMember_20091001_20100930" decimals="0" unitRef="U_iso4217USD">3222896</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000460" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThirteenDollarsAndTwelveCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20091001_20100930" decimals="INF" unitRef="U_shares">659299</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000461" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThirteenDollarsAndTwelveCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20091001_20100930" decimals="0" unitRef="U_iso4217USD">6593</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000462" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThirteenDollarsAndTwelveCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20091001_20100930" decimals="0" unitRef="U_iso4217USD">7861985</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000463" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThirteenDollarsAndTwelveCentsPerShareMember_20091001_20100930" decimals="0" unitRef="U_iso4217USD">7868578</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax id="F_000464" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20091001_20100930" decimals="0" unitRef="U_iso4217USD">-4169907</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax>
  <us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax id="F_000465" contextRef="C_0000879407_20091001_20100930" decimals="0" unitRef="U_iso4217USD">-4169907</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000466" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToCalandoStockholdersInExchangeForCalandoSSharesMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20091001_20100930" decimals="INF" unitRef="U_shares">122000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000467" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToCalandoStockholdersInExchangeForCalandoSSharesMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20091001_20100930" decimals="0" unitRef="U_iso4217USD">1220</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000468" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToCalandoStockholdersInExchangeForCalandoSSharesMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20091001_20100930" decimals="0" unitRef="U_iso4217USD">-160667</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000469" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToCalandoStockholdersInExchangeForCalandoSSharesMember_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20091001_20100930" decimals="0" unitRef="U_iso4217USD">159447</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000470" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToUnidymStockholdersInExchangeForUnidymsSharesMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20091001_20100930" decimals="INF" unitRef="U_shares">15318</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000471" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToUnidymStockholdersInExchangeForUnidymsSharesMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20091001_20100930" decimals="0" unitRef="U_iso4217USD">153</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000472" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToUnidymStockholdersInExchangeForUnidymsSharesMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20091001_20100930" decimals="0" unitRef="U_iso4217USD">-1435</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000473" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToUnidymStockholdersInExchangeForUnidymsSharesMember_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20091001_20100930" decimals="0" unitRef="U_iso4217USD">1282</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="F_000474" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20091001_20100930" decimals="0" unitRef="U_iso4217USD">1582149</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="F_000475" contextRef="C_0000879407_20091001_20100930" decimals="0" unitRef="U_iso4217USD">1582149</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000476" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20091001_20100930" decimals="INF" unitRef="U_shares">225189</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000477" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20091001_20100930" decimals="0" unitRef="U_iso4217USD">2250</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000478" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20091001_20100930" decimals="0" unitRef="U_iso4217USD">1063600</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000479" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20091001_20100930" decimals="0" unitRef="U_iso4217USD">200</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000480" contextRef="C_0000879407_20091001_20100930" decimals="0" unitRef="U_iso4217USD">1066050</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:ProfitLoss id="F_000481" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20091001_20100930" decimals="0" unitRef="U_iso4217USD">-5774048</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss id="F_000482" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20091001_20100930" decimals="0" unitRef="U_iso4217USD">-1182990</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss id="F_000483" contextRef="C_0000879407_20091001_20100930" decimals="0" unitRef="U_iso4217USD">-6957038</us-gaap:ProfitLoss>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000484" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20100930" decimals="0" unitRef="U_iso4217USD">71734</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000485" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20100930" decimals="0" unitRef="U_iso4217USD">119716834</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000486" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20100930" decimals="0" unitRef="U_iso4217USD">-110742867</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000487" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20100930" decimals="0" unitRef="U_iso4217USD">-967406</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000488" contextRef="C_0000879407_20100930" decimals="0" unitRef="U_iso4217USD">8078295</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:SharesIssued id="F_000489" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20100930" decimals="INF" unitRef="U_shares">7172014</us-gaap:SharesIssued>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000490" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20101001_20110930" decimals="INF" unitRef="U_shares">8656</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000491" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20101001_20110930" decimals="0" unitRef="U_iso4217USD">87</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000492" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20101001_20110930" decimals="0" unitRef="U_iso4217USD">43192</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000493" contextRef="C_0000879407_20101001_20110930" decimals="0" unitRef="U_iso4217USD">43279</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised id="F_000494" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20101001_20110930" decimals="INF" unitRef="U_shares">2700</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000495" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20101001_20110930" decimals="0" unitRef="U_iso4217USD">27</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000496" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20101001_20110930" decimals="0" unitRef="U_iso4217USD">13857</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000497" contextRef="C_0000879407_20101001_20110930" decimals="0" unitRef="U_iso4217USD">13884</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest id="F_000498" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20101001_20110930" decimals="0" unitRef="U_iso4217USD">254275</us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest>
  <us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest id="F_000499" contextRef="C_0000879407_20101001_20110930" decimals="0" unitRef="U_iso4217USD">254275</us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest>
  <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock id="F_000500" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20101001_20110930" decimals="0" unitRef="U_iso4217USD">1618509</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
  <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock id="F_000501" contextRef="C_0000879407_20101001_20110930" decimals="0" unitRef="U_iso4217USD">1618509</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
  <us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance id="F_000502" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20101001_20110930" decimals="0" unitRef="U_iso4217USD">-849707</us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance>
  <us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance id="F_000503" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20101001_20110930" decimals="0" unitRef="U_iso4217USD">849707</us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="F_000504" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20101001_20110930" decimals="0" unitRef="U_iso4217USD">1404640</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="F_000505" contextRef="C_0000879407_20101001_20110930" decimals="0" unitRef="U_iso4217USD">1404640</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000506" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThreeDollarsAndEightyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20101001_20110930" decimals="INF" unitRef="U_shares">1458917</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000507" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThreeDollarsAndEightyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20101001_20110930" decimals="0" unitRef="U_iso4217USD">14574</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000508" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThreeDollarsAndEightyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20101001_20110930" decimals="0" unitRef="U_iso4217USD">4629110</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000509" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThreeDollarsAndEightyCentsPerShareMember_20101001_20110930" decimals="0" unitRef="U_iso4217USD">4643684</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000510" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuanceOfCommonStockForSubscriptionMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20101001_20110930" decimals="0" unitRef="U_iso4217USD">900000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000511" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuanceOfCommonStockForSubscriptionMember_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20101001_20110930" decimals="0" unitRef="U_iso4217USD">-900000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:ProfitLoss id="F_000512" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20101001_20110930" decimals="0" unitRef="U_iso4217USD">-3128885</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss id="F_000513" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20101001_20110930" decimals="0" unitRef="U_iso4217USD">-363514</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss id="F_000514" contextRef="C_0000879407_20101001_20110930" decimals="0" unitRef="U_iso4217USD">-3492399</us-gaap:ProfitLoss>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000515" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20110930" decimals="0" unitRef="U_iso4217USD">86422</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000516" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20110930" decimals="0" unitRef="U_iso4217USD">127476436</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000517" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20110930" decimals="2" unitRef="U_iso4217USD">-900000.00</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000518" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20110930" decimals="0" unitRef="U_iso4217USD">-113871752</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000519" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20110930" decimals="0" unitRef="U_iso4217USD">-226938</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000520" contextRef="C_0000879407_20110930" decimals="0" unitRef="U_iso4217USD">12564167</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:SharesIssued id="F_000521" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20110930" decimals="INF" unitRef="U_shares">8642286</us-gaap:SharesIssued>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised id="F_000522" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20111001_20120930" decimals="INF" unitRef="U_shares">4583</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000523" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">45</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000524" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">23788</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000525" contextRef="C_0000879407_20111001_20120930" decimals="0" unitRef="U_iso4217USD">23833</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="F_000526" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">1241404</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="F_000527" contextRef="C_0000879407_20111001_20120930" decimals="0" unitRef="U_iso4217USD">1241404</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000528" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThreeDollarsAndEightyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20111001_20120930" decimals="INF" unitRef="U_shares">138158</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000529" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThreeDollarsAndEightyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">1382</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000530" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThreeDollarsAndEightyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">523618</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000531" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThreeDollarsAndEightyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">-100000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000532" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThreeDollarsAndEightyCentsPerShareMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">425000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000533" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThreeDollarsAndSeventyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20111001_20120930" decimals="INF" unitRef="U_shares">675000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000534" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThreeDollarsAndSeventyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">6750</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000535" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThreeDollarsAndSeventyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">2241000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000536" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThreeDollarsAndSeventyCentsPerShareMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">2247750</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000537" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFourDollarsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20111001_20120930" decimals="INF" unitRef="U_shares">100000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000538" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFourDollarsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">1000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000539" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFourDollarsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">399000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000540" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFourDollarsPerShareMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">400000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000541" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtSixDollarsAndTwentyThreeCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20111001_20120930" decimals="INF" unitRef="U_shares">83211</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000542" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtSixDollarsAndTwentyThreeCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">83</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000543" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtSixDollarsAndTwentyThreeCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">499918</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000544" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtSixDollarsAndTwentyThreeCentsPerShareMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">500001</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000545" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiveDollarsAndElevenCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20111001_20120930" decimals="INF" unitRef="U_shares">97831</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000546" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiveDollarsAndElevenCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">98</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000547" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiveDollarsAndElevenCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">499903</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000548" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiveDollarsAndElevenCentsPerShareMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">500001</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000549" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwoDollarsAndSeventySixCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20111001_20120930" decimals="INF" unitRef="U_shares">2260869</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000550" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwoDollarsAndSeventySixCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">2261</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000551" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwoDollarsAndSeventySixCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">5809979</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000552" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwoDollarsAndSeventySixCentsPerShareMember_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">-16000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000553" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwoDollarsAndSeventySixCentsPerShareMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">5796240</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000554" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedUnderCommittedCapitalAgreementMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20111001_20120930" decimals="INF" unitRef="U_shares">68926</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000555" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedUnderCommittedCapitalAgreementMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">689</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000556" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedUnderCommittedCapitalAgreementMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">-689</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000557" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_us-gaapEquityIssuedInBusinessCombinationMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20111001_20120930" decimals="INF" unitRef="U_shares">1217159</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000558" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_us-gaapEquityIssuedInBusinessCombinationMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">9332</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000559" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_us-gaapEquityIssuedInBusinessCombinationMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">6138498</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000560" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_us-gaapEquityIssuedInBusinessCombinationMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">6147830</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesReverseStockSplits id="F_000561" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20111001_20120930" decimals="INF" unitRef="U_shares">131</us-gaap:StockIssuedDuringPeriodSharesReverseStockSplits>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000562" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrPreferredStockIssuedAtThousandDollarsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20111001_20120930" decimals="INF" unitRef="U_shares">1015</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000563" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrPreferredStockIssuedAtThousandDollarsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">1</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000564" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrPreferredStockIssuedAtThousandDollarsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">1014999</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000565" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrPreferredStockIssuedAtThousandDollarsPerShareMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">1015000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits id="F_000566" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20111001_20120930" decimals="INF" unitRef="U_shares">275782</us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits>
  <us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits id="F_000567" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20111001_20120930" decimals="INF" unitRef="U_shares">-1015</us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits id="F_000568" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">276</us-gaap:StockIssuedDuringPeriodValueConversionOfUnits>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits id="F_000569" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">-1</us-gaap:StockIssuedDuringPeriodValueConversionOfUnits>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits id="F_000570" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">-275</us-gaap:StockIssuedDuringPeriodValueConversionOfUnits>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000571" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToCalandoStockholdersInExchangeForCalandoSSharesMember_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">8000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000572" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToCalandoStockholdersInExchangeForCalandoSSharesMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">8000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000573" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20111001_20120930" decimals="INF" unitRef="U_shares">15511</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000574" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">16</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000575" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">50390</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000576" contextRef="C_0000879407_20111001_20120930" decimals="0" unitRef="U_iso4217USD">50406</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:ProfitLoss id="F_000577" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">-21125928</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss id="F_000578" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">-984795</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss id="F_000579" contextRef="C_0000879407_20111001_20120930" decimals="0" unitRef="U_iso4217USD">-22110723</us-gaap:ProfitLoss>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000580" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20120930" decimals="0" unitRef="U_iso4217USD">108354</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000581" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20120930" decimals="0" unitRef="U_iso4217USD">145917968</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000582" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20120930" decimals="2" unitRef="U_iso4217USD">-1016000.00</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000583" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20120930" decimals="0" unitRef="U_iso4217USD">-134997680</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000584" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20120930" decimals="0" unitRef="U_iso4217USD">-1203733</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000585" contextRef="C_0000879407_20120930" decimals="0" unitRef="U_iso4217USD">8808909</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:SharesIssued id="F_000586" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20120930" decimals="INF" unitRef="U_shares">13579185</us-gaap:SharesIssued>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000587" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20121001_20130930" decimals="INF" unitRef="U_shares">1182451</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000588" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20121001_20130930" decimals="0" unitRef="U_iso4217USD">1183</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000589" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20121001_20130930" decimals="0" unitRef="U_iso4217USD">2053416</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000590" contextRef="C_0000879407_20121001_20130930" decimals="0" unitRef="U_iso4217USD">2054599</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised id="F_000591" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20121001_20130930" decimals="INF" unitRef="U_shares">675</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000592" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20121001_20130930" decimals="0" unitRef="U_iso4217USD">1</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000593" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20121001_20130930" decimals="0" unitRef="U_iso4217USD">2578</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000594" contextRef="C_0000879407_20121001_20130930" decimals="0" unitRef="U_iso4217USD">2579</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="F_000595" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20121001_20130930" decimals="0" unitRef="U_iso4217USD">1536271</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="F_000596" contextRef="C_0000879407_20121001_20130930" decimals="0" unitRef="U_iso4217USD">1536271</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <arwr:SubscriptionReceivable id="F_000597" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20121001_20130930" decimals="0" unitRef="U_iso4217USD">16000</arwr:SubscriptionReceivable>
  <arwr:SubscriptionReceivable id="F_000598" contextRef="C_0000879407_20121001_20130930" decimals="0" unitRef="U_iso4217USD">16000</arwr:SubscriptionReceivable>
  <arwr:CancellationOfSharesRelatedToSubscriptionReceivables id="F_000599" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20121001_20130930" decimals="INF" unitRef="U_shares">267444</arwr:CancellationOfSharesRelatedToSubscriptionReceivables>
  <arwr:CancellationOfSubscriptionReceivables id="F_000600" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20121001_20130930" decimals="0" unitRef="U_iso4217USD">-2674</arwr:CancellationOfSubscriptionReceivables>
  <arwr:CancellationOfSubscriptionReceivables id="F_000601" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20121001_20130930" decimals="0" unitRef="U_iso4217USD">-997326</arwr:CancellationOfSubscriptionReceivables>
  <arwr:CancellationOfSubscriptionReceivables id="F_000602" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20121001_20130930" decimals="0" unitRef="U_iso4217USD">1000000</arwr:CancellationOfSubscriptionReceivables>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000603" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFourDollarsAndFortyNineCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20121001_20130930" decimals="INF" unitRef="U_shares">239894</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000604" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFourDollarsAndFortyNineCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20121001_20130930" decimals="0" unitRef="U_iso4217USD">240</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000605" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFourDollarsAndFortyNineCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20121001_20130930" decimals="0" unitRef="U_iso4217USD">985809</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000606" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFourDollarsAndFortyNineCentsPerShareMember_20121001_20130930" decimals="0" unitRef="U_iso4217USD">986049</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000607" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwoDollarsAndTwentySixCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20121001_20130930" decimals="INF" unitRef="U_shares">1825079</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000608" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwoDollarsAndTwentySixCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20121001_20130930" decimals="0" unitRef="U_iso4217USD">1825</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000609" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwoDollarsAndTwentySixCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20121001_20130930" decimals="0" unitRef="U_iso4217USD">3814643</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000610" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwoDollarsAndTwentySixCentsPerShareMember_20121001_20130930" decimals="0" unitRef="U_iso4217USD">3816468</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000611" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwoDollarsAndTwelveCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20121001_20130930" decimals="INF" unitRef="U_shares">1667051</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000612" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwoDollarsAndTwelveCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20121001_20130930" decimals="0" unitRef="U_iso4217USD">1667</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000613" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwoDollarsAndTwelveCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20121001_20130930" decimals="0" unitRef="U_iso4217USD">3255192</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000614" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwoDollarsAndTwelveCentsPerShareMember_20121001_20130930" decimals="0" unitRef="U_iso4217USD">3256859</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000615" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtOneDollarAndEightyThreeCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20121001_20130930" decimals="INF" unitRef="U_shares">14262553</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000616" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtOneDollarAndEightyThreeCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20121001_20130930" decimals="0" unitRef="U_iso4217USD">14263</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000617" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtOneDollarAndEightyThreeCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20121001_20130930" decimals="0" unitRef="U_iso4217USD">25445236</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000618" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtOneDollarAndEightyThreeCentsPerShareMember_20121001_20130930" decimals="0" unitRef="U_iso4217USD">25459499</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax id="F_000619" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20121001_20130930" decimals="0" unitRef="U_iso4217USD">1600989</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax>
  <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax id="F_000620" contextRef="C_0000879407_20121001_20130930" decimals="0" unitRef="U_iso4217USD">1600989</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000621" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrPreferredStockIssuedAtThousandDollarsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20121001_20130930" decimals="INF" unitRef="U_shares">9900</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000622" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrPreferredStockIssuedAtThousandDollarsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20121001_20130930" decimals="0" unitRef="U_iso4217USD">10</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000623" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrPreferredStockIssuedAtThousandDollarsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20121001_20130930" decimals="0" unitRef="U_iso4217USD">9899990</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000624" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrPreferredStockIssuedAtThousandDollarsPerShareMember_20121001_20130930" decimals="0" unitRef="U_iso4217USD">9900000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:ProfitLoss id="F_000625" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20121001_20130930" decimals="0" unitRef="U_iso4217USD">-31143289</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss id="F_000626" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20121001_20130930" decimals="0" unitRef="U_iso4217USD">-560144</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss id="F_000627" contextRef="C_0000879407_20121001_20130930" decimals="0" unitRef="U_iso4217USD">-31703433</us-gaap:ProfitLoss>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000628" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20130930" decimals="0" unitRef="U_iso4217USD">124859</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000629" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20130930" decimals="0" unitRef="U_iso4217USD">10</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000630" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20130930" decimals="0" unitRef="U_iso4217USD">193514766</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000631" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20130930" decimals="0" unitRef="U_iso4217USD">-166140969</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000632" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20130930" decimals="0" unitRef="U_iso4217USD">-1763877</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:SharesIssued id="F_000633" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20130930" decimals="INF" unitRef="U_shares">32489444</us-gaap:SharesIssued>
  <us-gaap:SharesIssued id="F_000634" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20130930" decimals="INF" unitRef="U_shares">9900</us-gaap:SharesIssued>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000635" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20131001_20140331" decimals="INF" unitRef="U_shares">1869005</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000636" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20131001_20140331" decimals="0" unitRef="U_iso4217USD">1869</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000637" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20131001_20140331" decimals="0" unitRef="U_iso4217USD">5738785</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000638" contextRef="C_0000879407_20131001_20140331" decimals="0" unitRef="U_iso4217USD">5740654</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised id="F_000639" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20131001_20140331" decimals="INF" unitRef="U_shares">342338</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000640" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20131001_20140331" decimals="0" unitRef="U_iso4217USD">342</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000641" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20131001_20140331" decimals="0" unitRef="U_iso4217USD">2238314</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000642" contextRef="C_0000879407_20131001_20140331" decimals="0" unitRef="U_iso4217USD">2238656</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="F_000643" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20131001_20140331" decimals="0" unitRef="U_iso4217USD">1719582</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="F_000644" contextRef="C_0000879407_20131001_20140331" decimals="0" unitRef="U_iso4217USD">1719582</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000645" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiveDollarsAndEightySixCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20131001_20140331" decimals="INF" unitRef="U_shares">3071672</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000646" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiveDollarsAndEightySixCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20131001_20140331" decimals="0" unitRef="U_iso4217USD">3072</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000647" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiveDollarsAndEightySixCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20131001_20140331" decimals="0" unitRef="U_iso4217USD">14057040</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000648" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiveDollarsAndEightySixCentsPerShareMember_20131001_20140331" decimals="0" unitRef="U_iso4217USD">14060112</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000649" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtEighteenDollarAndNinetyFiveCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20131001_20140331" decimals="INF" unitRef="U_shares">6325000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000650" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtEighteenDollarAndNinetyFiveCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20131001_20140331" decimals="0" unitRef="U_iso4217USD">6325</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000651" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtEighteenDollarAndNinetyFiveCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20131001_20140331" decimals="0" unitRef="U_iso4217USD">112575234</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000652" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtEighteenDollarAndNinetyFiveCentsPerShareMember_20131001_20140331" decimals="0" unitRef="U_iso4217USD">112581559</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000653" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrPreferredStockIssuedAtThousandDollarsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20131001_20140331" decimals="INF" unitRef="U_shares">46000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000654" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrPreferredStockIssuedAtThousandDollarsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20131001_20140331" decimals="0" unitRef="U_iso4217USD">46</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000655" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrPreferredStockIssuedAtThousandDollarsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20131001_20140331" decimals="0" unitRef="U_iso4217USD">45999954</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000656" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrPreferredStockIssuedAtThousandDollarsPerShareMember_20131001_20140331" decimals="0" unitRef="U_iso4217USD">46000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000657" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToGallowayMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20131001_20140331" decimals="INF" unitRef="U_shares">131579</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000658" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToGallowayMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20131001_20140331" decimals="0" unitRef="U_iso4217USD">132</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000659" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToGallowayMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20131001_20140331" decimals="0" unitRef="U_iso4217USD">499868</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000660" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToGallowayMember_20131001_20140331" decimals="0" unitRef="U_iso4217USD">500000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax id="F_000661" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20131001_20140331" decimals="0" unitRef="U_iso4217USD">5630636</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax>
  <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax id="F_000662" contextRef="C_0000879407_20131001_20140331" decimals="0" unitRef="U_iso4217USD">5630636</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax>
  <us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits id="F_000663" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20131001_20140331" decimals="INF" unitRef="U_shares">7638033</us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits>
  <us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits id="F_000664" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20131001_20140331" decimals="INF" unitRef="U_shares">-34609</us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits id="F_000665" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20131001_20140331" decimals="0" unitRef="U_iso4217USD">7638</us-gaap:StockIssuedDuringPeriodValueConversionOfUnits>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits id="F_000666" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20131001_20140331" decimals="0" unitRef="U_iso4217USD">-35</us-gaap:StockIssuedDuringPeriodValueConversionOfUnits>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits id="F_000667" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20131001_20140331" decimals="0" unitRef="U_iso4217USD">-7603</us-gaap:StockIssuedDuringPeriodValueConversionOfUnits>
  <us-gaap:ProfitLoss id="F_000668" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20131001_20140331" decimals="0" unitRef="U_iso4217USD">-24570831</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss id="F_000669" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20131001_20140331" decimals="0" unitRef="U_iso4217USD">-97600</us-gaap:ProfitLoss>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000670" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20140331" decimals="0" unitRef="U_iso4217USD">144237</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000671" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20140331" decimals="0" unitRef="U_iso4217USD">21</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000672" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20140331" decimals="0" unitRef="U_iso4217USD">381966576</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000673" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20140331" decimals="0" unitRef="U_iso4217USD">-190711800</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000674" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20140331" decimals="0" unitRef="U_iso4217USD">-1861477</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:SharesIssued id="F_000675" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20140331" decimals="INF" unitRef="U_shares">51867071</us-gaap:SharesIssued>
  <us-gaap:SharesIssued id="F_000676" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20140331" decimals="INF" unitRef="U_shares">21291</us-gaap:SharesIssued>
  <arwr:CommonStockAndWarrantsIssuedForCashPricePerUnit id="F_000677" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtZeroPointZeroOneDollarsPerUnitMember_20030930" decimals="INF" unitRef="U_iso4217USD_shares">0.01</arwr:CommonStockAndWarrantsIssuedForCashPricePerUnit>
  <arwr:CommonStockAndWarrantsIssuedForCashPricePerUnit id="F_000678" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtTenDollarPerUnitMember_20030930" decimals="INF" unitRef="U_iso4217USD_shares">10.00</arwr:CommonStockAndWarrantsIssuedForCashPricePerUnit>
  <arwr:CommonStockAndWarrantsIssuedForCashPricePerUnit id="F_000679" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtTenDollarPerUnitMember_20040930" decimals="INF" unitRef="U_iso4217USD_shares">10.00</arwr:CommonStockAndWarrantsIssuedForCashPricePerUnit>
  <arwr:CommonStockAndWarrantsIssuedForCashPricePerUnit id="F_000680" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForMarketableSecuritiesAtTenDollarPerUnitMember_20040930" decimals="INF" unitRef="U_iso4217USD_shares">10.00</arwr:CommonStockAndWarrantsIssuedForCashPricePerUnit>
  <arwr:CommonStockAndWarrantsIssuedForCashPricePerUnit id="F_000681" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtFifteenDollarPerUnitMember_20040930" decimals="INF" unitRef="U_iso4217USD_shares">15.00</arwr:CommonStockAndWarrantsIssuedForCashPricePerUnit>
  <arwr:CommonStockAndWarrantsIssuedForCashPricePerUnit id="F_000682" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAsGiftForTenDollarAndNinetyCentsPerShareMember_20040930" decimals="INF" unitRef="U_iso4217USD_shares">10.90</arwr:CommonStockAndWarrantsIssuedForCashPricePerUnit>
  <arwr:CommonStockAndWarrantsIssuedForCashPricePerUnit id="F_000683" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAsStockIssuanceCostAtFifteenDollarPerUnitMember_20040930" decimals="INF" unitRef="U_iso4217USD_shares">15.00</arwr:CommonStockAndWarrantsIssuedForCashPricePerUnit>
  <arwr:ExerciseOfStockOptionsPricePerShare id="F_000684" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtTwoDollarPerShareMember_20040930" decimals="INF" unitRef="U_iso4217USD_shares">2.00</arwr:ExerciseOfStockOptionsPricePerShare>
  <arwr:ExerciseOfStockOptionsPricePerShare id="F_000685" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtTenDollarPerShareMember_20040930" decimals="INF" unitRef="U_iso4217USD_shares">10.00</arwr:ExerciseOfStockOptionsPricePerShare>
  <arwr:ExerciseOfStockOptionsPricePerShare id="F_000686" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtFifteenDollarPerShareMember_20050930" decimals="INF" unitRef="U_iso4217USD_shares">15.00</arwr:ExerciseOfStockOptionsPricePerShare>
  <arwr:ExerciseOfStockOptionsPricePerShare id="F_000687" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtTenDollarPerShareMember_20050930" decimals="INF" unitRef="U_iso4217USD_shares">10.00</arwr:ExerciseOfStockOptionsPricePerShare>
  <arwr:CommonStockIssuanceValuePerShare id="F_000688" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToPurchaseInsertTherapeuticsShareAtThirtyNineDollarsAndEightyCentsPerShareMember_20050930" decimals="INF" unitRef="U_iso4217USD_shares">39.80</arwr:CommonStockIssuanceValuePerShare>
  <arwr:CommonStockIssuanceValuePerShare id="F_000689" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFortyEightDollarsAndEightyCentsPerShareMember_20060930" decimals="INF" unitRef="U_iso4217USD_shares">48.80</arwr:CommonStockIssuanceValuePerShare>
  <arwr:CommonStockIssuanceValuePerShare id="F_000690" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThirtyEightDollarsAndFortyCentsPerShareMember_20060930" decimals="INF" unitRef="U_iso4217USD_shares">38.40</arwr:CommonStockIssuanceValuePerShare>
  <arwr:CommonStockIssuanceValuePerShare id="F_000691" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThirtyFiveDollarsPerShareMember_20060930" decimals="INF" unitRef="U_iso4217USD_shares">35.00</arwr:CommonStockIssuanceValuePerShare>
  <arwr:CommonStockIssuanceValuePerShare id="F_000692" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiftyNineDollarsAndTenCentsPerShareMember_20060930" decimals="INF" unitRef="U_iso4217USD_shares">59.10</arwr:CommonStockIssuanceValuePerShare>
  <arwr:CommonStockIssuanceValuePerShare id="F_000693" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToPurchaseCalandoPharmaceuticalsIncAtFiftyOneDollarsAndSeventyCentsPerShareMember_20060930" decimals="INF" unitRef="U_iso4217USD_shares">51.70</arwr:CommonStockIssuanceValuePerShare>
  <arwr:CommonStockIssuanceValuePerShare id="F_000694" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiftySevenDollarsAndEightyCentsPerShareMember_20070930" decimals="INF" unitRef="U_iso4217USD_shares">57.80</arwr:CommonStockIssuanceValuePerShare>
  <arwr:CommonStockIssuanceValuePerShare id="F_000695" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForPurchaseOfCarbonNanotechnologiesIncAtThirtySevenDollarsAndSeventyCentsPerShareMember_20070930" decimals="INF" unitRef="U_iso4217USD_shares">37.70</arwr:CommonStockIssuanceValuePerShare>
  <arwr:CommonStockIssuanceValuePerShare id="F_000696" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtApproximatelyEighteenDollarPerShareNetMember_20080930" decimals="INF" unitRef="U_iso4217USD_shares">18.00</arwr:CommonStockIssuanceValuePerShare>
  <arwr:CommonStockIssuanceValuePerShare id="F_000697" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentySevenDollarsAndTwentyCentsPerShareToRiceUniversityMember_20080930" decimals="INF" unitRef="U_iso4217USD_shares">27.20</arwr:CommonStockIssuanceValuePerShare>
  <arwr:CommonStockIssuanceValuePerShare id="F_000698" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyEightDollarsAndThirtyCentsPerShareToPurchaseSharesOfUnidymIncMember_20080930" decimals="INF" unitRef="U_iso4217USD_shares">28.30</arwr:CommonStockIssuanceValuePerShare>
  <arwr:CommonStockIssuanceValuePerShare id="F_000699" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyNineDollarsAndFiftyCentsPerShareToPurchaseMasaEnergyLlcMember_20080930" decimals="INF" unitRef="U_iso4217USD_shares">29.50</arwr:CommonStockIssuanceValuePerShare>
  <arwr:CommonStockIssuanceValuePerShare id="F_000700" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyOneDollarsAndNinetyCentsPerShareToUnidymForAcquisitionOfNanoconductionMember_20080930" decimals="INF" unitRef="U_iso4217USD_shares">21.90</arwr:CommonStockIssuanceValuePerShare>
  <arwr:CommonStockIssuanceValuePerShare id="F_000701" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyOneDollarsAndEightyCentsPerShareMember_20080930" decimals="INF" unitRef="U_iso4217USD_shares">21.80</arwr:CommonStockIssuanceValuePerShare>
  <arwr:CommonStockIssuanceValuePerShare id="F_000702" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiveDollarsAndFiftyCentsPerShareToUnidymStockholderInExchangeForUnidymSSharesMember_20090930" decimals="INF" unitRef="U_iso4217USD_shares">5.50</arwr:CommonStockIssuanceValuePerShare>
  <arwr:CommonStockIssuanceValuePerShare id="F_000703" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiveDollarsAndTwentyCentsPerShareToTelVenturesInExchangeForUnidymSSharesMember_20090930" decimals="INF" unitRef="U_iso4217USD_shares">5.20</arwr:CommonStockIssuanceValuePerShare>
  <arwr:CommonStockIssuanceValuePerShare id="F_000704" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThreeDollarsPerShareMember_20090930" decimals="INF" unitRef="U_iso4217USD_shares">3.00</arwr:CommonStockIssuanceValuePerShare>
  <arwr:CommonStockIssuanceValuePerShare id="F_000705" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtSixDollarsAndThirtyFourCentsPerShareMember_20100930" decimals="INF" unitRef="U_iso4217USD_shares">6.34</arwr:CommonStockIssuanceValuePerShare>
  <arwr:CommonStockIssuanceValuePerShare id="F_000706" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThirteenDollarsAndTwelveCentsPerShareMember_20100930" decimals="INF" unitRef="U_iso4217USD_shares">13.12</arwr:CommonStockIssuanceValuePerShare>
  <arwr:CommonStockIssuanceValuePerShare id="F_000707" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThreeDollarsAndEightyCentsPerShareMember_20110930" decimals="INF" unitRef="U_iso4217USD_shares">3.80</arwr:CommonStockIssuanceValuePerShare>
  <arwr:CommonStockIssuanceValuePerShare id="F_000708" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThreeDollarsAndEightyCentsPerShareMember_20120930" decimals="INF" unitRef="U_iso4217USD_shares">3.80</arwr:CommonStockIssuanceValuePerShare>
  <arwr:CommonStockIssuanceValuePerShare id="F_000709" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThreeDollarsAndSeventyCentsPerShareMember_20120930" decimals="INF" unitRef="U_iso4217USD_shares">3.70</arwr:CommonStockIssuanceValuePerShare>
  <arwr:CommonStockIssuanceValuePerShare id="F_000710" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFourDollarsPerShareMember_20120930" decimals="INF" unitRef="U_iso4217USD_shares">4.00</arwr:CommonStockIssuanceValuePerShare>
  <arwr:CommonStockIssuanceValuePerShare id="F_000711" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtSixDollarsAndTwentyThreeCentsPerShareMember_20120930" decimals="INF" unitRef="U_iso4217USD_shares">6.23</arwr:CommonStockIssuanceValuePerShare>
  <arwr:CommonStockIssuanceValuePerShare id="F_000712" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiveDollarsAndElevenCentsPerShareMember_20120930" decimals="INF" unitRef="U_iso4217USD_shares">5.11</arwr:CommonStockIssuanceValuePerShare>
  <arwr:CommonStockIssuanceValuePerShare id="F_000713" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwoDollarsAndSeventySixCentsPerShareMember_20120930" decimals="INF" unitRef="U_iso4217USD_shares">2.76</arwr:CommonStockIssuanceValuePerShare>
  <arwr:PreferredStockIssuanceValuePerShare id="F_000714" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrPreferredStockIssuedAtThousandDollarsPerShareMember_20120930" decimals="INF" unitRef="U_iso4217USD_shares">1000</arwr:PreferredStockIssuanceValuePerShare>
  <arwr:CommonStockIssuanceValuePerShare id="F_000715" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFourDollarsAndFortyNineCentsPerShareMember_20130930" decimals="INF" unitRef="U_iso4217USD_shares">4.49</arwr:CommonStockIssuanceValuePerShare>
  <arwr:CommonStockIssuanceValuePerShare id="F_000716" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwoDollarsAndTwentySixCentsPerShareMember_20130930" decimals="INF" unitRef="U_iso4217USD_shares">2.26</arwr:CommonStockIssuanceValuePerShare>
  <arwr:CommonStockIssuanceValuePerShare id="F_000717" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwoDollarsAndTwelveCentsPerShareMember_20130930" decimals="INF" unitRef="U_iso4217USD_shares">2.12</arwr:CommonStockIssuanceValuePerShare>
  <arwr:CommonStockIssuanceValuePerShare id="F_000718" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtOneDollarAndEightyThreeCentsPerShareMember_20130930" decimals="INF" unitRef="U_iso4217USD_shares">1.83</arwr:CommonStockIssuanceValuePerShare>
  <arwr:PreferredStockIssuanceValuePerShare id="F_000719" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrPreferredStockIssuedAtThousandDollarsPerShareMember_20130930" decimals="INF" unitRef="U_iso4217USD_shares">1000</arwr:PreferredStockIssuanceValuePerShare>
  <arwr:CommonStockIssuanceValuePerShare id="F_000720" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiveDollarsAndEightySixCentsPerShareMember_20140331" decimals="INF" unitRef="U_iso4217USD_shares">5.86</arwr:CommonStockIssuanceValuePerShare>
  <arwr:CommonStockIssuanceValuePerShare id="F_000721" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtEighteenDollarAndNinetyFiveCentsPerShareMember_20140331" decimals="INF" unitRef="U_iso4217USD_shares">18.95</arwr:CommonStockIssuanceValuePerShare>
  <arwr:PreferredStockIssuanceValuePerShare id="F_000722" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrPreferredStockIssuedAtThousandDollarsPerShareMember_20140331" decimals="INF" unitRef="U_iso4217USD_shares">1000</arwr:PreferredStockIssuanceValuePerShare>
  <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax id="F_000723" contextRef="C_0000879407_20121001_20130331" decimals="0" unitRef="U_iso4217USD">-354</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax>
  <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax id="F_000724" contextRef="C_0000879407_20030501_20140331" decimals="0" unitRef="U_iso4217USD">-42838408</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax>
  <us-gaap:GainLossOnSaleOfInvestments id="F_000725" contextRef="C_0000879407_20030501_20140331" decimals="0" unitRef="U_iso4217USD">762954</us-gaap:GainLossOnSaleOfInvestments>
  <arwr:ProvisionForAllowanceForBadDebtsAndSalesRelatedAllowances id="F_000726" contextRef="C_0000879407_20030501_20140331" decimals="0" unitRef="U_iso4217USD">2497300</arwr:ProvisionForAllowanceForBadDebtsAndSalesRelatedAllowances>
  <arwr:GainLossFromSaleOfSubsidiary id="F_000727" contextRef="C_0000879407_20030501_20140331" decimals="0" unitRef="U_iso4217USD">306344</arwr:GainLossFromSaleOfSubsidiary>
  <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims id="F_000728" contextRef="C_0000879407_20030501_20140331" decimals="0" unitRef="U_iso4217USD">741632</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
  <us-gaap:ResearchAndDevelopmentInProcess id="F_000729" contextRef="C_0000879407_20030501_20140331" decimals="0" unitRef="U_iso4217USD">15851555</us-gaap:ResearchAndDevelopmentInProcess>
  <us-gaap:AmortizationOfDebtDiscountPremium id="F_000730" contextRef="C_0000879407_20131001_20140331" decimals="0" unitRef="U_iso4217USD">269313</us-gaap:AmortizationOfDebtDiscountPremium>
  <us-gaap:AmortizationOfDebtDiscountPremium id="F_000731" contextRef="C_0000879407_20121001_20130331" decimals="0" unitRef="U_iso4217USD">36931</us-gaap:AmortizationOfDebtDiscountPremium>
  <us-gaap:AmortizationOfDebtDiscountPremium id="F_000732" contextRef="C_0000879407_20030501_20140331" decimals="0" unitRef="U_iso4217USD">399171</us-gaap:AmortizationOfDebtDiscountPremium>
  <arwr:NonCashImpairmentCharges id="F_000733" contextRef="C_0000879407_20121001_20130331" decimals="0" unitRef="U_iso4217USD">1279882</arwr:NonCashImpairmentCharges>
  <arwr:NonCashImpairmentCharges id="F_000734" contextRef="C_0000879407_20030501_20140331" decimals="0" unitRef="U_iso4217USD">3958496</arwr:NonCashImpairmentCharges>
  <us-gaap:GainLossOnSaleOfEquityInvestments id="F_000735" contextRef="C_0000879407_20121001_20130331" decimals="0" unitRef="U_iso4217USD">-221169</us-gaap:GainLossOnSaleOfEquityInvestments>
  <us-gaap:GainLossOnSaleOfEquityInvestments id="F_000736" contextRef="C_0000879407_20030501_20140331" decimals="0" unitRef="U_iso4217USD">-963407</us-gaap:GainLossOnSaleOfEquityInvestments>
  <arwr:NoncontrollingInterest id="F_000737" contextRef="C_0000879407_20131001_20140331" decimals="0" unitRef="U_iso4217USD">97600</arwr:NoncontrollingInterest>
  <arwr:NoncontrollingInterest id="F_000738" contextRef="C_0000879407_20121001_20130331" decimals="0" unitRef="U_iso4217USD">348650</arwr:NoncontrollingInterest>
  <arwr:NoncontrollingInterest id="F_000739" contextRef="C_0000879407_20030501_20140331" decimals="0" unitRef="U_iso4217USD">19477029</arwr:NoncontrollingInterest>
  <us-gaap:IncreaseDecreaseInReceivables id="F_000740" contextRef="C_0000879407_20131001_20140331" decimals="0" unitRef="U_iso4217USD">-75000</us-gaap:IncreaseDecreaseInReceivables>
  <us-gaap:IncreaseDecreaseInReceivables id="F_000741" contextRef="C_0000879407_20121001_20130331" decimals="0" unitRef="U_iso4217USD">-9375</us-gaap:IncreaseDecreaseInReceivables>
  <us-gaap:IncreaseDecreaseInReceivables id="F_000742" contextRef="C_0000879407_20030501_20140331" decimals="0" unitRef="U_iso4217USD">-109415</us-gaap:IncreaseDecreaseInReceivables>
  <us-gaap:IncreaseDecreaseInOtherReceivables id="F_000743" contextRef="C_0000879407_20131001_20140331" decimals="0" unitRef="U_iso4217USD">611360</us-gaap:IncreaseDecreaseInOtherReceivables>
  <us-gaap:IncreaseDecreaseInOtherReceivables id="F_000744" contextRef="C_0000879407_20121001_20130331" decimals="0" unitRef="U_iso4217USD">-1080</us-gaap:IncreaseDecreaseInOtherReceivables>
  <us-gaap:IncreaseDecreaseInOtherReceivables id="F_000745" contextRef="C_0000879407_20030501_20140331" decimals="0" unitRef="U_iso4217USD">3153422</us-gaap:IncreaseDecreaseInOtherReceivables>
  <us-gaap:IncreaseDecreaseInPrepaidExpense id="F_000746" contextRef="C_0000879407_20131001_20140331" decimals="0" unitRef="U_iso4217USD">69608</us-gaap:IncreaseDecreaseInPrepaidExpense>
  <us-gaap:IncreaseDecreaseInPrepaidExpense id="F_000747" contextRef="C_0000879407_20121001_20130331" decimals="0" unitRef="U_iso4217USD">-191732</us-gaap:IncreaseDecreaseInPrepaidExpense>
  <us-gaap:IncreaseDecreaseInPrepaidExpense id="F_000748" contextRef="C_0000879407_20030501_20140331" decimals="0" unitRef="U_iso4217USD">505994</us-gaap:IncreaseDecreaseInPrepaidExpense>
  <us-gaap:IncreaseDecreaseInOtherOperatingAssets id="F_000749" contextRef="C_0000879407_20131001_20140331" decimals="0" unitRef="U_iso4217USD">136403</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
  <us-gaap:IncreaseDecreaseInOtherOperatingAssets id="F_000750" contextRef="C_0000879407_20121001_20130331" decimals="0" unitRef="U_iso4217USD">214318</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
  <us-gaap:IncreaseDecreaseInOtherOperatingAssets id="F_000751" contextRef="C_0000879407_20030501_20140331" decimals="0" unitRef="U_iso4217USD">301969</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
  <us-gaap:IncreaseDecreaseInAccountsPayable id="F_000752" contextRef="C_0000879407_20131001_20140331" decimals="0" unitRef="U_iso4217USD">1311947</us-gaap:IncreaseDecreaseInAccountsPayable>
  <us-gaap:IncreaseDecreaseInAccountsPayable id="F_000753" contextRef="C_0000879407_20121001_20130331" decimals="0" unitRef="U_iso4217USD">-6279</us-gaap:IncreaseDecreaseInAccountsPayable>
  <us-gaap:IncreaseDecreaseInAccountsPayable id="F_000754" contextRef="C_0000879407_20030501_20140331" decimals="0" unitRef="U_iso4217USD">2131904</us-gaap:IncreaseDecreaseInAccountsPayable>
  <us-gaap:IncreaseDecreaseInAccruedLiabilities id="F_000755" contextRef="C_0000879407_20131001_20140331" decimals="0" unitRef="U_iso4217USD">275370</us-gaap:IncreaseDecreaseInAccruedLiabilities>
  <us-gaap:IncreaseDecreaseInAccruedLiabilities id="F_000756" contextRef="C_0000879407_20121001_20130331" decimals="0" unitRef="U_iso4217USD">199242</us-gaap:IncreaseDecreaseInAccruedLiabilities>
  <us-gaap:IncreaseDecreaseInAccruedLiabilities id="F_000757" contextRef="C_0000879407_20030501_20140331" decimals="0" unitRef="U_iso4217USD">1024199</us-gaap:IncreaseDecreaseInAccruedLiabilities>
  <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities id="F_000758" contextRef="C_0000879407_20131001_20140331" decimals="0" unitRef="U_iso4217USD">-214329</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
  <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities id="F_000759" contextRef="C_0000879407_20121001_20130331" decimals="0" unitRef="U_iso4217USD">26516</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
  <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities id="F_000760" contextRef="C_0000879407_20030501_20140331" decimals="0" unitRef="U_iso4217USD">727922</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
  <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations id="F_000761" contextRef="C_0000879407_20131001_20140331" decimals="0" unitRef="U_iso4217USD">-14720054</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
  <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations id="F_000762" contextRef="C_0000879407_20121001_20130331" decimals="0" unitRef="U_iso4217USD">-8304350</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
  <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations id="F_000763" contextRef="C_0000879407_20030501_20140331" decimals="0" unitRef="U_iso4217USD">-109630676</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment id="F_000764" contextRef="C_0000879407_20131001_20140331" decimals="0" unitRef="U_iso4217USD">607772</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment id="F_000765" contextRef="C_0000879407_20121001_20130331" decimals="0" unitRef="U_iso4217USD">31468</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment id="F_000766" contextRef="C_0000879407_20030501_20140331" decimals="0" unitRef="U_iso4217USD">4949961</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments id="F_000767" contextRef="C_0000879407_20121001_20130331" decimals="0" unitRef="U_iso4217USD">1160181</us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments>
  <us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments id="F_000768" contextRef="C_0000879407_20030501_20140331" decimals="0" unitRef="U_iso4217USD">4732688</us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments>
  <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment id="F_000769" contextRef="C_0000879407_20121001_20130331" decimals="0" unitRef="U_iso4217USD">129454</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
  <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment id="F_000770" contextRef="C_0000879407_20030501_20140331" decimals="0" unitRef="U_iso4217USD">522192</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
  <us-gaap:PaymentsToAcquireMarketableSecurities id="F_000771" contextRef="C_0000879407_20131001_20140331" decimals="0" unitRef="U_iso4217USD">46365528</us-gaap:PaymentsToAcquireMarketableSecurities>
  <us-gaap:PaymentsToAcquireMarketableSecurities id="F_000772" contextRef="C_0000879407_20030501_20140331" decimals="0" unitRef="U_iso4217USD">75674014</us-gaap:PaymentsToAcquireMarketableSecurities>
  <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities id="F_000773" contextRef="C_0000879407_20131001_20140331" decimals="0" unitRef="U_iso4217USD">5010238</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
  <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities id="F_000774" contextRef="C_0000879407_20030501_20140331" decimals="0" unitRef="U_iso4217USD">23898503</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
  <us-gaap:CashDivestedFromDeconsolidation id="F_000775" contextRef="C_0000879407_20030501_20140331" decimals="0" unitRef="U_iso4217USD">1579365</us-gaap:CashDivestedFromDeconsolidation>
  <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired id="F_000776" contextRef="C_0000879407_20030501_20140331" decimals="0" unitRef="U_iso4217USD">250000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
  <us-gaap:PaymentsToAcquireAdditionalInterestInSubsidiaries id="F_000777" contextRef="C_0000879407_20030501_20140331" decimals="0" unitRef="U_iso4217USD">2000000</us-gaap:PaymentsToAcquireAdditionalInterestInSubsidiaries>
  <us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates id="F_000778" contextRef="C_0000879407_20030501_20140331" decimals="0" unitRef="U_iso4217USD">10150000</us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates>
  <us-gaap:ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates id="F_000779" contextRef="C_0000879407_20030501_20140331" decimals="0" unitRef="U_iso4217USD">10529594</us-gaap:ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates>
  <us-gaap:ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries id="F_000780" contextRef="C_0000879407_20030501_20140331" decimals="0" unitRef="U_iso4217USD">359375</us-gaap:ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries>
  <us-gaap:PaymentsToAcquireIntangibleAssets id="F_000781" contextRef="C_0000879407_20030501_20140331" decimals="0" unitRef="U_iso4217USD">303440</us-gaap:PaymentsToAcquireIntangibleAssets>
  <us-gaap:IncreaseDecreaseInRestrictedCash id="F_000782" contextRef="C_0000879407_20030501_20140331" decimals="0" unitRef="U_iso4217USD">-50773</us-gaap:IncreaseDecreaseInRestrictedCash>
  <us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations id="F_000783" contextRef="C_0000879407_20131001_20140331" decimals="0" unitRef="U_iso4217USD">-41963062</us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations>
  <us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations id="F_000784" contextRef="C_0000879407_20121001_20130331" decimals="0" unitRef="U_iso4217USD">1258167</us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations>
  <us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations id="F_000785" contextRef="C_0000879407_20030501_20140331" decimals="0" unitRef="U_iso4217USD">-54813655</us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations>
  <us-gaap:RepaymentsOfLongTermCapitalLeaseObligations id="F_000786" contextRef="C_0000879407_20131001_20140331" decimals="0" unitRef="U_iso4217USD">204448</us-gaap:RepaymentsOfLongTermCapitalLeaseObligations>
  <us-gaap:RepaymentsOfLongTermCapitalLeaseObligations id="F_000787" contextRef="C_0000879407_20121001_20130331" decimals="0" unitRef="U_iso4217USD">106595</us-gaap:RepaymentsOfLongTermCapitalLeaseObligations>
  <us-gaap:RepaymentsOfLongTermCapitalLeaseObligations id="F_000788" contextRef="C_0000879407_20030501_20140331" decimals="0" unitRef="U_iso4217USD">615855</us-gaap:RepaymentsOfLongTermCapitalLeaseObligations>
  <us-gaap:ProceedsFromIssuanceOfCommonStock id="F_000789" contextRef="C_0000879407_20131001_20140331" decimals="0" unitRef="U_iso4217USD">180620980</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:ProceedsFromIssuanceOfCommonStock id="F_000790" contextRef="C_0000879407_20121001_20130331" decimals="0" unitRef="U_iso4217USD">7089327</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:ProceedsFromIssuanceOfCommonStock id="F_000791" contextRef="C_0000879407_20030501_20140331" decimals="0" unitRef="U_iso4217USD">331379995</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:ProceedsFromIssuanceOfLongTermDebt id="F_000792" contextRef="C_0000879407_20030501_20140331" decimals="0" unitRef="U_iso4217USD">2516467</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
  <arwr:ProceedsFromSaleOfStockInSubsidiary id="F_000793" contextRef="C_0000879407_20030501_20140331" decimals="0" unitRef="U_iso4217USD">20902100</arwr:ProceedsFromSaleOfStockInSubsidiary>
  <us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations id="F_000794" contextRef="C_0000879407_20131001_20140331" decimals="0" unitRef="U_iso4217USD">180416532</us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations>
  <us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations id="F_000795" contextRef="C_0000879407_20121001_20130331" decimals="0" unitRef="U_iso4217USD">6982732</us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations>
  <us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations id="F_000796" contextRef="C_0000879407_20030501_20140331" decimals="0" unitRef="U_iso4217USD">354182707</us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations>
  <us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations id="F_000797" contextRef="C_0000879407_20121001_20130331" decimals="0" unitRef="U_iso4217USD">-354</us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations>
  <us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations id="F_000798" contextRef="C_0000879407_20030501_20140331" decimals="0" unitRef="U_iso4217USD">-46004141</us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations>
  <us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations id="F_000799" contextRef="C_0000879407_20030501_20140331" decimals="0" unitRef="U_iso4217USD">790625</us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations>
  <us-gaap:CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations id="F_000800" contextRef="C_0000879407_20030501_20140331" decimals="0" unitRef="U_iso4217USD">-1677000</us-gaap:CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations>
  <us-gaap:NetCashProvidedByUsedInDiscontinuedOperations id="F_000801" contextRef="C_0000879407_20121001_20130331" decimals="0" unitRef="U_iso4217USD">-354</us-gaap:NetCashProvidedByUsedInDiscontinuedOperations>
  <us-gaap:NetCashProvidedByUsedInDiscontinuedOperations id="F_000802" contextRef="C_0000879407_20030501_20140331" decimals="0" unitRef="U_iso4217USD">-46890516</us-gaap:NetCashProvidedByUsedInDiscontinuedOperations>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease id="F_000803" contextRef="C_0000879407_20131001_20140331" decimals="0" unitRef="U_iso4217USD">123733416</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease id="F_000804" contextRef="C_0000879407_20121001_20130331" decimals="0" unitRef="U_iso4217USD">-63805</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease id="F_000805" contextRef="C_0000879407_20030501_20140331" decimals="0" unitRef="U_iso4217USD">142847860</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue id="F_000806" contextRef="C_0000879407_20120930" decimals="0" unitRef="U_iso4217USD">3377288</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue id="F_000807" contextRef="C_0000879407_20130331" decimals="0" unitRef="U_iso4217USD">3313483</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:InterestPaid id="F_000808" contextRef="C_0000879407_20131001_20140331" decimals="0" unitRef="U_iso4217USD">17105</us-gaap:InterestPaid>
  <us-gaap:InterestPaid id="F_000809" contextRef="C_0000879407_20121001_20130331" decimals="0" unitRef="U_iso4217USD">21828</us-gaap:InterestPaid>
  <us-gaap:InterestPaid id="F_000810" contextRef="C_0000879407_20030501_20140331" decimals="0" unitRef="U_iso4217USD">339837</us-gaap:InterestPaid>
  <us-gaap:IncomeTaxesPaid id="F_000811" contextRef="C_0000879407_20030501_20140331" decimals="0" unitRef="U_iso4217USD">742500</us-gaap:IncomeTaxesPaid>
  <us-gaap:CommonStockSharesIssued id="F_000812" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToGallowayMember_20140218" decimals="INF" unitRef="U_shares">131579</us-gaap:CommonStockSharesIssued>
  <arwr:CommonStockPurchasedFromMinorityShareHolders id="F_000813" contextRef="C_0000879407_deiLegalEntityAxis_arwrInsertTherapeuticsIncMember_20050323" decimals="INF" unitRef="U_shares">7375000</arwr:CommonStockPurchasedFromMinorityShareHolders>
  <us-gaap:CommonStockSharesIssued id="F_000814" contextRef="C_0000879407_deiLegalEntityAxis_arwrInsertTherapeuticsIncMember_20050323" decimals="INF" unitRef="U_shares">50226</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockValue id="F_000815" contextRef="C_0000879407_deiLegalEntityAxis_arwrInsertTherapeuticsIncMember_20050323" decimals="0" unitRef="U_iso4217USD">2000000</us-gaap:CommonStockValue>
  <arwr:CommonStockPurchasedFromMinorityShareHolders id="F_000816" contextRef="C_0000879407_deiLegalEntityAxis_arwrCalandoPharmaceuticalsIncMember_20060331" decimals="INF" unitRef="U_shares">964000</arwr:CommonStockPurchasedFromMinorityShareHolders>
  <us-gaap:CommonStockSharesIssued id="F_000817" contextRef="C_0000879407_deiLegalEntityAxis_arwrCalandoPharmaceuticalsIncMember_20060331" decimals="INF" unitRef="U_shares">20838</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockValue id="F_000818" contextRef="C_0000879407_deiLegalEntityAxis_arwrCalandoPharmaceuticalsIncMember_20060331" decimals="0" unitRef="U_iso4217USD">1077333</us-gaap:CommonStockValue>
  <arwr:ValueOfCommonStockPurchasedFromMinorityShareHolders id="F_000819" contextRef="C_0000879407_deiLegalEntityAxis_arwrCalandoPharmaceuticalsIncMember_20060331" decimals="0" unitRef="U_iso4217USD">1928000</arwr:ValueOfCommonStockPurchasedFromMinorityShareHolders>
  <arwr:ValueOfCommonStockPurchasedByCash id="F_000820" contextRef="C_0000879407_deiLegalEntityAxis_arwrCalandoPharmaceuticalsIncMember_20060331" decimals="0" unitRef="U_iso4217USD">850667</arwr:ValueOfCommonStockPurchasedByCash>
  <us-gaap:CommonStockSharesIssued id="F_000821" contextRef="C_0000879407_deiLegalEntityAxis_arwrCarbonNanotechnologiesIncMember_us-gaapStatementClassOfStockAxis_us-gaapSeriesEPreferredStockMember_20070420" decimals="INF" unitRef="U_shares">143122</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockValue id="F_000822" contextRef="C_0000879407_deiLegalEntityAxis_arwrCarbonNanotechnologiesIncMember_us-gaapStatementClassOfStockAxis_us-gaapSeriesEPreferredStockMember_20070420" decimals="0" unitRef="U_iso4217USD">5400000</us-gaap:CommonStockValue>
  <arwr:CommonStockPurchasedFromMinorityShareHolders id="F_000823" contextRef="C_0000879407_deiLegalEntityAxis_arwrUnidymIncMember_20080423" decimals="INF" unitRef="U_shares">200000</arwr:CommonStockPurchasedFromMinorityShareHolders>
  <us-gaap:CommonStockSharesIssued id="F_000824" contextRef="C_0000879407_deiLegalEntityAxis_arwrUnidymIncMember_20080423" decimals="INF" unitRef="U_shares">7054</us-gaap:CommonStockSharesIssued>
  <arwr:ValueOfCommonStockPurchasedByCash id="F_000825" contextRef="C_0000879407_deiLegalEntityAxis_arwrUnidymIncMember_20080423" decimals="0" unitRef="U_iso4217USD">200000</arwr:ValueOfCommonStockPurchasedByCash>
  <us-gaap:CommonStockSharesIssued id="F_000826" contextRef="C_0000879407_deiLegalEntityAxis_arwrMsEnergyLlcMember_20080429" decimals="INF" unitRef="U_shares">10504</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockValue id="F_000827" contextRef="C_0000879407_deiLegalEntityAxis_arwrMsEnergyLlcMember_20080429" decimals="0" unitRef="U_iso4217USD">310000</us-gaap:CommonStockValue>
  <arwr:ValueOfCommonStockPurchasedFromMinorityShareHolders id="F_000828" contextRef="C_0000879407_deiLegalEntityAxis_arwrMsEnergyLlcMember_20080429" decimals="0" unitRef="U_iso4217USD">560000</arwr:ValueOfCommonStockPurchasedFromMinorityShareHolders>
  <arwr:ValueOfCommonStockPurchasedByCash id="F_000829" contextRef="C_0000879407_deiLegalEntityAxis_arwrMsEnergyLlcMember_20080429" decimals="0" unitRef="U_iso4217USD">250000</arwr:ValueOfCommonStockPurchasedByCash>
  <us-gaap:CommonStockSharesIssued id="F_000830" contextRef="C_0000879407_deiLegalEntityAxis_arwrUnidymIncMember_20080808" decimals="INF" unitRef="U_shares">11411</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockValue id="F_000831" contextRef="C_0000879407_deiLegalEntityAxis_arwrUnidymIncMember_20080808" decimals="0" unitRef="U_iso4217USD">250000</us-gaap:CommonStockValue>
  <us-gaap:CommonStockSharesIssued id="F_000832" contextRef="C_0000879407_deiLegalEntityAxis_arwrUnidymIncMember_us-gaapStatementClassOfStockAxis_us-gaapSeriesAPreferredStockMember_20090611" decimals="INF" unitRef="U_shares">132462</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockValue id="F_000833" contextRef="C_0000879407_deiLegalEntityAxis_arwrUnidymIncMember_us-gaapStatementClassOfStockAxis_us-gaapSeriesAPreferredStockMember_20090611" decimals="0" unitRef="U_iso4217USD">688802</us-gaap:CommonStockValue>
  <us-gaap:CommonStockSharesIssued id="F_000834" contextRef="C_0000879407_deiLegalEntityAxis_arwrUnidymIncMember_us-gaapStatementClassOfStockAxis_us-gaapSeriesCPreferredStockMember_20090625" decimals="INF" unitRef="U_shares">194444</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockValue id="F_000835" contextRef="C_0000879407_deiLegalEntityAxis_arwrUnidymIncMember_us-gaapStatementClassOfStockAxis_us-gaapSeriesCPreferredStockMember_20090625" decimals="0" unitRef="U_iso4217USD">972222</us-gaap:CommonStockValue>
  <us-gaap:CommonStockSharesIssued id="F_000836" contextRef="C_0000879407_deiLegalEntityAxis_arwrUnidymIncMember_us-gaapStatementClassOfStockAxis_us-gaapSeriesAPreferredStockMember_20090922" decimals="INF" unitRef="U_shares">9149</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockValue id="F_000837" contextRef="C_0000879407_deiLegalEntityAxis_arwrUnidymIncMember_us-gaapStatementClassOfStockAxis_us-gaapSeriesAPreferredStockMember_20090922" decimals="0" unitRef="U_iso4217USD">46662</us-gaap:CommonStockValue>
  <us-gaap:CommonStockSharesIssued id="F_000838" contextRef="C_0000879407_deiLegalEntityAxis_arwrUnidymIncMember_20090928" decimals="INF" unitRef="U_shares">64227</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesIssued id="F_000839" contextRef="C_0000879407_deiLegalEntityAxis_arwrUnidymIncMember_us-gaapStatementClassOfStockAxis_us-gaapSeriesAPreferredStockMember_20090928" decimals="INF" unitRef="U_shares">5574</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesIssued id="F_000840" contextRef="C_0000879407_deiLegalEntityAxis_arwrUnidymIncMember_us-gaapStatementClassOfStockAxis_us-gaapSeriesCPreferredStockMember_20090928" decimals="INF" unitRef="U_shares">636699</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockValue id="F_000841" contextRef="C_0000879407_deiLegalEntityAxis_arwrUnidymIncMember_20090928" decimals="0" unitRef="U_iso4217USD">398209</us-gaap:CommonStockValue>
  <us-gaap:CommonStockSharesIssued id="F_000842" contextRef="C_0000879407_deiLegalEntityAxis_arwrUnidymIncMember_us-gaapStatementClassOfStockAxis_arwrSeriesCOnePreferredStockMember_20090930" decimals="INF" unitRef="U_shares">27777</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockValue id="F_000843" contextRef="C_0000879407_deiLegalEntityAxis_arwrUnidymIncMember_us-gaapStatementClassOfStockAxis_arwrSeriesCOnePreferredStockMember_20090930" decimals="0" unitRef="U_iso4217USD">186111</us-gaap:CommonStockValue>
  <us-gaap:CommonStockSharesIssued id="F_000844" contextRef="C_0000879407_deiLegalEntityAxis_arwrUnidymIncMember_us-gaapStatementClassOfStockAxis_us-gaapSeriesCPreferredStockMember_20091130" decimals="INF" unitRef="U_shares">15317</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockValue id="F_000845" contextRef="C_0000879407_deiLegalEntityAxis_arwrUnidymIncMember_us-gaapStatementClassOfStockAxis_us-gaapSeriesCPreferredStockMember_20091130" decimals="0" unitRef="U_iso4217USD">47485</us-gaap:CommonStockValue>
  <arwr:CommonStockPurchasedFromMinorityShareHolders id="F_000846" contextRef="C_0000879407_deiLegalEntityAxis_arwrCalandoPharmaceuticalsIncMember_20091130" decimals="INF" unitRef="U_shares">2850000</arwr:CommonStockPurchasedFromMinorityShareHolders>
  <us-gaap:CommonStockSharesIssued id="F_000847" contextRef="C_0000879407_deiLegalEntityAxis_arwrCalandoPharmaceuticalsIncMember_20091130" decimals="INF" unitRef="U_shares">114000</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockValue id="F_000848" contextRef="C_0000879407_deiLegalEntityAxis_arwrCalandoPharmaceuticalsIncMember_20091130" decimals="0" unitRef="U_iso4217USD">706800</us-gaap:CommonStockValue>
  <arwr:WarrantsIssued id="F_000849" contextRef="C_0000879407_deiLegalEntityAxis_arwrCalandoPharmaceuticalsIncMember_20091130" decimals="INF" unitRef="U_shares">24000</arwr:WarrantsIssued>
  <arwr:WarrantsPurchased id="F_000850" contextRef="C_0000879407_deiLegalEntityAxis_arwrCalandoPharmaceuticalsIncMember_20091130" decimals="INF" unitRef="U_shares">600000</arwr:WarrantsPurchased>
  <arwr:CommonStockPurchasedFromMinorityShareHolders id="F_000851" contextRef="C_0000879407_deiLegalEntityAxis_arwrCalandoPharmaceuticalsIncMember_20100228" decimals="INF" unitRef="U_shares">200000</arwr:CommonStockPurchasedFromMinorityShareHolders>
  <us-gaap:CommonStockSharesIssued id="F_000852" contextRef="C_0000879407_deiLegalEntityAxis_arwrCalandoPharmaceuticalsIncMember_20100228" decimals="INF" unitRef="U_shares">8000</us-gaap:CommonStockSharesIssued>
  <arwr:WarrantsIssued id="F_000853" contextRef="C_0000879407_deiLegalEntityAxis_arwrCalandoPharmaceuticalsIncMember_20100228" decimals="INF" unitRef="U_shares">2400</arwr:WarrantsIssued>
  <arwr:WarrantsPurchased id="F_000854" contextRef="C_0000879407_deiLegalEntityAxis_arwrCalandoPharmaceuticalsIncMember_20100228" decimals="INF" unitRef="U_shares">60000</arwr:WarrantsPurchased>
  <arwr:ExercisePriceOfWarrants id="F_000855" contextRef="C_0000879407_deiLegalEntityAxis_arwrCalandoPharmaceuticalsIncMember_20100228" decimals="INF" unitRef="U_iso4217USD_shares">5.00</arwr:ExercisePriceOfWarrants>
  <us-gaap:CommonStockSharesIssued id="F_000856" contextRef="C_0000879407_20100331" decimals="INF" unitRef="U_shares">12870</us-gaap:CommonStockSharesIssued>
  <arwr:WarrantsExercised id="F_000857" contextRef="C_0000879407_20100331" decimals="INF" unitRef="U_shares">24788</arwr:WarrantsExercised>
  <arwr:CommonStockPurchasedFromMinorityShareHolders id="F_000858" contextRef="C_0000879407_deiLegalEntityAxis_arwrCalandoPharmaceuticalsIncMember_us-gaapStatementClassOfStockAxis_us-gaapSeriesAPreferredStockMember_20100930" decimals="INF" unitRef="U_shares">1562.5</arwr:CommonStockPurchasedFromMinorityShareHolders>
  <arwr:WarrantsIssued id="F_000859" contextRef="C_0000879407_deiLegalEntityAxis_arwrCalandoPharmaceuticalsIncMember_us-gaapStatementClassOfStockAxis_us-gaapSeriesAPreferredStockMember_20100930" decimals="INF" unitRef="U_shares">390625</arwr:WarrantsIssued>
  <arwr:ExercisePriceOfWarrants id="F_000860" contextRef="C_0000879407_deiLegalEntityAxis_arwrCalandoPharmaceuticalsIncMember_us-gaapStatementClassOfStockAxis_us-gaapSeriesAPreferredStockMember_20100930" decimals="INF" unitRef="U_iso4217USD_shares">5.00</arwr:ExercisePriceOfWarrants>
  <us-gaap:CommonStockSharesIssued id="F_000861" contextRef="C_0000879407_deiLegalEntityAxis_arwrRocheMadisonMember_20111021" decimals="INF" unitRef="U_shares">1288158</us-gaap:CommonStockSharesIssued>
  <arwr:BusinessCombinationConsiderationPromissoryNoteIssued id="F_000862" contextRef="C_0000879407_deiLegalEntityAxis_arwrRocheMadisonMember_20111021" decimals="0" unitRef="U_iso4217USD">50000</arwr:BusinessCombinationConsiderationPromissoryNoteIssued>
  <us-gaap:CommonStockSharesIssued id="F_000863" contextRef="C_0000879407_deiLegalEntityAxis_arwrAlvosTherapeuticsMember_20120405" decimals="INF" unitRef="U_shares">315457</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesIssued id="F_000864" contextRef="C_0000879407_deiLegalEntityAxis_arwrRocheMadisonMember_20121021" decimals="INF" unitRef="U_shares">239894</us-gaap:CommonStockSharesIssued>
  <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 id="F_000865" contextRef="C_0000879407_20121020_20121021" decimals="0" unitRef="U_iso4217USD">986049</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
  <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock id="F_000866" contextRef="C_0000879407_20131001_20140331">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;NOTE 1. &lt;/font&gt;&lt;font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES&lt;/font&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt; &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-style:italic;;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Nature of Business &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;Arrowhead Research Corporation is a biopharmaceutical company developing targeted &lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;RNAi therapeutics. The Company is leveraging its proprietary drug delivery technologies to develop targeted drugs based on the RNA interference mechanism that efficiently silence disease-causing genes. Arrowhead technologies also enable partners to create peptide-drug conjugates that specifically home to cell types of interest while sparing off-target tissues. Arrowhead&amp;#8217;s pipeline includes clinical programs in chronic hepatitis B virus and obesity and partner-based programs in oncology.&lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-style:italic;;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Liquidity &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;Historically, the Company&amp;#8217;s primary source of financing has been through the sale of securities of Arrowhead&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;.  Research and development activities have required significant capital investment since the Company&amp;#8217;s inception and we expect our operations to continue to require cash investment in fiscal 2014 and beyond as the Company advances its research and development efforts, including clinical trials, and related drug manufacturing.&amp;nbsp;&amp;nbsp; &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;At March 31, 201&lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;, the Company had $142.8 million in cash to fund operations. In addition to its cash resources, the Company has invested excess cash in investment grade commercial bonds maturing in less than 30 months.&amp;nbsp;&amp;nbsp;These bonds provide a source of liquidity, though the Company plans to hold them until maturity.&amp;nbsp;&amp;nbsp;At March 31, 2014, the Company had invested $51.8 million in bonds.&amp;nbsp;&amp;nbsp;During the six months ended March 31, 2014, the Company&amp;#8217;s cash position increased by $123.7 million. The Company received cash from the issuance of equity of $172.6 million and cash from the exercise of warrants and options of $8.0 million during the six months ended March 31, 2014.&amp;nbsp;&amp;nbsp;Net cash invested in fixed income investments totaled a net change of $41.4 million. During the six months ended March 31, 2014, the Company had cash outflow of $14.7 million related to its continuing operating activities and capital expenditures of $&lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.6&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; million. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-style:italic;;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Summary of Significant Accounting Policies &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;Principles of Consolidation&amp;#8212;The&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; consolidated financial statements include the accounts of Arrowhead and its Subsidiaries.&amp;nbsp;&amp;nbsp;Arrowhead&amp;#8217;s primary operating subsidiary is Arrowhead Madison, which is located in Madison, Wisconsin, where the Company&amp;#8217;s research and development facilities are located.&amp;nbsp;&amp;nbsp;All significant intercompany accounts and transactions are eliminated in consolidation, and noncontrolling interests are accounted for in the Company&amp;#8217;s financial statements. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;Basis of Presentation&amp;#8212;The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (&amp;#8220;GAAP&amp;#8221;) for interim financial information and in accordance with the instructions to Form&amp;#160;10-Q and Article&amp;#160;8 of Regulation S-X.&amp;nbsp;&amp;nbsp;Accordingly, the financial statements do not include all of the information and notes required by GAAP for complete financial statements. In the opinion of management, all adjustments, including normal recurring accruals, considered necessary for a fair presentation have been included. Interim results are not necessarily indicative of results for a fu&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;ll year.&amp;nbsp;&amp;nbsp;The September 30, 2013 balance sheet was derived from audited financial statements, but does not include all disclosures required by GAAP. This financial information should be read in conjunction with the consolidated financial statements and notes included in the Company&amp;#8217;s Annual Report on Form&amp;#160;10-K for the year ended September&amp;#160;30, 2013.&amp;nbsp;&amp;nbsp;Certain reclassifications have been made to prior period financial statements to conform to the current period presentation.  &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;Use of Estimates&amp;#8212;The&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the accompanying financial statements. Actual results could differ from those estimates.&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;Cash and Cash Equivalents&amp;#8212;The Company considers all liquid debt instruments purchased with a maturity of three months or less to be cash equivalents.&amp;nbsp;&amp;nbsp;The Company had no&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; restricted cash at March 31, 2014 and 2013.&lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;Concentration of Credit Risk&amp;#8212;The Company maintains several checking accounts for its operations at two financial institutions. These accounts are insured by the Federal Deposit Insurance Corporation (FDIC) for up to $250,000&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; per account. Management believes the Company is not exposed to significant credit risk due to the financial position of the depository institutions in which these deposits are held. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;Investments&amp;#8212;The Company invests excess cash balances in short-term and long-term marketable debt securities. Investments may consist of certificates of deposits, money market accounts, government-sponsored enterprise securities, corporate bonds and/or commercial paper. The Company accounts for its investment in marketable securities in accordance with FASB ASC 320, Investments &amp;#8211; Debt and Equity Securities.&amp;#160;This statement requires certain securities to be classified into three categories: &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:4.53%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Held-to-maturity&amp;#8212;Debt securities that the entity has the positive intent and ability to hold to maturity are reported at amortized cost. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:4.53%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Trading Securities&amp;#8212;Debt and equity securities that are bought and held primarily for the purpose of selling in the near term are reported at fair value, with unrealized gains and losses included in earnings. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:4.53%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Available-for-Sale&amp;#8212;Debt and equity securities not classified as either securities held-to-maturity or trading securities are reported at fair value with unrealized gains or losses excluded from earnings and reported as a separate component of shareholders&amp;#8217; equity. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;The Company classifies its investments in marketable debt securities based on the facts and circumstances present at the time of purchase of the securities. At &lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;March 31, 2014&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;, the Company classified all of its investments as held-to-maturity. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;Held-to-maturity investments are measured and recorded at amortized cost on the Company&amp;#8217;s Consolidated Balance Sheet. Discounts and premiums to par value of the debt securities are amortized to interest income/expense over the term of the security. No gains or losses on investment securities are realized until they are sold or a decline in fair value is determined to be other-than-temporary. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;As of March 31, 2014&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;, all short-term investments were comprised of corporate bonds with maturity dates of less than one year. Certain investments maturing in excess of twelve months, but less than 30 months are classified as long-term investments.&amp;nbsp;&amp;nbsp;As of March 31, 2014, the amortized cost of such bonds was $51,846,834. As of March 31, 2014, gross unrealized losses were $283,376; there were no gross unrealized gains. The total fair value of the investments at &lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;March 31, 2014&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; was $51,563,458.&lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;See further information regarding fair market value of marketable debt securities in Note 1&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1 &amp;#8211; Fair Value Measurements, such fair market data is obtained from independent pricing services. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;Property and Equipment&amp;#8212;Property and equipment are recorded at cost, which may equal fair market value in the case of property and equipment acquired in conjunction with a business acquisition. Depreciation of property and equipment is recorded using the straight-line method over the respective useful lives of the assets ranging from three&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; to seven years. Leasehold improvements are amortized over the lesser of the expected useful life or the remaining lease term. Long-lived assets, including property and equipment are reviewed for impairment whenever events or circumstances indicate that the carrying amount of these assets may not be recoverable. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;Intangible Assets Subject to Amortization&amp;#8212;At &lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;March 31, 2014&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;, intangible assets subject to amortization included certain license agreements acquired through business combinations. Intangible assets subject to amortization are reviewed for impairment whenever events or circumstances indicate that the carrying amount of these assets may not be recoverable. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;In-Process Research&amp;#160;&amp;amp; Development (IPR&amp;amp;D)&amp;#8212;IPR&amp;amp;D assets represent capitalized on-going research projects that Arrowhead acquired through business combinations. Such assets are initially measured at their acquisition date fair values. The amounts capitalized are being accounted for as indefinite-lived intangible assets, subject to impairment testing until completion or abandonment of R&amp;amp;D efforts associated with the project. Upon successful completion of a project, Arrowhead will make a determination as to the then remaining useful life of the intangible asset and begin amortization. Based on early adoption of ASU 2012-02, Arrowhead tests its indefinite-lived assets for impairment at least annually, through a two-step process. The first step is a qualitative assessment to determine if it is more likely than not that the indefinite lived assets are impaired. Arrowhead considers relevant events and circumstances that could affect the inputs used to determine the fair value of the intangible assets. If the qualitative assessment indicates that it is more likely than not that the intangible assets is impaired, a second step is performed which is a quantitative test to determine the fair value of the intangible asset. If the carrying amount of the intangible assets exceeds its fair value, an impairment loss is recorded in the amount of that excess. If circumstances determine that it is appropriate, the Company may also elect to bypass step one, and proceed directly to the second step. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;Contingent Consideration - &lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The consideration for our acquisitions often includes future payments that are contingent upon the occurrence of a particular event.&amp;nbsp;&amp;nbsp;For example, milestone payments might be based on the achievement of various regulatory approvals or future sales milestones, and royalty payments might be based on drug product sales levels. We record a contingent consideration obligation for such contingent payments at fair value on the acquisition date. We estimate the fair value of contingent consideration obligations through valuation models designed to estimate the probability of such contingent payments based on various assumptions and incorporating estimated success rates.&amp;nbsp;&amp;nbsp;Estimated payments are discounted using present value techniques to arrive at estimated fair value at the balance sheet date. Changes in the fair value of our contingent consideration obligations are recognized within our consolidated statements of operations. Changes in the fair value of the contingent consideration obligations can result from changes to one or multiple inputs, including adjustments to the discount rates, changes in the amount or timing of expected expenditures associated with product development, changes in the amount or timing of cash flows from products upon commercialization, changes in the assumed achievement or timing of any development milestones, changes in the probability of certain clinical events and changes in the assumed probability associated with regulatory approval. These fair value measurements are based on significant inputs not observable in the market. Significant judgment is employed in determining the appropriateness of these assumptions as of the acquisition date and for each subsequent period. Accordingly, changes in assumptions could have a material impact on the amount of contingent consideration expense we record in any given period.&lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;Minority Equity Investments&amp;#8212;The Company&amp;#8217;s had a minority equity investment in Leonardo, a privately held biotechnology company.&amp;nbsp;&amp;nbsp;This investment has been fully impaired and the net book value at March 31, 2014&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; is $0.&amp;nbsp;&amp;nbsp;The operations of Leonardo ceased in December 2013. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;Noncontrolling Interests in Majority-Owned Subsidiaries&amp;#8212;Operating losses applicable to majority-owned Calando, &lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Ablaris and, prior to its disposal, Unidym have periodically exceeded the noncontrolling interests in the equity capital of either Subsidiary. Such excess losses applicable to the noncontrolling interests have been and are borne by the Company as there is no obligation of the noncontrolling interests to fund any losses in excess of their original investment. There is also no obligation or commitment on the part of the Company to fund operating losses of any Subsidiary whether wholly-owned or majority-owned. The Company allocates the noncontrolling interest&amp;#8217;s share of net loss in excess of the noncontrolling interest&amp;#8217;s initial investment in accordance with FASB ASC 810-10. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;When there is a change in the Company&amp;#8217;s proportionate ownership &lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;share of a development-stage Subsidiary resulting from additional equity transactions in the Subsidiary, the change is accounted for as an equity transaction in consolidation. To the extent that the increase in the calculated value of the Company&amp;#8217;s interest in the equity of the Subsidiary exceeds the Company&amp;#8217;s investment in the transaction, that increase in value is referred to as the Company&amp;#8217;s &amp;#8220;increase in its proportionate share of the Subsidiary&amp;#8217;s equity&amp;#8221; and the amount is recorded as an increase in the Company&amp;#8217;s Additional Paid-in Capital. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;Revenue Recognition&amp;#8212;Revenue from license fees are recorded when persuasive evidence of an arrangement exists, title has passed or services have been rendered, a price is fixed and determinable, and collection is reasonably assured. We may generate revenue from product sales, technology licenses, collaborative research and development arrangements, and research grants. Revenue under technology licenses and collaborative agreements typically consists of nonrefundable and/or guaranteed technology license fees, collaborative research funding and various milestone and future product royalty or profit-sharing payments. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;Revenue associated payments under collaborative research and development &lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;agreements, is recognized ratably over the relevant periods specified in the agreement, generally the period during which research and development is conducted. Revenue from up-front license fees, milestones and product royalties are recognized as earned based on the completion of the milestones and product sales, as defined in the respective agreements. Payments received in advance of recognition as revenue are recorded as deferred revenue. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;Allowance for Doubtful Accounts&amp;#8212;The Company accrues an allowance for doubtful accounts based on estimates of uncollectible revenues by analyzing historical collections, accounts receivable aging and other factors. Accounts receivable are written off when all collection attempts have failed. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;Research and Development&amp;#8212;Costs and expenses that can be clearly identified as research and development are charged to expense as incurred in accordance with FASB ASC 730-10. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;Earnings (Loss) per Share&amp;#8212;Basic earnings (loss) per share is computed using the weighted-average number of common shares outstanding during the period. Diluted earnings (loss) per share are computed using the weighted-average number of common shares and dilutive potential common shares outstanding during the period. Dilutive potential common shares primarily consist of stock options issued to employees and consultants and warrants to purchase Common Stock of the Company.&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;Stock-Based Compensation&amp;#8212;The Company accounts for share-based compensation arrangements in accordance with FASB ASC 718, which requires the measurement and recognition of compensation expense for all share-based payment awards to be based on estimated fair values. We use the Black-Scholes option valuation model to estimate the fair value of our stock options at the date of grant. The Black-Scholes option valuation model requires the input of subjective assumptions to calculate the value of stock options. We use historical data and&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; other information to estimate the expected price volatility and the expected forfeiture rate. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;Derivative Assets and Liabilities - &lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We account for warrants and other derivative financial instruments as either equity or assets/liabilities based upon the characteristics and provisions of each instrument. Warrants classified as equity are recorded as additional paid-in capital on our consolidated balance sheet and no further adjustments to their valuation are made. Some of our warrants were determined to be ineligible for equity classification because of provisions that may result in an adjustment to their exercise price. Warrants classified as derivative liabilities and other derivative financial instruments that require separate accounting as assets or liabilities are recorded on our consolidated balance sheet at their fair value on the date of issuance and are revalued on each subsequent balance sheet date until such instruments are exercised or expire, with any changes in the fair value between reporting periods recorded as other income or expense. We estimate the fair value of these assets/liabilities using option pricing models that are based on the individual characteristics of the warrants or instruments on the valuation date, as well as assumptions for expected volatility, expected life and risk-free interest rate. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;Income Taxes&amp;#8212;The Company accounts for income taxes under the liability method, which requires the recognition of deferred income tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this method, deferred income taxes are recognized for the tax consequences in future years of differences between the tax bases of assets and liabilities and their financial reporting amounts at each period end based on enacted tax laws and statutory tax rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred income tax assets to the amount expected to be realized. The provision for income taxes, if any, represents the tax payable for the period and the change in deferred income tax assets and liabilities during the period. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Recently Issued Accounting Standards &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;In July 2013, the FASB issued ASU 2013-11, &lt;/font&gt;&lt;font style="font-style:italic;;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;Income Taxes (Topic 740): Presentation of an Unrecognized Tax Benefit When a Net Operating Loss &lt;/font&gt;&lt;font style="font-style:italic;;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;, which eliminates diversity in practice for the presentation of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss or a tax credit carryforward is available to reduce the taxable income or tax payable that would result from disallowance of a tax position. ASU 2013-11 affects only the presentation of such amounts in an entity&amp;#8217;s balance sheet and is effective for fiscal years beginning after December 15, 2013 and interim periods within those years. Early adoption is permitted. We are evaluating the impact, if any, of the adoption of ASU 2013-11 on our balance sheet.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock>
  <us-gaap:CostAndEquityMethodInvestmentsDisclosureTextBlock id="F_000867" contextRef="C_0000879407_20131001_20140331">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;NOTE 2. &lt;/font&gt;&lt;font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;INVESTMENTS&lt;/font&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt; &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;The Company invests its excess cash balances in short-term and long-term debt securities.&amp;nbsp;&amp;nbsp;Investments at March 31, 2014&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; consisted of corporate bonds with maturities remaining of less than three years at the time of purchase.&amp;nbsp;&amp;nbsp;The Company may also invest excess cash balances in certificates of deposit, money market accounts, US Treasuries, US government agency obligations, corporate debt securities, and/or commercial paper.&amp;nbsp;&amp;nbsp;The Company accounts for its investments in accordance with FASB ASC 320, Investments &amp;#8211; Debt and Equity Securities.&amp;nbsp;&amp;nbsp;At &lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;March 31, 2014&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;, all investments were classified as held-to-maturity securities.&lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;The following tables summarize the Company&amp;#8217;s short and long-term investments as of March 31, 2014&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;, and September 30, 2013. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:92%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:41%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="14" valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of March 31, 2014&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:41%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Amortized Cost&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Gross Unrealized Gains&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Gross Unrealized Losses&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Fair Value&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top" bgcolor="#CFF0FC" style="width:41%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;text-indent:-12.25pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Commercial notes (due within one year)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;17,798,475&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(115,181&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;17,683,294&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top" style="width:41%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;text-indent:-12.25pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Commercial notes (due after one year through two years)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;34,048,359&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(168,195&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;33,880,164&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top" bgcolor="#CFF0FC" style="width:41%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;text-indent:-12.25pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;51,846,834&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(283,376&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;51,563,458&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:92%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:41%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="14" valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of September&amp;#160;30, 2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:41%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Amortized Cost&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Gross Unrealized Gains&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Gross Unrealized Losses&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Fair Value&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top" bgcolor="#CFF0FC" style="width:41%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;text-indent:-12.25pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Commercial notes (due within one year)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9,030,261&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7,500&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(39,281&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8,998,480&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top" style="width:41%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;text-indent:-12.25pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Commercial notes (due after one year through two years)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,702,153&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(2,362&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,699,791&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top" bgcolor="#CFF0FC" style="width:41%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;text-indent:-12.25pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10,732,414&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7,500&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(41,643&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10,698,271&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/div&gt;</us-gaap:CostAndEquityMethodInvestmentsDisclosureTextBlock>
  <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock id="F_000868" contextRef="C_0000879407_20131001_20140331">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:10pt;;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;NOTE 3. &lt;/font&gt;&lt;font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;FIXED ASSETS&lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-weight:bold;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;Property, equipment and other fixed assets are recorded at cost, which may equal fair market value in the case of property and equipment acquired in conjunction with a business acquisition. Depreciation of property and equipment is recorded using the straight-line method over the respective useful lives of the assets ranging from three to seven years. Leasehold improvements are amortized over the lesser of the expected useful life or the remaining lease term.&lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:76%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:51%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Balance as of&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:51%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&lt;font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;March 31, 2014&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;September 30, 2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:51%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Computers, office equipment and furniture&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;317,867&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Arial;font-size:10pt;"&gt;&lt;font style="font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;323,376&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:51%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Research equipment&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,826,494&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Arial;font-size:10pt;"&gt;&lt;font style="font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,452,013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:51%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Software&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;69,623&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Arial;font-size:10pt;"&gt;&lt;font style="font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;69,623&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:51%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Leasehold improvements&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,749,409&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Arial;font-size:10pt;"&gt;&lt;font style="font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,749,409&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:51%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total gross fixed assets &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,963,393&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Arial;font-size:10pt;"&gt;&lt;font style="font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,594,421&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:51%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Less:&amp;nbsp;&amp;nbsp; Accumulated depreciation and amortization&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(3,673,123&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Arial;font-size:10pt;"&gt;&lt;font style="font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(3,081,186&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:51%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Property and equipment, net &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,290,270&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Arial;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,513,235&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
  <us-gaap:BusinessCombinationDisclosureTextBlock id="F_000869" contextRef="C_0000879407_20131001_20140331">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;NOTE 4. &lt;/font&gt;&lt;font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;ACQUISITIONS&lt;/font&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt; &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Roche Madison &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;On October&amp;#160;21, 2011, the Company entered into a Stock and Asset Purchase Agreement (the &amp;#8220;RNAi&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; Purchase Agreement&amp;#8221;) with Hoffmann-La Roche Inc. and F Hoffmann-La Roche Ltd (collectively, &amp;#8220;Roche&amp;#8221;), pursuant to which the Company purchased from Roche (i)&amp;#160;all of the outstanding common stock of Roche Madison Inc. (&amp;#8220;Roche Madison&amp;#8221;, now &amp;#8220;Arrowhead Madison&amp;#8221;) and (ii)&amp;#160;the intellectual property rights then held by Roche related to its RNAi business and identified in the RNAi Purchase Agreement (the &amp;#8220;Transaction&amp;#8221;). In consideration for the purchase of Roche Madison and the Roche RNAi assets, the Company issued to Roche a promissory note with a principal value of $50,000 and 1,288,158 shares of Common Stock. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;Pursuant to the RNAi&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; Purchase Agreement, Roche has a right of first negotiation on certain product candidates developed by the Company and its affiliates relating to the purchased assets. If the Company proposes to out-license or enters into substantive negotiations to out-license, any Clinical Candidate or Existing Candidate (as such terms are defined in the RNAi Purchase Agreement), the Company must give notice of the Candidate it proposes to out-license and negotiate exclusively and in good faith with Roche for 90 days regarding the applicable out-license. This right of first negotiation applies to all Existing Candidates (as defined in the RNAi Purchase Agreement) and the first five Clinical Candidates for which the Company delivers notice to Roche and subsequently enters into an out-license. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;In addition to the consideration paid by the Company as per the closing terms, the Company is obligated to make certain royalty and milestone payments to Roche upon the occurrence of certain events. For certain product candidates that are developed by the Company that are covered by a valid claim by the patent rights transferred in the Transaction for which the Company and Roche do not enter into a licensing arrangement, the Company will be obligated to pay a 3&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;% royalty on Net Sales (as defined in the RNAi Purchase Agreement), provided that the royalty rate may be reduced or offset in certain circumstances. The obligation to pay royalties on such candidates will last until the later of (i)&amp;#160;the expiration of the last to expire patent right related to such product candidate that was transferred in the Transaction and (ii)&amp;#160;ten years after the first commercial sale of such product candidate. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;The Company will also be obligated to make cash payments to Roche upon the achievement of various milestones for certain clinical candidates, for which the Company and Roche do not enter into a licensing arrangement, including the first regulatory approval in certain jurisdictions, and upon certain annual sales milestones for candidates that receive regulatory approval. The potential payments range from $2,500,000&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; to $6,000,000 per milestone. At the time of acquisition, the Company&amp;#8217;s estimate of future payments for potential royalties and milestones had a net present value of $84,935 which was recorded as contingent consideration as a part of other noncurrent liabilities.&amp;nbsp;&amp;nbsp;Contingent consideration is calculated by modeling research and development activities for clinical candidates, forecasting timelines to market, and using &amp;#8220;peak sales&amp;#8221; estimate modeling, cash flows and potential milestone and royalty payments are calculated.&amp;nbsp;&amp;nbsp;The modeling assumes certain success rates, and discount factors related to riskiness of projects and the time value of money to calculate a net present value of future consideration payments to Roche.&amp;nbsp;&amp;nbsp;These estimates are based on many unknown variables that are difficult to estimate, and due to the extended process of drug development prior to marketing of drug candidates, the models must extend many years into the future.&amp;nbsp;&amp;nbsp;Such predictions are inherently uncertain.&amp;nbsp;&amp;nbsp;Each year, the Company re-evaluates its contingent consideration, and if material, makes adjustments to the recorded liability.&amp;nbsp;&amp;nbsp;Any adjustment to the contingent consideration liability is reflected in the Company&amp;#8217;s Statement of Operations.&amp;nbsp;&amp;nbsp;During fiscal 2013, the contingent consideration liability was increased by $1.4 million, which is recorded as a part of other noncurrent liabilities on the Company&amp;#8217;s Consolidated Balance Sheet. For additional information related to our valuation of this obligation, see &lt;/font&gt;&lt;font style="font-style:italic;;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Note 11, Fair Value Measurements&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
  <us-gaap:IntangibleAssetsDisclosureTextBlock id="F_000870" contextRef="C_0000879407_20131001_20140331">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;NOTE 5. &lt;/font&gt;&lt;font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;INTANGIBLE ASSETS&lt;/font&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt; &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;Intangible assets consist of in-process research and development (&amp;#8220;IPR&amp;amp;D&amp;#8221;) not subject to amortization, and other intangible assets subject to amortization, which were capitalized as a part of a business combination. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;IPR&amp;amp;D represents projects that have not yet received regulatory approval and are required to be classified as indefinite assets until the successful completion or the abandonment of the associated R&amp;amp;D efforts. Accordingly, during the development period after the date of acquisition, these assets will not be amortized until approval is obtained in one or more jurisdictions which, individually or combined, are expected to generate a significant portion of the total revenue expected to be earned by an IPR&amp;amp;D project. At that time, we will determine the useful life of the asset, reclassify the asset out of IPR&amp;amp;D and begin amortization. If the associated R&amp;amp;D effort is abandoned the related IPR&amp;amp;D assets will likely be written off and we would record an impairment loss. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;Intangible assets subject to amortization include patents capitalized as part of a business combination as well as license agreements capitalized as part of a business combination from the acquisition of Roche Madison.&amp;nbsp;&amp;nbsp; &lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The license agreements are being amortized over the estimated life remaining at the time of acquisition which was 4 years. Patents are amortized over a period of three years to twenty years. The weighted average original amortization period is twelve years. Amortization of license agreements and patents is expected to be approximately $55,000 for fiscal years 201&lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4 and &lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;201&lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;, $13,000 in 2016, and zero thereafter. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;We review amounts capitalized as IPR&amp;amp;D for impairment at least annually in the fourth quarter, and whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. In the event the carrying value of the assets is not expected to be recovered, the assets are written down to their estimated fair values. We continue to test our indefinite-lived IPR&amp;amp;D assets for potential impairment until the projects are completed or abandoned. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;The following table provides details on our intangible asset balances: &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:84%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:46%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Intangible&amp;#160;assets&lt;/font&gt;&lt;font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;br /&gt;&lt;/font&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;not subject to&lt;br /&gt;amortization&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&lt;font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Intangible&amp;#160;assets&lt;br /&gt;subject to&lt;br /&gt;amortization&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&lt;font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;br /&gt;Intangible&amp;#160;assets&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&lt;font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top" bgcolor="#CFF0FC" style="width:46%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Balance at September&amp;#160;30, 2011&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,731,211&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,731,211&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top" style="width:46%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Additions&lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Madison acquisition&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;944,935&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;230,000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,174,935&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top" bgcolor="#CFF0FC" style="width:46%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Additions&lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Alvos acquisition&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,172,387&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,172,387&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top" style="width:46%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Amortization&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(293,964&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(293,964&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top" bgcolor="#CFF0FC" style="width:46%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Balance at September&amp;#160;30, 2012&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,117,322&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,667,247&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,784,569&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top" style="width:46%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Impairment&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1,308,047&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1,308,047&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height:11.5pt;"&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:46%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Amortization&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(236,009 &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(236,009&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height:11.5pt;"&gt;
&lt;td valign="bottom" style="width:46%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Balance at September&amp;#160;30, 2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,117,322&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;123,191&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,240,513&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height:11.5pt;"&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:46%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Amortization&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(27,327&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(27,327&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top" style="width:46%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Balance at March 31, 2014&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,117,322&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;95,864&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,213,186&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/div&gt;</us-gaap:IntangibleAssetsDisclosureTextBlock>
  <us-gaap:EquityMethodInvestmentsDisclosureTextBlock id="F_000871" contextRef="C_0000879407_20131001_20140331">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;NOTE 6. &lt;/font&gt;&lt;font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;INVESTMENT IN SUBSIDIARIES&lt;/font&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt; &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;In addition to 100&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;% ownership interest in Arrowhead Madison Inc., Arrowhead also maintains majority ownership in Calando Pharmaceuticals, Ablaris Therapeutics, Inc., and a minority investment in Leonardo Biosystems, Inc. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-style:italic;;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Calando Pharmaceuticals, Inc. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-family:;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;Calando is a developer of polymer delivery systems for siRNA and small molecule based therapeutics.&amp;nbsp;&amp;nbsp;Calando&amp;#8217;s current cash resources preclude additional development of its platform technology and therapeutic candidates.&amp;nbsp;&amp;nbsp;Arrowhead has determined that it will not provide substantial further investment to Calando based on Arrowhead evaluation of Calando&amp;#8217;s development and business prospects and Calando has been unsuccessful in its efforts to obtain capital from other sources.&amp;nbsp;&amp;nbsp;Calando has ceased operations and terminated its technology license with the California Institute of Technology on which its siRNA therapeutic development efforts were based.&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&amp;nbsp;Further, pursuant to an involuntary petition by an unpaid Noteholder, Calando is undergoing Chapter 7 bankruptcy proceedings.&lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;In 2009, Calando outlicensed&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; its small molecule program to Cerulean Pharma, Inc., a Boston, MA-based biotech company which has continued the development of the program.&amp;nbsp;&amp;nbsp;Under the license, as the development program progresses, Calando could collect partnership, milestone and royalty programs from Cerulean.&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;Calando has an outstanding promissory note with a balance of principal and interest totaling $&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,210,000 as of March 31, 2014.&amp;nbsp;&amp;nbsp;The promissory note became due November&amp;#160;26, 2013; see Note 7 for further information.&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;As of March 31, 2014&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;, Calando owed to Arrowhead $&lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4.6&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; million under a series of 8% simple interest notes and advances. It is unlikely these notes will be repaid in full. The balance of the notes and advances is eliminated in consolidation. In fiscal 2013, the Calando patent estate was returned to Caltech, and the Calando technology is not being pursued.&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;As of March 31, 2014&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;, Arrowhead owned &lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;79&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;% of the outstanding shares of Calando and &lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;76&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;% on a fully diluted basis.&amp;nbsp;&amp;nbsp;As a result of the pending bankruptcy proceeding for Calando, we do not expect our equity ownership to result in any return of capital as part of the liquidation of Calando.&amp;nbsp;&amp;nbsp;. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-style:italic;;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Ablaris Therapeutics, Inc. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;Ablaris was formed and began operations in fiscal 2011, based on the license of certain anti-obesity technology developed at the MD Anderson Cancer Center at the University of Texas. During fiscal 2011, Ablaris raised $2.9&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; million in cash, of which $1.3 million was invested by Arrowhead and $1.6 million was invested by outside investors, through the issuance of Ablaris Series A Preferred stock. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;As of March 31, 2014&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;, Arrowhead owned &lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;64&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;% of the outstanding shares of Ablaris and &lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;64&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;% on a fully diluted basis. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-style:italic;;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Leonardo Biosystems, Inc. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;Leonardo, a privately-held drug-delivery company in which Arrowhead has a 3% ownership interest,&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; ceased operations in December 2013. Arrowhead&amp;#8217;s investment in Leonardo and its receivable from Leonardo have been fully reserved.&amp;nbsp;&amp;nbsp; &lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:EquityMethodInvestmentsDisclosureTextBlock>
  <us-gaap:DebtDisclosureTextBlock id="F_000872" contextRef="C_0000879407_20131001_20140331">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;NOTE 7. &lt;/font&gt;&lt;font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;NOTES PAYABLE&lt;/font&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt; &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;On November&amp;#160;26, 2008, Calando entered into Unsecured Convertible Promissory Note Agreements (&amp;#8220;Notes&amp;#8221;) for $2.5&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; million with accredited investors and Arrowhead, which invested $200,000 in the Notes offering. Arrowhead subsequently invested an additional $600,000 in the same offering. Except for one Note in the principal amount of $500,000, all Notes and accrued interest were converted into a total of 2,950 shares of Calando Series A Preferred Stock on June&amp;#160;23, 2009. The remaining Note had a 10% interest rate, matured on November&amp;#160;26, 2010, and was renegotiated and extended until November&amp;#160;26, 2013. The terms of the new note include a 10% interest rate and require two times principal payment at maturity. The interest rate while the Note is in default is 15%.&amp;nbsp;&amp;nbsp;The Note became due on November 26, 2013, but was not repaid due to lack of cash resources at Calando.&amp;nbsp;&amp;nbsp;At March 31, 2014, the Note is reflected on the balance sheet at the maturity amount of $1.&lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; million.&amp;nbsp;&amp;nbsp;Accrued interest in the amount of $210,000 is reflected as a part of accrued expenses on the Company&amp;#8217;s Consolidated Balance Sheet. The holder of the Note initiated an involuntary petition of bankruptcy against Calando; Arrowhead did not object.&amp;nbsp;&amp;nbsp;A trustee has been appointed and a meeting of Calando creditors has occurred.&amp;nbsp;&amp;nbsp;It is expected that the trustee will dispose of Calando assets, primarily its license agreement with Cerulean.&amp;nbsp;&amp;nbsp;We cannot estimate the proceeds from the disposition of Calando&amp;#8217;s assets, nor how it will be distributed amongst its various creditors, which includes Arrowhead and the holder of the Note.  &lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
  <us-gaap:StockholdersEquityNoteDisclosureTextBlock id="F_000873" contextRef="C_0000879407_20131001_20140331">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;NOTE 8. &lt;/font&gt;&lt;font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;STOCKHOLDERS&amp;#8217; EQUITY&lt;/font&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt; &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;At March 31, 2014&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;, the Company had a total of 150,000,000 shares of capital stock authorized for issuance, consisting of 145,000,000 shares of Common Stock, par value $0.001, and 5,000,000 shares of Preferred Stock, par value $0.001. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt; At &lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;March 31, 2014, &lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;51,867,071&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; shares of Common Stock were outstanding.&amp;nbsp;&amp;nbsp;Additionally, 21,291 shares of Preferred Stock were outstanding, including 5,291 shares of Series B Preferred Stock, convertible into 2,891,257 shares of Common Stock, and 16,000 shares of Series C Preferred Stock, convertible into 2,730,375 shares of Common Stock, (collectively, the &amp;#8220;Outstanding Preferred Stock&amp;#8221;). At March 31, 2014, 3,451,210 shares were reserved for issuance upon exercise of options granted under Arrowhead&amp;#8217;s 2000 Stock Option Plan, 2004 Equity Incentive Plan, and 2013 Incentive Plan, as well as for inducement grants made to new employees. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;The Outstanding Preferred Stock is convertible to Common Stock by each&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; holder at its stated conversion price, subject to a 9.99% beneficial ownership limit for each holder.&amp;nbsp;&amp;nbsp;The holders of Outstanding Preferred Stock are eligible to vote with the Common Stock of the Company on an as-converted basis, but only to the extent they are eligible for conversion without exceeding the 9.99% ownership limitation. The Outstanding Preferred Stock does not carry a coupon, but is entitled to receive dividends on a pari passu basis with the Common Stock, when and if declared.&amp;nbsp;&amp;nbsp;In any liquidation or dissolution of the Company, the holders of Outstanding Preferred Stock are entitled to participate in the distribution of the assets, to the extent legally available for distribution, on a pari passu basis with the Common Stock.&lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;On October&amp;#160;20, 2011, the Company and Lincoln Park Capital Fund, LLC, an Illinois limited liability company (&amp;#8220;LPC&amp;#8221;) entered into a $15&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; million purchase agreement (the &amp;#8220;Purchase Agreement&amp;#8221;), whereby LPC agreed to purchase up to $15 million of Common Stock, subject to certain limitations, from time to time during the three-year term of the Purchase Agreement. The Company has the right, in its sole discretion, over a 36-month period to sell up to $15 million of Common Stock (subject to certain limitations) to LPC, depending on certain conditions as set forth in the Purchase Agreement. As of March 31, 2014, the Company had drawn $1 million from the facility. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;On October&amp;#160;21, 2011 and October&amp;#160;24, 2011, the Company entered into Subscription Agreements with certain accredited investors (the &amp;#8220;Series A Purchasers&amp;#8221;), pursuant to which the Company issued and sold an aggregate of 1,015&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; shares of Series A Preferred Convertible Stock, $0.001 par value per share, at a purchase price of $1,000 per share. The aggregate purchase price paid for the shares of Series A Preferred was $1,015,000. On February&amp;#160;16, 2012, upon approval by the Company&amp;#8217;s shareholders, 1,015 shares of Arrowhead Series A Preferred Convertible Stock, $0.001 par value per share, were converted to 275,782 shares of Common Stock. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;On October&amp;#160;21, 2011, the Company entered into a Subscription Agreement with an accredited investor, pursuant to which the Company issued and sold an aggregate of 675,000&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; shares of Common Stock, $0.001 par value per share, at a purchase price of $3.70 per share. The aggregate purchase price paid by the purchaser for the shares of Common Stock is $2,497,500. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;On August&amp;#160;10, 2012 the Company sold 2,260,869&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; units at a price of $2.76 per unit. Each unit consisted of one share of common stock and a warrant to purchase 0.75 shares of common stock at an exercise price of $3.25. Gross proceeds from the offering were $6.2 million excluding offering fees and expenses. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;In December 2012, the Company sold 1,825,079&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; units at a price of $2.26 per unit. Each unit consisted of one share of common stock and a warrant to purchase 0.5 shares of common stock. Gross proceeds from the offering were $4.1 million excluding offering fees and expenses. The exercise price of these warrants was $1.83 as of September&amp;#160;30, 2013, and may decrease based on certain specified events.&amp;nbsp;&amp;nbsp;As a result, the Company determined these warrants were ineligible for equity classification.&amp;nbsp;&amp;nbsp;Refer to Note 11 for further discussion regarding these warrants. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;In January 2013, the Company sold 1,667,051&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; units at a price of $2.12 per unit. Each unit consisted of one share of common stock and a warrant to purchase 0.5 shares of common stock. Gross proceeds from the offering were $3.5 million excluding offering fees and expenses. The exercise price of these warrants was $1.83 as of September&amp;#160;30, 2013, and may decrease based on certain specified events.&amp;nbsp;&amp;nbsp;As a result, the Company determined these warrants were ineligible for equity classification.&amp;nbsp;&amp;nbsp;Refer to Note 11 for further discussion regarding these warrants. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;In May 2013, the Company sold 14.3&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;million shares of Arrowhead common stock at a price of $1.83 per share and 9,900 shares of Arrowhead series B convertible preferred stock at a price of $1,000 per share. The series B preferred stock is convertible into common stock at a conversion price of $1.83. Gross proceeds were $36 million. No warrants were issued in the May 2013 financing. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;On October&amp;#160;11, 2013, the Company sold 3,071,672&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; shares of common stock, at a price of $5.86 per share, and 46,000 shares of Series&amp;#160;C Convertible Preferred Stock (the &amp;#8220;Preferred Shares&amp;#8221;), at a price of $1,000 per share. The Preferred Shares are convertible into shares of common stock at a conversion price of $5.86. The aggregate purchase price paid by the Purchasers for the Shares and Preferred Shares was $64,000,000 and the Company received net proceeds of approximately $60,000,000, after advisory fees and offering expenses. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;On February 24, 2014, the Company sold 6,325,000&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; shares of common stock, at a public offering price of $18.95 per share.&amp;nbsp;&amp;nbsp;Net proceeds were approximately $112.6 million after underwriting commissions and discounts and other offering expense.&lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;The following table summarizes information about warrants outstanding at March 31, 2014&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;: &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:76%;"&gt;
&lt;tr&gt;
&lt;td colspan="3" valign="top" style="width:58.84%; border-bottom:solid 1pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-weight:bold;;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Exercise&amp;#160;prices&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" style="width:1.38%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:17.8%; border-bottom:solid 1pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Number&amp;#160;of&amp;#160;&lt;br /&gt;Warrants&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.44%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&lt;font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.44%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:17.78%; border-bottom:solid 1pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Remaining&lt;/font&gt;&lt;font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;br /&gt;&lt;/font&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Life&amp;#160;in&amp;#160;Years&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.32%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top" bgcolor="#CFF0FC" style="width:1.98%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" bgcolor="#CFF0FC" style="width:8.56%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;70.60&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:48.28%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" bgcolor="#CFF0FC" style="width:1.38%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.38%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:16.42%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;94,897&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.44%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.44%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.36%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:16.42%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3.1&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.32%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top" style="width:1.98%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" style="width:8.56%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5.00&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:48.28%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" style="width:1.38%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.38%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:16.42%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;995,692&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.44%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.44%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.36%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:16.42%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.7&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.32%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top" bgcolor="#CFF0FC" style="width:1.98%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" bgcolor="#CFF0FC" style="width:8.56%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5.09&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:48.28%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" bgcolor="#CFF0FC" style="width:1.38%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.38%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:16.42%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;291,204&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.44%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.44%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.36%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:16.42%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.7&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.32%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top" style="width:1.98%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" style="width:8.56%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.38&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:48.28%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" style="width:1.38%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.38%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:16.42%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;24,324&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.44%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.44%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.36%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:16.42%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.7&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.32%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top" bgcolor="#CFF0FC" style="width:1.98%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" bgcolor="#CFF0FC" style="width:8.56%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4.16&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:48.28%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" bgcolor="#CFF0FC" style="width:1.38%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.38%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:16.42%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.44%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.44%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.36%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:16.42%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2.7&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.32%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top" style="width:1.98%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" style="width:8.56%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3.25&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:48.28%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" style="width:1.38%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.38%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160; &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:16.42%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;746,306 &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.44%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.44%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.36%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:16.42%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2.4&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.32%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top" bgcolor="#CFF0FC" style="width:1.98%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" bgcolor="#CFF0FC" style="width:8.56%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2.12&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:48.28%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" bgcolor="#CFF0FC" style="width:1.38%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.38%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:16.42%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;75,000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.44%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.44%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.36%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:16.42%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3.7&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.32%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top" style="width:1.98%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" style="width:8.56%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.83&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:48.28%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" style="width:1.38%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.38%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:16.42%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;305,084&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.44%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.44%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.36%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:16.42%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3.7&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.32%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td colspan="3" valign="top" bgcolor="#CFF0FC" style="width:58.84%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total warrants outstanding&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" bgcolor="#CFF0FC" style="width:1.38%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.38%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160; &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:16.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,533,507 &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.44%; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.44%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.36%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:16.42%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.32%; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
  <us-gaap:LeasesOfLesseeDisclosureTextBlock id="F_000874" contextRef="C_0000879407_20131001_20140331">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;NOTE 9. &lt;/font&gt;&lt;font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;LEASES&lt;/font&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt; &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;The Company leases office space for its corporate headquarters in Pasadena, California. In March 2014, the Company signed a lease addendum to expand its corporate headquarters.&amp;nbsp;&amp;nbsp;It is expected the new space will be available in August 201&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4.&amp;nbsp;&amp;nbsp;The leases for the expansion space and the current space will expire in July 2018.&amp;nbsp;&amp;nbsp; Rental costs, including the expansion space are approximately $22,000 per month, increasing 3% annually.  &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;The Company&amp;#8217;s research facility in Madison, Wisconsin is leased through February&amp;#160;28, 2019&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;. Monthly rental expense is approximately $23,000. Other monthly rental expenses include common area maintenance and real estate taxes totaling approximately $15,000 per month. Utilities costs are approximately $14,000 per month. Including monthly payments recorded under a capital lease of approximately $19,000, total monthly costs are approximately $71,000 per month. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;Facility and equipment rent expense, related to continuing operations, for six&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; months ended March 31, 2014 and 201&lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; was $264,000 and $281,000, respectively. From inception to date, rent expense was $4,924,000. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;As of March 31, 2014&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;, future minimum lease payments due in fiscal years under capitalized leases are as follows: &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:68%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:56%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;201&lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4 (remainder of)&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;114,211&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:56%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;201&lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5 &lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;228,420&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:56%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;201&lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6 &lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;228,420&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:56%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;201&lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7 &lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;228,420&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:56%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;201&lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8 &lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;228,420&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:56%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;201&lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9 &lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;and thereafter&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;95,175&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:56%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Less interest&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160; &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(45,055 &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:56%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Principal&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,078,011&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:56%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Less current portion&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(212,234 &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:56%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Noncurrent portion&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;865,777&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;As of March 31, 2014&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;, future minimum lease payments due in fiscal years under operating leases are as follows: &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:68%;"&gt;
&lt;tr&gt;
&lt;td valign="top" bgcolor="#CFF0FC" style="width:56%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;201&lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4 (remainder of)&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;234,692&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top" style="width:56%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;201&lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5 &lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;552,028&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top" bgcolor="#CFF0FC" style="width:56%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;201&lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6 &lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;567,904&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top" style="width:56%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;201&lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7 &lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;583,932&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top" bgcolor="#CFF0FC" style="width:56%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;201&lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8 &lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;607,437&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top" style="width:56%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;201&lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9 &lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;and thereafter&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;393,133 &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top" bgcolor="#CFF0FC" style="width:56%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,939,126&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/div&gt;</us-gaap:LeasesOfLesseeDisclosureTextBlock>
  <us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock id="F_000875" contextRef="C_0000879407_20131001_20140331">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;NOTE 10. &lt;/font&gt;&lt;font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;STOCK-BASED COMPENSATION&lt;/font&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt; &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;Arrowhead has three plans that provide for equity-based compensation. Under the 2000 Stock Option Plan, &lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;50,750 shares of Arrowhead&amp;#8217;s Common Stock are reserved for issuance upon exercise of non-qualified stock options. No further grants can be made under the 2000 Stock Option Plan. The 2004 Equity Incentive Plan reserves 2,735,597 shares for the grant of stock options, stock appreciation rights, restricted stock awards and performance unit/share awards to employees, consultants and others.  The 2013 Incentive Plan reserves 4,000,000 shares for the grant of stock options, stock appreciation rights, restricted stock awards and performance awards to employees, consultant and others.&amp;nbsp;&amp;nbsp;As of March 31, 2014, there were options granted and outstanding to purchase 50,750, 2,733,595 and 615,000 shares of Common Stock under the 2000 Stock Option Plan, the 2004 Equity Incentive Plan and the 2013 Incentive Plan, respectively. Also, as of March 31, 2014, there were 417,406 shares reserved for options issued outside of equity compensation plans as inducement grants to new employees. During the six months ended March 31, 2014, no options were granted under the 2004 Equity Incentive Plan, 615,000 were issued under the 2013 Incentive Plan and 165,000 options were granted outside of equity incentive plans as inducement stock options to new employees. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;The following tables summarize information about stock options:&lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:92%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:41%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unit/Share&lt;/font&gt;&lt;/p&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Number&amp;#160;of&lt;br /&gt;Options&lt;br /&gt;Outstanding&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&lt;font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted-&lt;br /&gt;Average&lt;br /&gt;Exercise&lt;br /&gt;Price&lt;br /&gt;Per&amp;#160;Share&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&lt;font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted-&lt;br /&gt;Average&lt;br /&gt;Remaining&lt;br /&gt;Contractual&lt;br /&gt;Term&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&lt;font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Aggregate&lt;br /&gt;Intrinsic&lt;br /&gt;Value&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:41%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Balance At September&amp;#160;30, 201&lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;729,096&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9.03&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:41%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Granted&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,229,500&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4.40&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:41%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cancelled&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(&lt;/font&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;42,919&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;11.77&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:41%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Exercised&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(&lt;/font&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,883&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5.20&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="middle" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="middle" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:41%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Balance At September&amp;#160;30, 201&lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,910,794&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6.10&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:41%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Granted&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,509,166&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2.03&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:41%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cancelled&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:41%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Exercised&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(675 &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3.93&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="middle" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="middle" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:41%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Balance At September&amp;#160;30, 201&lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,419,285 &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4.68&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:41%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Granted&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;780,000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;13.51&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:41%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cancelled&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(40,196&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4.68&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:41%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Exercised&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(342,338&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6.54&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:41%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Balance At March 31, 2014&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,816,751&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5.81&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7.5 years&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;38,622,771&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:41%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Exercisable At March 31, 2014&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,351,974 &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5.91&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7.2 years&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;14,710,062&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;Stock-based compensation expense for the six&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; months ended March 31, 2014 and 201&lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; was $1,719,582 and $750,782, respectively. There is no income tax benefit as the Company is currently operating at a loss and an actual income tax benefit may not be realized. The loss creates a timing difference, resulting in a deferred tax asset, which is fully reserved by a valuation allowance. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;The fair value of the options granted by the Company during&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; the three months ended March 31, 2014 and 201&lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; is estimated at $&lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7,085,656&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; and $&lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;103,293&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;, respectively.&lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;The intrinsic value of the options exercised during the six&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; months ended March 31, 2014 and 201&lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; was $3,115,175 and $&lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;, respectively; no options were exercised during the six months ended March 31, 2013. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;As of March 31, 2014&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;, the pre-tax compensation expense for all unvested stock options in the amount of approximately $17,294,117 will be recognized in our results of operations over a weighted average period of &lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3.5 &lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;years. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;The fair value of each stock option award is estimated on the date of grant using the Black-Scholes option pricing model. The Black-Scholes option valuation model was developed for use in estimating the fair value of traded options, which do not have vesting restrictions and are fully transferable. The determination of the fair value of each stock option is affected by our stock price on the date of grant, as well as assumptions regarding a number of highly complex and subjective variables. Because the Company&amp;#8217;s employee stock options have characteristics significantly different from those of traded options, and because changes in the subjective input assumptions can materially affect the fair value estimate, in management&amp;#8217;s opinion, the existing models do not necessarily provide a reliable single measure of the fair value of its employee stock options. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;The assumptions used to value stock options are as follows: &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:76%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:62.32%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" style="width:1.46%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="3" valign="bottom" style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:36.22%; border-bottom:solid 1pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Six months&amp;#160;ended&amp;#160;March 31,&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:62.32%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" style="width:1.46%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:17.38%; border-bottom:solid 1pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;201&lt;/font&gt;&lt;font style="font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;4&lt;/font&gt;&lt;font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.46%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:17.38%; border-bottom:solid 1pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;201&lt;/font&gt;&lt;font style="font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;3&lt;/font&gt;&lt;font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:62.32%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Dividend yield&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" bgcolor="#CFF0FC" style="width:1.46%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:17.38%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.46%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:17.38%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:62.32%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Risk-free interest rate&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" style="width:1.46%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:17.38%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.9% to 2.26%&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.46%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:17.38%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.7%&amp;#160; to&amp;#160;1.0%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:62.32%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Volatility&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" bgcolor="#CFF0FC" style="width:1.46%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:17.38%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;69%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.46%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:17.38%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;69%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:62.32%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Expected life (in years)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" style="width:1.46%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:17.38%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5.5 to 6.25&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.46%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:17.38%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5.5 to 6.25&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:62.32%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted average grant date fair value per share of options granted&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" bgcolor="#CFF0FC" style="width:1.46%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:17.38%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$9.08&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.46%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:17.38%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$1.31&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;The dividend yield is zero&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; as the Company currently does not pay a dividend. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;The risk-free interest rate is based on the U.S. Treasury bond. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;Volatility is estimated based on volatility average of the Company&amp;#8217;s Common Stock price. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Restricted Stock Units&lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;Restricted Stock Units (RSUs) are granted under our 2013 Incentive Plan.&amp;nbsp;&amp;nbsp;During the quarter ended March 31, 2014, the Company issued 470,0&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;00 restricted stock units to certain members of management and certain members of its Board of Directors.&amp;nbsp;&amp;nbsp;At vesting each RSU will be exchanged for one share of the Company&amp;#8217;s Common Stock. The RSUs issued to management vest in equal installments on the one and two year anniversary of the date of grant.&amp;nbsp;&amp;nbsp;The RSUs issued to the members of the Board of Directors vest upon the one year anniversary of the date of grant.&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;The following table summarizes the activity of the Company&amp;#8217;s Restricted Stock&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; Units:&lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:76%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:64.68%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:16.76%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;br /&gt;Number of&lt;br /&gt;RSUs&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.38%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&lt;font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:0.96%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:11.9%; border-bottom:solid 1pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted-&lt;br /&gt;Average&lt;br /&gt;Grant&lt;br /&gt;Date&lt;br /&gt;Fair Value&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.38%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&lt;font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.38%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:0.78%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:64.68%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unvested at September&amp;#160;30, 201&lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.08%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:15.7%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;- &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.38%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:0.96%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.4%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10.5%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.38%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.38%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:0.78%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:0.76%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:64.68%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Granted&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.08%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:15.7%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;470,000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.38%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:0.96%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.4%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10.5%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;14.54&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.38%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.38%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:0.78%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:0.76%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:64.68%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Vested&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.08%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:15.7%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.38%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:0.96%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.4%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10.5%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.38%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.38%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:0.78%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:0.76%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:64.68%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Forfeited&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.08%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:15.7%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.38%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:0.96%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.4%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10.5%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.38%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.38%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:0.78%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:0.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:64.68%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unvested at March 31, 2014&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.08%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:15.7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;470,000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.38%; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:0.96%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.4%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10.5%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;14.54&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.38%; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.38%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:0.78%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:0.76%; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;The Company recorded $570,707&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; and $0 of expense relating to restricted stock units during the six months ended March 31, 2014 and 2013 respectively, and such expense is included in stock-based compensation expense.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock>
  <us-gaap:FairValueDisclosuresTextBlock id="F_000876" contextRef="C_0000879407_20131001_20140331">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;NOTE 11. &lt;/font&gt;&lt;font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;FAIR VALUE MEASUREMENTS&lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;The Company measures its financial assets and liabilities at fair value. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (i.e., exit price) in an orderly transaction between market participants at the measurement date. Additionally, the Company is required to provide disclosure and categorize assets and liabilities measured at fair value into one of three different levels depending on the assumptions (i.e., inputs) used in the valuation. Level&amp;#160;1 provides the most reliable measure of fair value while Level&amp;#160;3 generally requires significant management judgment. Financial assets and liabilities are classified in their entirety based on the lowest level of input significant to the fair value measurement. The fair value hierarchy is defined as follows: &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;Level&amp;#160;1&amp;#8212;Valuations are based on unadjusted quoted prices in active markets for identical assets or liabilities. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;Level&amp;#160;2&amp;#8212;Valuations are based on quoted prices for similar assets or liabilities in active markets, or quoted prices in markets that are not active for which significant inputs are observable, either directly or indirectly. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;Level&amp;#160;3&amp;#8212;Valuations are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. Inputs reflect management&amp;#8217;s best estimate of what market participants would use in valuing the asset or liability at the measurement date. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;The following table summarizes fair value measurements at March 31, 2014&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; and September&amp;#160;30, 2013 for assets and liabilities measured at fair value on a recurring basis: &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;March 31, 2014: &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:92%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:41%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 1&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 2&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 3&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&lt;font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:41%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cash and cash equivalents&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;142,847,860&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;142,847,860&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:41%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Derivative assets&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:41%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Derivative liabilities&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,936,530&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,936,530&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:41%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Acquisition related contingent consideration obligations&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,595,273&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,595,273&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;September&amp;#160;30, &lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2013&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;: &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:92%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:41%;"&gt;&lt;p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 1&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 2&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 3&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:41%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cash and cash equivalents&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;19,114,444&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;19,114,444&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:41%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Derivative assets&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:41%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Derivative liabilities&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,096,363&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,096,363&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:41%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Acquisition related contingent consideration obligations&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,595,273&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,595,273&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;The Company invests its excess cash balances in short and long-term corporate bonds, generally with remaining maturities of less than two years.&amp;nbsp;&amp;nbsp;At March 31, 2014&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;, the Company had short-term investments of $17,798,475, and long-term investments of $34,048,359, for a total of $51,846,834.&amp;nbsp;&amp;nbsp;The fair value of its investment at March 31, 2014 was $51,563,458.&amp;nbsp;&amp;nbsp;The Company expects to hold such investments until maturity, and thus unrealized gains and losses from the fluctuations in the fair value of the securities are not likely to be realized.&lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;As part of the proceeds from the sale of Unidym&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; in January 2011, Arrowhead received a bond from Wisepower in the face amount of $2.5 million. The bond is convertible to Wisepower common stock at a price of $2.00 per share. The conversion feature is subject to derivative accounting as prescribed under ASC 815. Accordingly, the fair value of the conversion feature on the date of issuance was estimated using an option pricing model and recorded on the Company&amp;#8217;s consolidated balance sheet as a derivative asset. The fair value of the conversion feature is estimated at the end of each reporting period and the change in the fair value of the conversion feature is recorded as a nonoperating gain/loss as change in value of derivatives in Company&amp;#8217;s Consolidated Statement of Operations. During the quarter ended March&amp;#160;31, 2013, the trading of Wisepower stock was halted. Trading resumed in July 2013, but the trading price is significantly below the conversion price.&amp;nbsp;&amp;nbsp;During fiscal 2013, the Company determined that the probability of realizing value from the conversion feature was remote, and the derivative asset value was reduced to zero.&lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;During the six&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; months ended March 31, 2014, there was no change in the fair value of the derivative asset. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;The assumptions used in valuing the derivative asset were not applicable as the value has been determined to be zero at March 31, 2014&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; and September 30, 2013. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-size:12pt;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:76%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:71%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:14%; border-bottom:solid 1pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;March&amp;#160;31,&amp;#160; 201&lt;/font&gt;&lt;font style="font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;4&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:14%; border-bottom:solid 1pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;September&amp;#160;30,&amp;#160; &lt;/font&gt;&lt;font style="font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:71%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Risk free interest rate&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:14.06%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:14%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:71%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Expected life&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:14.06%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:14%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:71%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Dividend yield&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:14.06%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:14%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:71%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Volatility&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:14.06%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:14%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;The following is a reconciliation of the derivative asset: &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:68%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:56%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Value at September&amp;#160;30, 2012&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;250,250&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:56%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Receipt of instruments&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:56%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Decrease &lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;in value&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(250,250&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:56%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net settlements&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:56%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Value at September&amp;#160;30, 2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:56%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Receipt of instruments&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:56%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Decrease in value&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:56%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net settlements&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:56%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Value at March 31, 2014&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;As part of an equity financing in June 2010, Arrowhead issued warrants to acquire up to 329,649&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; shares of Common Stock (the &amp;#8220;2010 Warrants&amp;#8221;), of which 24,324 warrants were outstanding at March 31, 2014, which contain a mechanism to adjust the strike price upon the issuance of certain dilutive equity securities. If during the term of the 2010 Warrants, the Company issues Common Stock at a price lower than the exercise price of the 2010 Warrants, the exercise price of the 2010 Warrants would be reduced to the amount equal to the issuance price of the Common Stock. Similarly, as part of a financing in December 2012, Arrowhead issued warrants to acquire up to 912,543 shares of Common Stock (the &amp;#8220;2012 Warrants&amp;#8221;) of which 265,461 warrants were outstanding at March 31, 2014, which contain a mechanism to adjust the strike price upon the issuance of certain dilutive equity securities. If during the term of the 2012 Warrants, the Company issues Common Stock at a price lower than the exercise price of the 2012 Warrants, the exercise price of the 2012 Warrants would be reduced to the amount equal to the issuance price of the Common Stock. Further, as part of a financing in January 2013, Arrowhead issued warrants to acquire up to 833,530 shares of Common Stock (the &amp;#8220;2013 Warrants&amp;#8221;) of which 39,623 warrants were outstanding at March 31, 2014 which contain a mechanism to adjust the strike price upon the issuance of certain dilutive equity securities. If during the term of the 2013 Warrants, the Company issues Common Stock at a price lower than the exercise price of the 2013 Warrants, the exercise price of the 2013 Warrants would be reduced to the amount equal to the issuance price of the Common Stock.&amp;nbsp;&amp;nbsp;As a result of these features, the 2010 Warrants, the 2012 Warrants, and the 2013 Warrants are subject to derivative accounting as prescribed under ASC 815. Accordingly, the fair value of the Warrants on the date of issuance was estimated using an option pricing model and recorded on the Company&amp;#8217;s consolidated balance sheet as a derivative liability. The fair value of the Warrants is estimated at the end of each reporting period and the change in the fair value of the Warrants is recorded as a nonoperating gain or loss in the Company&amp;#8217;s consolidated statement of operations. During the six months ended March 31, 2014, the Company recorded a non-cash loss from the change in fair value of the derivative liability of $9,234,419. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;The assumptions used in valuing the derivative liability were as follows: &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-size:12pt;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:76%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:41.24%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2010 Warrants&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2.14%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:27.04%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="text-decoration:underline;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;March 31, 2014&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.58%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2.74%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:25.26%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="text-decoration:underline;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;September&amp;#160;30,&amp;#160;2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:41.24%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Risk free interest rate&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2.14%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:27.04%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.44%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.58%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2.74%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:25.26%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.33%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:41.24%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Expected life&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2.14%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:27.04%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:36pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2.0 Years&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.58%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:36pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2.74%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:25.26%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2.2&amp;#160;Years&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:41.24%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Dividend yield&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2.14%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:27.04%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;None&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.58%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2.74%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:25.26%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;None&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:41.24%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Volatility&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2.14%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:27.04%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;69%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.58%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2.74%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:25.26%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;69%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:41.24%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2.14%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:27.04%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.58%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2.74%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:25.26%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:41.24%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2012 Warrants&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2.14%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:27.04%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="text-decoration:underline;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;March 31, 2014&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.58%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2.74%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:25.26%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="text-decoration:underline;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;September 30, 2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:41.24%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Risk free interest rate&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2.14%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:27.04%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.31%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.58%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2.74%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:25.26%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.39%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:41.24%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Expected life&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2.14%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:27.04%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:36pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3.7 Years&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.58%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2.74%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:25.26%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4.2&amp;#160;Years&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:41.24%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Dividend yield&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2.14%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:27.04%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;None&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.58%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2.74%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:25.26%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;None&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:41.24%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Volatility&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2.14%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:27.04%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;69%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.58%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2.74%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:25.26%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;69%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:41.24%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2.14%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:27.04%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.58%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2.74%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:25.26%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:41.24%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2013 Warrants&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2.14%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:27.04%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="text-decoration:underline;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;March 31, 2014&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.58%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2.74%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:25.26%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="text-decoration:underline;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;September 30, 2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:41.24%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Risk free interest rate&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2.14%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:27.04%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.31%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.58%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2.74%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:25.26%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.39%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:41.24%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Expected life&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2.14%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:27.04%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:36pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3.8 Years&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.58%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2.74%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:25.26%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4.3&amp;#160;Years&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:41.24%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Dividend yield&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2.14%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:27.04%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;None&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.58%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2.74%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:25.26%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;None&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:41.24%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Volatility&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2.14%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:27.04%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;69%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.58%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2.74%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:25.26%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;69%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:1pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;The following is a reconciliation of the derivative liability related to these warrants: &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:68%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:56%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Value at September&amp;#160;30, 2012&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;626,195&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:56%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Issuance of instruments&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,153,819&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:56%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Change in value&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,066,591&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:56%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net settlements&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(3,754,808 &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:56%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Value at September&amp;#160;30, 2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,091,797&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:56%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Issuance of instruments&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:56%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Change in value&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9,234,419&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:56%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net settlements&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(8,447,443)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:56%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Value at March 31, 2014&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,878,773&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:56%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:1pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:1pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:1pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;In conjunction with the financing of Ablaris&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; in fiscal 2011, Arrowhead sold exchange rights to certain investors whereby the investors have the right to exchange their shares of Ablaris for a prescribed number of Arrowhead shares based upon a predefined ratio. The exchange rights have a seven-year term. During the first year, the exchange right allows the holder to exchange one Ablaris share for 0.06 Arrowhead shares (as adjusted for a subsequent reverse stock split). This ratio declines to 0.04 in the second year, 0.03 in the third year and 0.02 in the fourth year. In the fifth year and beyond the exchange ratio is 0.01. Exchange rights for 675,000 Ablaris shares were sold in fiscal 2011, and remain outstanding at March 31, 2014. The exchange rights are subject to derivative accounting as prescribed under ASC 815. Accordingly, the fair value of the exchange rights on the date of issuance was estimated using an option pricing model and recorded on the Company&amp;#8217;s consolidated balance sheet as a derivative liability. The fair value of the exchange rights is estimated at the end of each reporting period and the change in the fair value of the exchange rights is recorded as a nonoperating gain or loss in the Company&amp;#8217;s Consolidated Statement of Operations. During the six months ended March 31, 2014, the Company recorded a non-cash loss from the change in fair value of the derivative liability of $53,190.&lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:76%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:72.36%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:13.16%; border-bottom:solid 1pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&amp;#160; 31,&amp;#160; 201&lt;/font&gt;&lt;font style="font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;3&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.32%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:13.16%; border-bottom:solid 1pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;September&amp;#160;30,&amp;#160; 2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:72.36%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Risk free interest rate&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:13.16%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.31%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.32%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:13.16%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.39%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:72.36%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Expected life&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:13.16%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3.8 Years&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.32%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:13.16%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4.3 Years&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:72.36%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Dividend yield&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:13.16%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;None&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.32%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:13.16%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;None&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:72.36%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Volatility&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:13.16%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;69%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.32%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:13.16%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;69%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;The following is a reconciliation of the derivative liability related to these exchange rights: &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:76%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:85.3%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Value at September&amp;#160;30, 201&lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.48%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:11.76%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10,375&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.46%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:85.3%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Issuance of instruments&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.48%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:11.76%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.46%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:85.3%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Change in value&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.48%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:11.76%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(5,806&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.46%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:85.3%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net settlements&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.48%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:11.76%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.46%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:85.3%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Value at September&amp;#160;30, 201&lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.48%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:11.76%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,569&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.46%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:85.3%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Issuance of instruments&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.48%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:11.76%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.46%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:85.3%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Change in value&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.48%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:11.76%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;53,190&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.46%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:85.3%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net settlements&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.48%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:11.76%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.46%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:85.3%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Value at March 31, 2014&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.48%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:11.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;57,759&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.46%; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:85.3%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:4pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.48%; border-top:double 2.5pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:4pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:11.76%; border-top:double 2.5pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:4pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.46%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:4pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;The derivative assets/liabilities are estimated using option pricing models that are based on the individual characteristics of the warrants or instruments on the valuation date, as well as assumptions for expected volatility, expected life and risk-free interest rate. Changes in the assumptions used could have a material impact on the resulting fair value. The primary input affecting the value of our derivatives liabilities is the Company&amp;#8217;s stock price. Other inputs have a comparatively insignificant effect. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;During fiscal 2012, contingent consideration was recorded upon the acquisitions of Roche Madison Inc. and Alvos&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; Therapeutics, Inc., totaling $173,621. The fair value measurement of the contingent consideration obligations is determined using Level 3 inputs. The fair value of contingent consideration obligations is based on a discounted cash flow model using a probability-weighted income approach. The measurement is based upon unobservable inputs supported by little or no market activity based on our own assumptions and experience. Estimating timing to complete the development, and obtain approval of products is difficult, and there are inherent uncertainties in developing a product candidate, such as obtaining U.S. Food and Drug Administration (FDA) and other regulatory approvals. In determining the probability of regulatory approval and commercial success, we utilize data regarding similar milestone events from several sources, including industry studies and our own experience. These fair value measurements represent Level 3 measurements as they are based on significant inputs not observable in the market. Significant judgment is employed in determining the appropriateness of these assumptions as of the acquisition date and for each subsequent period. Accordingly, changes in assumptions could have a material impact on the amount of contingent consideration expense we record in any given period. Changes in the fair value of the contingent consideration obligations are recorded in our consolidated statement of operations. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;The following is a reconciliation of contingent consideration fair value. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:68%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:56%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12.25pt;;text-indent:-12.25pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Value at September&amp;#160;30, 201&lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;173,621&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:56%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12.25pt;;text-indent:-12.25pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Purchase price contingent consideration&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:56%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12.25pt;;text-indent:-12.25pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Contingent consideration payments&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:56%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12.25pt;;text-indent:-12.25pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Change in fair value of contingent consideration&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,421,652&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:56%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Value at September 30, 201&lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,595,273&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:56%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Purchase price contingent consideration&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:56%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Contingent consideration payments&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:56%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Change in fair value of contingent consideration&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:56%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Value at March 31, 2014&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,595,273&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;The fair value of contingent&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; consideration obligations is estimated through valuation models designed to estimate the probability of such contingent payments based on various assumptions and incorporating estimated success rates.&amp;nbsp;&amp;nbsp;Estimated payments are discounted using present value techniques to arrive at estimated fair value at the balance sheet date.&amp;nbsp;&amp;nbsp;Changes in the fair value of the contingent consideration obligations can result from changes to one or multiple inputs, including adjustments to the discount rates, changes in the amount or timing of expected expenditures associated with product development, changes in the amount or timing of cash flows from products upon commercialization, changes in the assumed achievement or timing of any development milestones, changes in the probability of certain clinical events and changes in the assumed probability associated with regulatory approval. Each of these assumptions can have a significant impact on the calculation of contingent consideration. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;The carrying amounts of the Company&amp;#8217;s other financial instruments, which include accounts receivable, accounts payable, and accrued expenses approximate their respective fair values due to the relatively short-term nature of these instruments. The carrying value of the Company&amp;#8217;s debt obligations approximates fair value based on market interest rates. &lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
  <us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock id="F_000877" contextRef="C_0000879407_20131001_20140331">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-style:italic;;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Nature of Business &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;Arrowhead Research Corporation is a biopharmaceutical company developing targeted &lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;RNAi therapeutics. The Company is leveraging its proprietary drug delivery technologies to develop targeted drugs based on the RNA interference mechanism that efficiently silence disease-causing genes. Arrowhead technologies also enable partners to create peptide-drug conjugates that specifically home to cell types of interest while sparing off-target tissues. Arrowhead&amp;#8217;s pipeline includes clinical programs in chronic hepatitis B virus and obesity and partner-based programs in oncology.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock>
  <us-gaap:LiquidityDisclosureTextBlock id="F_000878" contextRef="C_0000879407_20131001_20140331">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-style:italic;;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Liquidity &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;Historically, the Company&amp;#8217;s primary source of financing has been through the sale of securities of Arrowhead&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;.  Research and development activities have required significant capital investment since the Company&amp;#8217;s inception and we expect our operations to continue to require cash investment in fiscal 2014 and beyond as the Company advances its research and development efforts, including clinical trials, and related drug manufacturing.&amp;nbsp;&amp;nbsp; &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;At March 31, 201&lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;, the Company had $142.8 million in cash to fund operations. In addition to its cash resources, the Company has invested excess cash in investment grade commercial bonds maturing in less than 30 months.&amp;nbsp;&amp;nbsp;These bonds provide a source of liquidity, though the Company plans to hold them until maturity.&amp;nbsp;&amp;nbsp;At March 31, 2014, the Company had invested $51.8 million in bonds.&amp;nbsp;&amp;nbsp;During the six months ended March 31, 2014, the Company&amp;#8217;s cash position increased by $123.7 million. The Company received cash from the issuance of equity of $172.6 million and cash from the exercise of warrants and options of $8.0 million during the six months ended March 31, 2014.&amp;nbsp;&amp;nbsp;Net cash invested in fixed income investments totaled a net change of $41.4 million. During the six months ended March 31, 2014, the Company had cash outflow of $14.7 million related to its continuing operating activities and capital expenditures of $&lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.6&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; million. &lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:LiquidityDisclosureTextBlock>
  <us-gaap:ConsolidationPolicyTextBlock id="F_000879" contextRef="C_0000879407_20131001_20140331">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;Principles of Consolidation&amp;#8212;The&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; consolidated financial statements include the accounts of Arrowhead and its Subsidiaries.&amp;nbsp;&amp;nbsp;Arrowhead&amp;#8217;s primary operating subsidiary is Arrowhead Madison, which is located in Madison, Wisconsin, where the Company&amp;#8217;s research and development facilities are located.&amp;nbsp;&amp;nbsp;All significant intercompany accounts and transactions are eliminated in consolidation, and noncontrolling interests are accounted for in the Company&amp;#8217;s financial statements. &lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
  <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock id="F_000880" contextRef="C_0000879407_20131001_20140331">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;Basis of Presentation&amp;#8212;The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (&amp;#8220;GAAP&amp;#8221;) for interim financial information and in accordance with the instructions to Form&amp;#160;10-Q and Article&amp;#160;8 of Regulation S-X.&amp;nbsp;&amp;nbsp;Accordingly, the financial statements do not include all of the information and notes required by GAAP for complete financial statements. In the opinion of management, all adjustments, including normal recurring accruals, considered necessary for a fair presentation have been included. Interim results are not necessarily indicative of results for a fu&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;ll year.&amp;nbsp;&amp;nbsp;The September 30, 2013 balance sheet was derived from audited financial statements, but does not include all disclosures required by GAAP. This financial information should be read in conjunction with the consolidated financial statements and notes included in the Company&amp;#8217;s Annual Report on Form&amp;#160;10-K for the year ended September&amp;#160;30, 2013.&amp;nbsp;&amp;nbsp;Certain reclassifications have been made to prior period financial statements to conform to the current period presentation.  &lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
  <us-gaap:UseOfEstimates id="F_000881" contextRef="C_0000879407_20131001_20140331">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;Use of Estimates&amp;#8212;The&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the accompanying financial statements. Actual results could differ from those estimates.&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
  <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy id="F_000882" contextRef="C_0000879407_20131001_20140331">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;Cash and Cash Equivalents&amp;#8212;The Company considers all liquid debt instruments purchased with a maturity of three months or less to be cash equivalents.&amp;nbsp;&amp;nbsp;The Company had no&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; restricted cash at March 31, 2014 and 2013.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
  <us-gaap:ConcentrationRiskCreditRisk id="F_000883" contextRef="C_0000879407_20131001_20140331">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;Concentration of Credit Risk&amp;#8212;The Company maintains several checking accounts for its operations at two financial institutions. These accounts are insured by the Federal Deposit Insurance Corporation (FDIC) for up to $250,000&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; per account. Management believes the Company is not exposed to significant credit risk due to the financial position of the depository institutions in which these deposits are held. &lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:ConcentrationRiskCreditRisk>
  <us-gaap:InvestmentPolicyTextBlock id="F_000884" contextRef="C_0000879407_20131001_20140331">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;Investments&amp;#8212;The Company invests excess cash balances in short-term and long-term marketable debt securities. Investments may consist of certificates of deposits, money market accounts, government-sponsored enterprise securities, corporate bonds and/or commercial paper. The Company accounts for its investment in marketable securities in accordance with FASB ASC 320, Investments &amp;#8211; Debt and Equity Securities.&amp;#160;This statement requires certain securities to be classified into three categories: &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:4.53%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Held-to-maturity&amp;#8212;Debt securities that the entity has the positive intent and ability to hold to maturity are reported at amortized cost. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:4.53%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Trading Securities&amp;#8212;Debt and equity securities that are bought and held primarily for the purpose of selling in the near term are reported at fair value, with unrealized gains and losses included in earnings. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:4.53%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Available-for-Sale&amp;#8212;Debt and equity securities not classified as either securities held-to-maturity or trading securities are reported at fair value with unrealized gains or losses excluded from earnings and reported as a separate component of shareholders&amp;#8217; equity. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;The Company classifies its investments in marketable debt securities based on the facts and circumstances present at the time of purchase of the securities. At &lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;March 31, 2014&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;, the Company classified all of its investments as held-to-maturity. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;Held-to-maturity investments are measured and recorded at amortized cost on the Company&amp;#8217;s Consolidated Balance Sheet. Discounts and premiums to par value of the debt securities are amortized to interest income/expense over the term of the security. No gains or losses on investment securities are realized until they are sold or a decline in fair value is determined to be other-than-temporary. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;As of March 31, 2014&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;, all short-term investments were comprised of corporate bonds with maturity dates of less than one year. Certain investments maturing in excess of twelve months, but less than 30 months are classified as long-term investments.&amp;nbsp;&amp;nbsp;As of March 31, 2014, the amortized cost of such bonds was $51,846,834. As of March 31, 2014, gross unrealized losses were $283,376; there were no gross unrealized gains. The total fair value of the investments at &lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;March 31, 2014&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; was $51,563,458.&lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;See further information regarding fair market value of marketable debt securities in Note 1&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1 &amp;#8211; Fair Value Measurements, such fair market data is obtained from independent pricing services. &lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:InvestmentPolicyTextBlock>
  <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock id="F_000885" contextRef="C_0000879407_20131001_20140331">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;Property and Equipment&amp;#8212;Property and equipment are recorded at cost, which may equal fair market value in the case of property and equipment acquired in conjunction with a business acquisition. Depreciation of property and equipment is recorded using the straight-line method over the respective useful lives of the assets ranging from three&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; to seven years. Leasehold improvements are amortized over the lesser of the expected useful life or the remaining lease term. Long-lived assets, including property and equipment are reviewed for impairment whenever events or circumstances indicate that the carrying amount of these assets may not be recoverable. &lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
  <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock id="F_000886" contextRef="C_0000879407_20131001_20140331">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;Intangible Assets Subject to Amortization&amp;#8212;At &lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;March 31, 2014&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;, intangible assets subject to amortization included certain license agreements acquired through business combinations. Intangible assets subject to amortization are reviewed for impairment whenever events or circumstances indicate that the carrying amount of these assets may not be recoverable. &lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
  <us-gaap:InProcessResearchAndDevelopmentPolicy id="F_000887" contextRef="C_0000879407_20131001_20140331">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;In-Process Research&amp;#160;&amp;amp; Development (IPR&amp;amp;D)&amp;#8212;IPR&amp;amp;D assets represent capitalized on-going research projects that Arrowhead acquired through business combinations. Such assets are initially measured at their acquisition date fair values. The amounts capitalized are being accounted for as indefinite-lived intangible assets, subject to impairment testing until completion or abandonment of R&amp;amp;D efforts associated with the project. Upon successful completion of a project, Arrowhead will make a determination as to the then remaining useful life of the intangible asset and begin amortization. Based on early adoption of ASU 2012-02, Arrowhead tests its indefinite-lived assets for impairment at least annually, through a two-step process. The first step is a qualitative assessment to determine if it is more likely than not that the indefinite lived assets are impaired. Arrowhead considers relevant events and circumstances that could affect the inputs used to determine the fair value of the intangible assets. If the qualitative assessment indicates that it is more likely than not that the intangible assets is impaired, a second step is performed which is a quantitative test to determine the fair value of the intangible asset. If the carrying amount of the intangible assets exceeds its fair value, an impairment loss is recorded in the amount of that excess. If circumstances determine that it is appropriate, the Company may also elect to bypass step one, and proceed directly to the second step. &lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:InProcessResearchAndDevelopmentPolicy>
  <arwr:ContingentConsiderationPolicyTextBlock id="F_000888" contextRef="C_0000879407_20131001_20140331">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;Contingent Consideration - &lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The consideration for our acquisitions often includes future payments that are contingent upon the occurrence of a particular event.&amp;nbsp;&amp;nbsp;For example, milestone payments might be based on the achievement of various regulatory approvals or future sales milestones, and royalty payments might be based on drug product sales levels. We record a contingent consideration obligation for such contingent payments at fair value on the acquisition date. We estimate the fair value of contingent consideration obligations through valuation models designed to estimate the probability of such contingent payments based on various assumptions and incorporating estimated success rates.&amp;nbsp;&amp;nbsp;Estimated payments are discounted using present value techniques to arrive at estimated fair value at the balance sheet date. Changes in the fair value of our contingent consideration obligations are recognized within our consolidated statements of operations. Changes in the fair value of the contingent consideration obligations can result from changes to one or multiple inputs, including adjustments to the discount rates, changes in the amount or timing of expected expenditures associated with product development, changes in the amount or timing of cash flows from products upon commercialization, changes in the assumed achievement or timing of any development milestones, changes in the probability of certain clinical events and changes in the assumed probability associated with regulatory approval. These fair value measurements are based on significant inputs not observable in the market. Significant judgment is employed in determining the appropriateness of these assumptions as of the acquisition date and for each subsequent period. Accordingly, changes in assumptions could have a material impact on the amount of contingent consideration expense we record in any given period.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</arwr:ContingentConsiderationPolicyTextBlock>
  <us-gaap:EquityAndCostMethodInvestmentsPolicy id="F_000889" contextRef="C_0000879407_20131001_20140331">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;Minority Equity Investments&amp;#8212;The Company&amp;#8217;s had a minority equity investment in Leonardo, a privately held biotechnology company.&amp;nbsp;&amp;nbsp;This investment has been fully impaired and the net book value at March 31, 2014&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; is $0.&amp;nbsp;&amp;nbsp;The operations of Leonardo ceased in December 2013. &lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:EquityAndCostMethodInvestmentsPolicy>
  <arwr:NoncontrollingInterestsPolicyTextBlock id="F_000890" contextRef="C_0000879407_20131001_20140331">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;Noncontrolling Interests in Majority-Owned Subsidiaries&amp;#8212;Operating losses applicable to majority-owned Calando, &lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Ablaris and, prior to its disposal, Unidym have periodically exceeded the noncontrolling interests in the equity capital of either Subsidiary. Such excess losses applicable to the noncontrolling interests have been and are borne by the Company as there is no obligation of the noncontrolling interests to fund any losses in excess of their original investment. There is also no obligation or commitment on the part of the Company to fund operating losses of any Subsidiary whether wholly-owned or majority-owned. The Company allocates the noncontrolling interest&amp;#8217;s share of net loss in excess of the noncontrolling interest&amp;#8217;s initial investment in accordance with FASB ASC 810-10. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;When there is a change in the Company&amp;#8217;s proportionate ownership &lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;share of a development-stage Subsidiary resulting from additional equity transactions in the Subsidiary, the change is accounted for as an equity transaction in consolidation. To the extent that the increase in the calculated value of the Company&amp;#8217;s interest in the equity of the Subsidiary exceeds the Company&amp;#8217;s investment in the transaction, that increase in value is referred to as the Company&amp;#8217;s &amp;#8220;increase in its proportionate share of the Subsidiary&amp;#8217;s equity&amp;#8221; and the amount is recorded as an increase in the Company&amp;#8217;s Additional Paid-in Capital. &lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</arwr:NoncontrollingInterestsPolicyTextBlock>
  <us-gaap:RevenueRecognitionPolicyTextBlock id="F_000891" contextRef="C_0000879407_20131001_20140331">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;Revenue Recognition&amp;#8212;Revenue from license fees are recorded when persuasive evidence of an arrangement exists, title has passed or services have been rendered, a price is fixed and determinable, and collection is reasonably assured. We may generate revenue from product sales, technology licenses, collaborative research and development arrangements, and research grants. Revenue under technology licenses and collaborative agreements typically consists of nonrefundable and/or guaranteed technology license fees, collaborative research funding and various milestone and future product royalty or profit-sharing payments. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;Revenue associated payments under collaborative research and development &lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;agreements, is recognized ratably over the relevant periods specified in the agreement, generally the period during which research and development is conducted. Revenue from up-front license fees, milestones and product royalties are recognized as earned based on the completion of the milestones and product sales, as defined in the respective agreements. Payments received in advance of recognition as revenue are recorded as deferred revenue. &lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
  <us-gaap:TradeAndOtherAccountsReceivablePolicy id="F_000892" contextRef="C_0000879407_20131001_20140331">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;Allowance for Doubtful Accounts&amp;#8212;The Company accrues an allowance for doubtful accounts based on estimates of uncollectible revenues by analyzing historical collections, accounts receivable aging and other factors. Accounts receivable are written off when all collection attempts have failed. &lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:TradeAndOtherAccountsReceivablePolicy>
  <us-gaap:ResearchAndDevelopmentExpensePolicy id="F_000893" contextRef="C_0000879407_20131001_20140331">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;Research and Development&amp;#8212;Costs and expenses that can be clearly identified as research and development are charged to expense as incurred in accordance with FASB ASC 730-10. &lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
  <us-gaap:EarningsPerSharePolicyTextBlock id="F_000894" contextRef="C_0000879407_20131001_20140331">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;Earnings (Loss) per Share&amp;#8212;Basic earnings (loss) per share is computed using the weighted-average number of common shares outstanding during the period. Diluted earnings (loss) per share are computed using the weighted-average number of common shares and dilutive potential common shares outstanding during the period. Dilutive potential common shares primarily consist of stock options issued to employees and consultants and warrants to purchase Common Stock of the Company.&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; &lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
  <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy id="F_000895" contextRef="C_0000879407_20131001_20140331">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;Stock-Based Compensation&amp;#8212;The Company accounts for share-based compensation arrangements in accordance with FASB ASC 718, which requires the measurement and recognition of compensation expense for all share-based payment awards to be based on estimated fair values. We use the Black-Scholes option valuation model to estimate the fair value of our stock options at the date of grant. The Black-Scholes option valuation model requires the input of subjective assumptions to calculate the value of stock options. We use historical data and&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; other information to estimate the expected price volatility and the expected forfeiture rate. &lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
  <us-gaap:DerivativesPolicyTextBlock id="F_000896" contextRef="C_0000879407_20131001_20140331">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;Derivative Assets and Liabilities - &lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;We account for warrants and other derivative financial instruments as either equity or assets/liabilities based upon the characteristics and provisions of each instrument. Warrants classified as equity are recorded as additional paid-in capital on our consolidated balance sheet and no further adjustments to their valuation are made. Some of our warrants were determined to be ineligible for equity classification because of provisions that may result in an adjustment to their exercise price. Warrants classified as derivative liabilities and other derivative financial instruments that require separate accounting as assets or liabilities are recorded on our consolidated balance sheet at their fair value on the date of issuance and are revalued on each subsequent balance sheet date until such instruments are exercised or expire, with any changes in the fair value between reporting periods recorded as other income or expense. We estimate the fair value of these assets/liabilities using option pricing models that are based on the individual characteristics of the warrants or instruments on the valuation date, as well as assumptions for expected volatility, expected life and risk-free interest rate. &lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:DerivativesPolicyTextBlock>
  <us-gaap:IncomeTaxPolicyTextBlock id="F_000897" contextRef="C_0000879407_20131001_20140331">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;Income Taxes&amp;#8212;The Company accounts for income taxes under the liability method, which requires the recognition of deferred income tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this method, deferred income taxes are recognized for the tax consequences in future years of differences between the tax bases of assets and liabilities and their financial reporting amounts at each period end based on enacted tax laws and statutory tax rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred income tax assets to the amount expected to be realized. The provision for income taxes, if any, represents the tax payable for the period and the change in deferred income tax assets and liabilities during the period. &lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
  <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock id="F_000898" contextRef="C_0000879407_20131001_20140331">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Recently Issued Accounting Standards &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;In July 2013, the FASB issued ASU 2013-11, &lt;/font&gt;&lt;font style="font-style:italic;;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;Income Taxes (Topic 740): Presentation of an Unrecognized Tax Benefit When a Net Operating Loss &lt;/font&gt;&lt;font style="font-style:italic;;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;, which eliminates diversity in practice for the presentation of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss or a tax credit carryforward is available to reduce the taxable income or tax payable that would result from disallowance of a tax position. ASU 2013-11 affects only the presentation of such amounts in an entity&amp;#8217;s balance sheet and is effective for fiscal years beginning after December 15, 2013 and interim periods within those years. Early adoption is permitted. We are evaluating the impact, if any, of the adoption of ASU 2013-11 on our balance sheet.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
  <us-gaap:HeldToMaturitySecuritiesTextBlock id="F_000899" contextRef="C_0000879407_20131001_20140331">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;The following tables summarize the Company&amp;#8217;s short and long-term investments as of March 31, 2014&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;, and September 30, 2013. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:92%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:41%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="14" valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of March 31, 2014&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:41%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Amortized Cost&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Gross Unrealized Gains&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Gross Unrealized Losses&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Fair Value&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top" bgcolor="#CFF0FC" style="width:41%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;text-indent:-12.25pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Commercial notes (due within one year)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;17,798,475&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(115,181&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;17,683,294&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top" style="width:41%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;text-indent:-12.25pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Commercial notes (due after one year through two years)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;34,048,359&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(168,195&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;33,880,164&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top" bgcolor="#CFF0FC" style="width:41%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;text-indent:-12.25pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;51,846,834&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(283,376&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;51,563,458&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:92%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:41%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="14" valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of September&amp;#160;30, 2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:41%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Amortized Cost&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Gross Unrealized Gains&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Gross Unrealized Losses&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Fair Value&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top" bgcolor="#CFF0FC" style="width:41%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;text-indent:-12.25pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Commercial notes (due within one year)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9,030,261&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7,500&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(39,281&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8,998,480&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top" style="width:41%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;text-indent:-12.25pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Commercial notes (due after one year through two years)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,702,153&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(2,362&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,699,791&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top" bgcolor="#CFF0FC" style="width:41%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;text-indent:-12.25pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10,732,414&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7,500&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(41,643&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10,698,271&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/div&gt;</us-gaap:HeldToMaturitySecuritiesTextBlock>
  <us-gaap:PropertyPlantAndEquipmentTextBlock id="F_000900" contextRef="C_0000879407_20131001_20140331">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;"&gt;&amp;nbsp;&lt;/p&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:76%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:51%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Balance as of&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:51%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&lt;font style="color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;March 31, 2014&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;September 30, 2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:51%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Computers, office equipment and furniture&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;317,867&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Arial;font-size:10pt;"&gt;&lt;font style="font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;323,376&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:51%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Research equipment&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,826,494&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Arial;font-size:10pt;"&gt;&lt;font style="font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,452,013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:51%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Software&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;69,623&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Arial;font-size:10pt;"&gt;&lt;font style="font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;69,623&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:51%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Leasehold improvements&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,749,409&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Arial;font-size:10pt;"&gt;&lt;font style="font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,749,409&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:51%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total gross fixed assets &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,963,393&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Arial;font-size:10pt;"&gt;&lt;font style="font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,594,421&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:51%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Less:&amp;nbsp;&amp;nbsp; Accumulated depreciation and amortization&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(3,673,123&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Arial;font-size:10pt;"&gt;&lt;font style="font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(3,081,186&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:51%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Property and equipment, net &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,290,270&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Arial;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,513,235&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
  <us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock id="F_000901" contextRef="C_0000879407_20131001_20140331">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;The following table provides details on our intangible asset balances: &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:84%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:46%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Intangible&amp;#160;assets&lt;/font&gt;&lt;font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;br /&gt;&lt;/font&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;not subject to&lt;br /&gt;amortization&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&lt;font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Intangible&amp;#160;assets&lt;br /&gt;subject to&lt;br /&gt;amortization&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&lt;font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;br /&gt;Intangible&amp;#160;assets&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&lt;font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top" bgcolor="#CFF0FC" style="width:46%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Balance at September&amp;#160;30, 2011&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,731,211&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,731,211&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top" style="width:46%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Additions&lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Madison acquisition&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;944,935&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;230,000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,174,935&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top" bgcolor="#CFF0FC" style="width:46%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Additions&lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Alvos acquisition&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,172,387&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,172,387&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top" style="width:46%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Amortization&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(293,964&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(293,964&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top" bgcolor="#CFF0FC" style="width:46%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Balance at September&amp;#160;30, 2012&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,117,322&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,667,247&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,784,569&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top" style="width:46%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Impairment&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1,308,047&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1,308,047&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height:11.5pt;"&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:46%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Amortization&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(236,009 &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(236,009&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height:11.5pt;"&gt;
&lt;td valign="bottom" style="width:46%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Balance at September&amp;#160;30, 2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,117,322&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;123,191&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,240,513&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height:11.5pt;"&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:46%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Amortization&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(27,327&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(27,327&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top" style="width:46%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Balance at March 31, 2014&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,117,322&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;95,864&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,213,186&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/div&gt;</us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock>
  <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock id="F_000902" contextRef="C_0000879407_20131001_20140331">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;The following table summarizes information about warrants outstanding at March 31, 2014&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;: &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:76%;"&gt;
&lt;tr&gt;
&lt;td colspan="3" valign="top" style="width:58.84%; border-bottom:solid 1pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-weight:bold;;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Exercise&amp;#160;prices&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" style="width:1.38%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:17.8%; border-bottom:solid 1pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Number&amp;#160;of&amp;#160;&lt;br /&gt;Warrants&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.44%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&lt;font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.44%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:17.78%; border-bottom:solid 1pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Remaining&lt;/font&gt;&lt;font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;br /&gt;&lt;/font&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Life&amp;#160;in&amp;#160;Years&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.32%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top" bgcolor="#CFF0FC" style="width:1.98%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" bgcolor="#CFF0FC" style="width:8.56%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;70.60&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:48.28%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" bgcolor="#CFF0FC" style="width:1.38%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.38%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:16.42%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;94,897&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.44%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.44%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.36%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:16.42%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3.1&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.32%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top" style="width:1.98%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" style="width:8.56%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5.00&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:48.28%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" style="width:1.38%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.38%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:16.42%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;995,692&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.44%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.44%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.36%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:16.42%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.7&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.32%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top" bgcolor="#CFF0FC" style="width:1.98%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" bgcolor="#CFF0FC" style="width:8.56%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5.09&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:48.28%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" bgcolor="#CFF0FC" style="width:1.38%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.38%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:16.42%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;291,204&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.44%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.44%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.36%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:16.42%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.7&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.32%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top" style="width:1.98%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" style="width:8.56%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.38&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:48.28%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" style="width:1.38%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.38%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:16.42%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;24,324&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.44%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.44%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.36%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:16.42%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.7&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.32%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top" bgcolor="#CFF0FC" style="width:1.98%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" bgcolor="#CFF0FC" style="width:8.56%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4.16&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:48.28%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" bgcolor="#CFF0FC" style="width:1.38%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.38%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:16.42%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.44%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.44%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.36%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:16.42%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2.7&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.32%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top" style="width:1.98%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" style="width:8.56%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3.25&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:48.28%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" style="width:1.38%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.38%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160; &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:16.42%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;746,306 &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.44%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.44%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.36%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:16.42%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2.4&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.32%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top" bgcolor="#CFF0FC" style="width:1.98%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" bgcolor="#CFF0FC" style="width:8.56%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2.12&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:48.28%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" bgcolor="#CFF0FC" style="width:1.38%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.38%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:16.42%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;75,000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.44%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.44%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.36%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:16.42%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3.7&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.32%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top" style="width:1.98%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" style="width:8.56%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.83&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:48.28%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" style="width:1.38%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.38%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:16.42%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;305,084&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.44%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.44%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.36%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:16.42%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3.7&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.32%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td colspan="3" valign="top" bgcolor="#CFF0FC" style="width:58.84%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total warrants outstanding&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" bgcolor="#CFF0FC" style="width:1.38%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.38%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160; &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:16.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,533,507 &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.44%; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.44%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.36%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:16.42%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.32%; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/div&gt;</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
  <us-gaap:ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock id="F_000903" contextRef="C_0000879407_20131001_20140331">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;As of March 31, 2014&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;, future minimum lease payments due in fiscal years under capitalized leases are as follows: &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:68%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:56%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;201&lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4 (remainder of)&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;114,211&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:56%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;201&lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5 &lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;228,420&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:56%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;201&lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6 &lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;228,420&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:56%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;201&lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7 &lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;228,420&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:56%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;201&lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8 &lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;228,420&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:56%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;201&lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9 &lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;and thereafter&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;95,175&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:56%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Less interest&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160; &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(45,055 &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:56%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Principal&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,078,011&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:56%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Less current portion&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(212,234 &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:56%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Noncurrent portion&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;865,777&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/div&gt;</us-gaap:ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock>
  <us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock id="F_000904" contextRef="C_0000879407_20131001_20140331">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;As of March 31, 2014&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;, future minimum lease payments due in fiscal years under operating leases are as follows: &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:68%;"&gt;
&lt;tr&gt;
&lt;td valign="top" bgcolor="#CFF0FC" style="width:56%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;201&lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4 (remainder of)&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;234,692&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top" style="width:56%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;201&lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5 &lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;552,028&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top" bgcolor="#CFF0FC" style="width:56%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;201&lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6 &lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;567,904&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top" style="width:56%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;201&lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7 &lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;583,932&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top" bgcolor="#CFF0FC" style="width:56%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;201&lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8 &lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;607,437&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top" style="width:56%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;201&lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9 &lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;and thereafter&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;393,133 &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top" bgcolor="#CFF0FC" style="width:56%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,939,126&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/div&gt;</us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock>
  <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock id="F_000905" contextRef="C_0000879407_20131001_20140331">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;The following tables summarize information about stock options:&lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:92%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:41%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unit/Share&lt;/font&gt;&lt;/p&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Number&amp;#160;of&lt;br /&gt;Options&lt;br /&gt;Outstanding&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&lt;font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted-&lt;br /&gt;Average&lt;br /&gt;Exercise&lt;br /&gt;Price&lt;br /&gt;Per&amp;#160;Share&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&lt;font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted-&lt;br /&gt;Average&lt;br /&gt;Remaining&lt;br /&gt;Contractual&lt;br /&gt;Term&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&lt;font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Aggregate&lt;br /&gt;Intrinsic&lt;br /&gt;Value&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:41%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Balance At September&amp;#160;30, 201&lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;729,096&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9.03&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:41%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Granted&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,229,500&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4.40&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:41%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cancelled&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(&lt;/font&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;42,919&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;11.77&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:41%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Exercised&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(&lt;/font&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,883&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5.20&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="middle" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="middle" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:41%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Balance At September&amp;#160;30, 201&lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,910,794&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6.10&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:41%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Granted&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,509,166&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2.03&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:41%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cancelled&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:41%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Exercised&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(675 &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3.93&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="middle" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="middle" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:41%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Balance At September&amp;#160;30, 201&lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,419,285 &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4.68&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:41%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Granted&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;780,000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;13.51&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:41%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cancelled&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(40,196&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4.68&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:41%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Exercised&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(342,338&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6.54&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:41%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Balance At March 31, 2014&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,816,751&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5.81&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7.5 years&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;38,622,771&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:41%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Exercisable At March 31, 2014&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,351,974 &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5.91&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7.2 years&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;14,710,062&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
  <us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock id="F_000906" contextRef="C_0000879407_20131001_20140331">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;The assumptions used to value stock options are as follows: &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:76%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:62.32%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" style="width:1.46%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="3" valign="bottom" style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:36.22%; border-bottom:solid 1pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Six months&amp;#160;ended&amp;#160;March 31,&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:62.32%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" style="width:1.46%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:17.38%; border-bottom:solid 1pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;201&lt;/font&gt;&lt;font style="font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;4&lt;/font&gt;&lt;font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.46%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:17.38%; border-bottom:solid 1pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;201&lt;/font&gt;&lt;font style="font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;3&lt;/font&gt;&lt;font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:62.32%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Dividend yield&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" bgcolor="#CFF0FC" style="width:1.46%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:17.38%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.46%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:17.38%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:62.32%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Risk-free interest rate&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" style="width:1.46%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:17.38%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.9% to 2.26%&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.46%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:17.38%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.7%&amp;#160; to&amp;#160;1.0%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:62.32%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Volatility&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" bgcolor="#CFF0FC" style="width:1.46%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:17.38%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;69%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.46%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:17.38%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;69%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:62.32%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Expected life (in years)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" style="width:1.46%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:17.38%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5.5 to 6.25&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.46%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:17.38%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5.5 to 6.25&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:62.32%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted average grant date fair value per share of options granted&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top" bgcolor="#CFF0FC" style="width:1.46%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:17.38%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$9.08&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.46%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:17.38%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$1.31&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock>
  <us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock id="F_000907" contextRef="C_0000879407_20131001_20140331">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;The following table summarizes the activity of the Company&amp;#8217;s Restricted Stock&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; Units:&lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:76%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:64.68%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:16.76%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;br /&gt;Number of&lt;br /&gt;RSUs&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.38%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&lt;font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:0.96%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:11.9%; border-bottom:solid 1pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted-&lt;br /&gt;Average&lt;br /&gt;Grant&lt;br /&gt;Date&lt;br /&gt;Fair Value&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.38%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&lt;font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.38%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:0.78%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:64.68%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unvested at September&amp;#160;30, 201&lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.08%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:15.7%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;- &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.38%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:0.96%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.4%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10.5%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.38%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.38%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:0.78%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:0.76%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:64.68%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Granted&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.08%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:15.7%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;470,000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.38%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:0.96%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.4%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10.5%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;14.54&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.38%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.38%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:0.78%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:0.76%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:64.68%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Vested&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.08%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:15.7%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.38%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:0.96%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.4%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10.5%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.38%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.38%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:0.78%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:0.76%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:64.68%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Forfeited&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.08%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:15.7%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.38%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:0.96%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.4%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10.5%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.38%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.38%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:0.78%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:0.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:64.68%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unvested at March 31, 2014&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.08%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:15.7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;470,000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.38%; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:0.96%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.4%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10.5%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;14.54&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.38%; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.38%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:0.78%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:0.76%; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock>
  <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock id="F_000908" contextRef="C_0000879407_20131001_20140331">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;The following table summarizes fair value measurements at March 31, 2014&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; and September&amp;#160;30, 2013 for assets and liabilities measured at fair value on a recurring basis: &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;March 31, 2014: &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:92%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:41%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 1&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 2&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 3&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&lt;font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:41%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cash and cash equivalents&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;142,847,860&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;142,847,860&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:41%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Derivative assets&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:41%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Derivative liabilities&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,936,530&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,936,530&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:41%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Acquisition related contingent consideration obligations&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,595,273&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,595,273&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;September&amp;#160;30, &lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2013&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;: &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:92%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:41%;"&gt;&lt;p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 1&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 2&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 3&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:1%; border-bottom:solid 1pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:41%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cash and cash equivalents&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;19,114,444&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;19,114,444&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:41%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Derivative assets&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:41%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Derivative liabilities&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,096,363&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,096,363&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:41%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Acquisition related contingent consideration obligations&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,595,273&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,595,273&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:8pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
  <arwr:FairValueAssumptionsAndMethodologyForAssetsTableTextBlock id="F_000909" contextRef="C_0000879407_20131001_20140331">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;The assumptions used in valuing the derivative asset were not applicable as the value has been determined to be zero at March 31, 2014&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; and September 30, 2013. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-size:12pt;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:76%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:71%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:14%; border-bottom:solid 1pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;March&amp;#160;31,&amp;#160; 201&lt;/font&gt;&lt;font style="font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;4&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:14%; border-bottom:solid 1pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;September&amp;#160;30,&amp;#160; &lt;/font&gt;&lt;font style="font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:71%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Risk free interest rate&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:14.06%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:14%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:71%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Expected life&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:14.06%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:14%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:71%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Dividend yield&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:14.06%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:14%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:71%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Volatility&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:14.06%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:14%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/div&gt;</arwr:FairValueAssumptionsAndMethodologyForAssetsTableTextBlock>
  <us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock id="F_000910" contextRef="C_0000879407_20131001_20140331">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;The following is a reconciliation of the derivative asset: &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:68%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:56%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Value at September&amp;#160;30, 2012&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;250,250&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:56%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Receipt of instruments&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:56%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Decrease &lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;in value&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(250,250&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:56%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net settlements&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:56%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Value at September&amp;#160;30, 2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:56%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Receipt of instruments&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:56%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Decrease in value&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:56%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net settlements&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:56%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Value at March 31, 2014&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/div&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
  <arwr:FairValueAssumptionsAndMethodologyForLiabilitiesTableTextBlock id="F_000911" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_us-gaapWarrantMember_20131001_20140331">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;The assumptions used in valuing the derivative liability were as follows: &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-size:12pt;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:76%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:41.24%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2010 Warrants&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2.14%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:27.04%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="text-decoration:underline;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;March 31, 2014&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.58%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2.74%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:25.26%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="text-decoration:underline;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;September&amp;#160;30,&amp;#160;2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:41.24%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Risk free interest rate&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2.14%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:27.04%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.44%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.58%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2.74%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:25.26%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.33%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:41.24%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Expected life&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2.14%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:27.04%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:36pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2.0 Years&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.58%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:36pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2.74%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:25.26%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2.2&amp;#160;Years&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:41.24%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Dividend yield&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2.14%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:27.04%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;None&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.58%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2.74%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:25.26%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;None&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:41.24%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Volatility&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2.14%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:27.04%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;69%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.58%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2.74%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:25.26%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;69%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:41.24%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2.14%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:27.04%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.58%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2.74%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:25.26%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:41.24%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2012 Warrants&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2.14%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:27.04%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="text-decoration:underline;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;March 31, 2014&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.58%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2.74%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:25.26%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="text-decoration:underline;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;September 30, 2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:41.24%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Risk free interest rate&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2.14%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:27.04%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.31%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.58%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2.74%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:25.26%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.39%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:41.24%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Expected life&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2.14%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:27.04%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:36pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3.7 Years&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.58%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2.74%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:25.26%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4.2&amp;#160;Years&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:41.24%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Dividend yield&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2.14%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:27.04%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;None&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.58%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2.74%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:25.26%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;None&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:41.24%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Volatility&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2.14%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:27.04%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;69%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.58%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2.74%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:25.26%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;69%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:41.24%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2.14%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:27.04%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.58%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2.74%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:25.26%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:41.24%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2013 Warrants&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2.14%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:27.04%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="text-decoration:underline;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;March 31, 2014&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.58%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2.74%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:25.26%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="text-decoration:underline;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;September 30, 2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:41.24%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Risk free interest rate&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2.14%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:27.04%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.31%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.58%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2.74%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:25.26%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.39%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:41.24%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Expected life&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2.14%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:27.04%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:36pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3.8 Years&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.58%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2.74%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:25.26%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4.3&amp;#160;Years&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:41.24%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Dividend yield&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2.14%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:27.04%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;None&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.58%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2.74%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:25.26%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;None&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:41.24%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Volatility&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2.14%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:27.04%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;69%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.58%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2.74%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:25.26%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;69%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/div&gt;</arwr:FairValueAssumptionsAndMethodologyForLiabilitiesTableTextBlock>
  <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock id="F_000912" contextRef="C_0000879407_20131001_20140331">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;The following is a reconciliation of the derivative liability related to these warrants: &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:68%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:56%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Value at September&amp;#160;30, 2012&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;626,195&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:56%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Issuance of instruments&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,153,819&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:56%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Change in value&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,066,591&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:56%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net settlements&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(3,754,808 &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:56%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Value at September&amp;#160;30, 2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,091,797&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:56%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Issuance of instruments&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:56%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Change in value&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9,234,419&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:56%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net settlements&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(8,447,443)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:56%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Value at March 31, 2014&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,878,773&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:56%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:1pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:1pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:1pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/div&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
  <arwr:FairValueAssumptionsAndMethodologyForLiabilitiesTableTextBlock id="F_000913" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrExchangeRightsMember_20131001_20140331">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:76%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:72.36%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:13.16%; border-bottom:solid 1pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&amp;#160; 31,&amp;#160; 201&lt;/font&gt;&lt;font style="font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;3&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.32%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0.7pt;padding-Right:0.7pt;padding-Top:0pt;padding-Bottom:0pt;width:13.16%; border-bottom:solid 1pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;;"&gt;&lt;font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;September&amp;#160;30,&amp;#160; 2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:72.36%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Risk free interest rate&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:13.16%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.31%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.32%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:13.16%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.39%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:72.36%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Expected life&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:13.16%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3.8 Years&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.32%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:13.16%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4.3 Years&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:72.36%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Dividend yield&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:13.16%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;None&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.32%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:13.16%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;None&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:72.36%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Volatility&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:13.16%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;69%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.32%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-family:Times New RomanTimes New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:13.16%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;69%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/div&gt;</arwr:FairValueAssumptionsAndMethodologyForLiabilitiesTableTextBlock>
  <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock id="F_000914" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrExchangeRightsMember_20131001_20140331">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;The following is a reconciliation of the derivative liability related to these exchange rights: &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:76%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:85.3%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Value at September&amp;#160;30, 201&lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.48%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:11.76%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10,375&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.46%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:85.3%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Issuance of instruments&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.48%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:11.76%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.46%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:85.3%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Change in value&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.48%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:11.76%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(5,806&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.46%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:85.3%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net settlements&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.48%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:11.76%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.46%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:85.3%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Value at September&amp;#160;30, 201&lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.48%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:11.76%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,569&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.46%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:85.3%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Issuance of instruments&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.48%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:11.76%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.46%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:85.3%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Change in value&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.48%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:11.76%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;53,190&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.46%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:85.3%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net settlements&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.48%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:11.76%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1.46%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:85.3%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Value at March 31, 2014&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.48%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:11.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;57,759&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.46%; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:85.3%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:4pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.48%; border-top:double 2.5pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:4pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:11.76%; border-top:double 2.5pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-size:4pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1.46%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:4pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/div&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
  <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock id="F_000915" contextRef="C_0000879407_20131001_20140331">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;"&gt;The following is a reconciliation of contingent consideration fair value. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:68%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:56%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12.25pt;;text-indent:-12.25pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Value at September&amp;#160;30, 201&lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;173,621&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:56%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12.25pt;;text-indent:-12.25pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Purchase price contingent consideration&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:56%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12.25pt;;text-indent:-12.25pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Contingent consideration payments&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:56%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12.25pt;;text-indent:-12.25pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Change in fair value of contingent consideration&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,421,652&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:56%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Value at September 30, 201&lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,595,273&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:56%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Purchase price contingent consideration&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:56%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Contingent consideration payments&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="width:56%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Change in fair value of contingent consideration&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:56%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Value at March 31, 2014&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,595,273&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/div&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock>
  <us-gaap:DebtInstrumentMaturityDateDescription id="F_000916" contextRef="C_0000879407_20131001_20140331">Less than 30 months</us-gaap:DebtInstrumentMaturityDateDescription>
  <us-gaap:Investments id="F_000917" contextRef="C_0000879407_us-gaapSummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesByTypeAxis_us-gaapBondsMember_20140331" decimals="-5" unitRef="U_iso4217USD">51800000</us-gaap:Investments>
  <us-gaap:ProceedsFromIssuanceOrSaleOfEquity id="F_000918" contextRef="C_0000879407_20131001_20140331" decimals="-5" unitRef="U_iso4217USD">172600000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
  <us-gaap:ProceedsFromIssuanceOfWarrants id="F_000919" contextRef="C_0000879407_us-gaapStatementScenarioAxis_arwrWarrantsIssuedMember_20131001_20140331" decimals="-5" unitRef="U_iso4217USD">8000000</us-gaap:ProceedsFromIssuanceOfWarrants>
  <us-gaap:PaymentsToAcquireProjects id="F_000920" contextRef="C_0000879407_20131001_20140331" decimals="-5" unitRef="U_iso4217USD">41400000</us-gaap:PaymentsToAcquireProjects>
  <arwr:OperatingCashOutflow id="F_000921" contextRef="C_0000879407_20131001_20140331" decimals="-5" unitRef="U_iso4217USD">14700000</arwr:OperatingCashOutflow>
  <us-gaap:PaymentsToAcquireOtherPropertyPlantAndEquipment id="F_000922" contextRef="C_0000879407_20131001_20140331" decimals="-5" unitRef="U_iso4217USD">600000</us-gaap:PaymentsToAcquireOtherPropertyPlantAndEquipment>
  <us-gaap:RestrictedCashAndCashEquivalents id="F_000923" contextRef="C_0000879407_20140331" decimals="0" unitRef="U_iso4217USD">0</us-gaap:RestrictedCashAndCashEquivalents>
  <us-gaap:RestrictedCashAndCashEquivalents id="F_000924" contextRef="C_0000879407_20130331" decimals="0" unitRef="U_iso4217USD">0</us-gaap:RestrictedCashAndCashEquivalents>
  <us-gaap:CashFDICInsuredAmount id="F_000925" contextRef="C_0000879407_20140331" decimals="0" unitRef="U_iso4217USD">250000</us-gaap:CashFDICInsuredAmount>
  <us-gaap:DebtInstrumentMaturityDateDescription id="F_000926" contextRef="C_0000879407_us-gaapSummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesByTypeAxis_us-gaapBondsMember_20131001_20140331">Less than 30 months</us-gaap:DebtInstrumentMaturityDateDescription>
  <us-gaap:MarketableSecurities id="F_000927" contextRef="C_0000879407_20140331" decimals="0" unitRef="U_iso4217USD">51846834</us-gaap:MarketableSecurities>
  <us-gaap:UnrealizedLossOnSecurities id="F_000928" contextRef="C_0000879407_20131001_20140331" decimals="0" unitRef="U_iso4217USD">283376</us-gaap:UnrealizedLossOnSecurities>
  <us-gaap:UnrealizedGainOnSecurities id="F_000929" contextRef="C_0000879407_20131001_20140331" decimals="0" unitRef="U_iso4217USD">0</us-gaap:UnrealizedGainOnSecurities>
  <us-gaap:InvestmentsFairValueDisclosure id="F_000930" contextRef="C_0000879407_20140331" decimals="0" unitRef="U_iso4217USD">51563458</us-gaap:InvestmentsFairValueDisclosure>
  <us-gaap:PropertyPlantAndEquipmentUsefulLife id="F_000931" contextRef="C_0000879407_us-gaapRangeAxis_us-gaapMinimumMember_20131001_20140331">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <us-gaap:PropertyPlantAndEquipmentUsefulLife id="F_000932" contextRef="C_0000879407_us-gaapRangeAxis_us-gaapMaximumMember_20131001_20140331">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <arwr:CostMethodInvestmentAttributableToNoncontrollingInterest id="F_000933" contextRef="C_0000879407_20140331" decimals="0" unitRef="U_iso4217USD">0</arwr:CostMethodInvestmentAttributableToNoncontrollingInterest>
  <us-gaap:UnrealizedGainOnSecurities id="F_000934" contextRef="C_0000879407_us-gaapMajorTypesOfDebtAndEquitySecuritiesAxis_arwrCommercialNotesDueWithinOneYearMember_20131001_20140331" decimals="0" unitRef="U_iso4217USD">0</us-gaap:UnrealizedGainOnSecurities>
  <us-gaap:UnrealizedGainOnSecurities id="F_000935" contextRef="C_0000879407_us-gaapMajorTypesOfDebtAndEquitySecuritiesAxis_arwrCommercialNotesDueAfterOneYearThroughTwoYearsMember_20131001_20140331" decimals="0" unitRef="U_iso4217USD">0</us-gaap:UnrealizedGainOnSecurities>
  <us-gaap:UnrealizedLossOnSecurities id="F_000936" contextRef="C_0000879407_us-gaapMajorTypesOfDebtAndEquitySecuritiesAxis_arwrCommercialNotesDueWithinOneYearMember_20131001_20140331" decimals="0" unitRef="U_iso4217USD">115181</us-gaap:UnrealizedLossOnSecurities>
  <us-gaap:UnrealizedLossOnSecurities id="F_000937" contextRef="C_0000879407_us-gaapMajorTypesOfDebtAndEquitySecuritiesAxis_arwrCommercialNotesDueAfterOneYearThroughTwoYearsMember_20131001_20140331" decimals="0" unitRef="U_iso4217USD">168195</us-gaap:UnrealizedLossOnSecurities>
  <us-gaap:InvestmentsFairValueDisclosure id="F_000938" contextRef="C_0000879407_us-gaapMajorTypesOfDebtAndEquitySecuritiesAxis_arwrCommercialNotesDueWithinOneYearMember_20140331" decimals="0" unitRef="U_iso4217USD">17683294</us-gaap:InvestmentsFairValueDisclosure>
  <us-gaap:InvestmentsFairValueDisclosure id="F_000939" contextRef="C_0000879407_us-gaapMajorTypesOfDebtAndEquitySecuritiesAxis_arwrCommercialNotesDueAfterOneYearThroughTwoYearsMember_20140331" decimals="0" unitRef="U_iso4217USD">33880164</us-gaap:InvestmentsFairValueDisclosure>
  <us-gaap:MarketableSecuritiesNoncurrent id="F_000940" contextRef="C_0000879407_20140331" decimals="0" unitRef="U_iso4217USD">34048359</us-gaap:MarketableSecuritiesNoncurrent>
  <us-gaap:UnrealizedGainOnSecurities id="F_000941" contextRef="C_0000879407_us-gaapMajorTypesOfDebtAndEquitySecuritiesAxis_arwrCommercialNotesDueWithinOneYearMember_20121001_20130930" decimals="0" unitRef="U_iso4217USD">7500</us-gaap:UnrealizedGainOnSecurities>
  <us-gaap:UnrealizedGainOnSecurities id="F_000942" contextRef="C_0000879407_20121001_20130930" decimals="0" unitRef="U_iso4217USD">7500</us-gaap:UnrealizedGainOnSecurities>
  <us-gaap:UnrealizedLossOnSecurities id="F_000943" contextRef="C_0000879407_us-gaapMajorTypesOfDebtAndEquitySecuritiesAxis_arwrCommercialNotesDueWithinOneYearMember_20121001_20130930" decimals="0" unitRef="U_iso4217USD">39281</us-gaap:UnrealizedLossOnSecurities>
  <us-gaap:UnrealizedLossOnSecurities id="F_000944" contextRef="C_0000879407_us-gaapMajorTypesOfDebtAndEquitySecuritiesAxis_arwrCommercialNotesDueAfterOneYearThroughTwoYearsMember_20121001_20130930" decimals="0" unitRef="U_iso4217USD">2362</us-gaap:UnrealizedLossOnSecurities>
  <us-gaap:UnrealizedLossOnSecurities id="F_000945" contextRef="C_0000879407_20121001_20130930" decimals="0" unitRef="U_iso4217USD">41643</us-gaap:UnrealizedLossOnSecurities>
  <us-gaap:InvestmentsFairValueDisclosure id="F_000946" contextRef="C_0000879407_us-gaapMajorTypesOfDebtAndEquitySecuritiesAxis_arwrCommercialNotesDueWithinOneYearMember_20130930" decimals="0" unitRef="U_iso4217USD">8998480</us-gaap:InvestmentsFairValueDisclosure>
  <us-gaap:InvestmentsFairValueDisclosure id="F_000947" contextRef="C_0000879407_us-gaapMajorTypesOfDebtAndEquitySecuritiesAxis_arwrCommercialNotesDueAfterOneYearThroughTwoYearsMember_20130930" decimals="0" unitRef="U_iso4217USD">1699791</us-gaap:InvestmentsFairValueDisclosure>
  <us-gaap:InvestmentsFairValueDisclosure id="F_000948" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">10698271</us-gaap:InvestmentsFairValueDisclosure>
  <us-gaap:MarketableSecuritiesNoncurrent id="F_000949" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">1702153</us-gaap:MarketableSecuritiesNoncurrent>
  <us-gaap:MarketableSecurities id="F_000950" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">10732414</us-gaap:MarketableSecurities>
  <us-gaap:FurnitureAndFixturesGross id="F_000951" contextRef="C_0000879407_20140331" decimals="0" unitRef="U_iso4217USD">317867</us-gaap:FurnitureAndFixturesGross>
  <us-gaap:FurnitureAndFixturesGross id="F_000952" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">323376</us-gaap:FurnitureAndFixturesGross>
  <arwr:ResearchEquipment id="F_000953" contextRef="C_0000879407_20140331" decimals="0" unitRef="U_iso4217USD">3826494</arwr:ResearchEquipment>
  <arwr:ResearchEquipment id="F_000954" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">3452013</arwr:ResearchEquipment>
  <us-gaap:CapitalizedComputerSoftwareGross id="F_000955" contextRef="C_0000879407_20140331" decimals="0" unitRef="U_iso4217USD">69623</us-gaap:CapitalizedComputerSoftwareGross>
  <us-gaap:CapitalizedComputerSoftwareGross id="F_000956" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">69623</us-gaap:CapitalizedComputerSoftwareGross>
  <us-gaap:LeaseholdImprovementsGross id="F_000957" contextRef="C_0000879407_20140331" decimals="0" unitRef="U_iso4217USD">2749409</us-gaap:LeaseholdImprovementsGross>
  <us-gaap:LeaseholdImprovementsGross id="F_000958" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">2749409</us-gaap:LeaseholdImprovementsGross>
  <us-gaap:PropertyPlantAndEquipmentGross id="F_000959" contextRef="C_0000879407_20140331" decimals="0" unitRef="U_iso4217USD">6963393</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross id="F_000960" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">6594421</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment id="F_000961" contextRef="C_0000879407_20140331" decimals="0" unitRef="U_iso4217USD">3673123</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment id="F_000962" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">3081186</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <arwr:BusinessCombinationConsiderationPromissoryNoteIssued id="F_000963" contextRef="C_0000879407_us-gaapBusinessAcquisitionAxis_arwrRocheMadisonMember_20111021" decimals="0" unitRef="U_iso4217USD">50000</arwr:BusinessCombinationConsiderationPromissoryNoteIssued>
  <arwr:BusinessAcquisitionEquityInterestsIssuedNumberOfSharesIssued id="F_000964" contextRef="C_0000879407_us-gaapBusinessAcquisitionAxis_arwrRocheMadisonMember_20111021" decimals="INF" unitRef="U_shares">1288158</arwr:BusinessAcquisitionEquityInterestsIssuedNumberOfSharesIssued>
  <arwr:ApplicableOutLicenseTerm id="F_000965" contextRef="C_0000879407_us-gaapBusinessAcquisitionAxis_arwrRocheMadisonMember_20140331">P90D</arwr:ApplicableOutLicenseTerm>
  <arwr:PercentageOfRoyaltyLiability id="F_000966" contextRef="C_0000879407_us-gaapBusinessAcquisitionAxis_arwrRocheMadisonMember_20140331" decimals="2" unitRef="U_pure">0.03</arwr:PercentageOfRoyaltyLiability>
  <arwr:ObligationToPayRoyalties id="F_000967" contextRef="C_0000879407_20131001_20140331">later of (i) the expiration of the last to expire patent right related to such product candidate that was transferred in the Transaction and (ii) ten years after the first commercial sale of such product candidate.</arwr:ObligationToPayRoyalties>
  <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow id="F_000968" contextRef="C_0000879407_us-gaapBusinessAcquisitionAxis_arwrRocheMadisonMember_20140331" decimals="0" unitRef="U_iso4217USD">2500000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow>
  <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh id="F_000969" contextRef="C_0000879407_us-gaapBusinessAcquisitionAxis_arwrRocheMadisonMember_20140331" decimals="0" unitRef="U_iso4217USD">6000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
  <arwr:PresentValueOfContingentAcquisitionConsideration id="F_000970" contextRef="C_0000879407_20111001_20111021" decimals="0" unitRef="U_iso4217USD">84935</arwr:PresentValueOfContingentAcquisitionConsideration>
  <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 id="F_000971" contextRef="C_0000879407_20121001_20130930" decimals="-5" unitRef="U_iso4217USD">1400000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
  <us-gaap:FiniteLivedIntangibleAssetUsefulLife id="F_000972" contextRef="C_0000879407_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapLicensingAgreementsMember_20131001_20140331">P4Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
  <us-gaap:FiniteLivedIntangibleAssetUsefulLife id="F_000973" contextRef="C_0000879407_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapPatentsMember_us-gaapRangeAxis_us-gaapMinimumMember_20131001_20140331">P3Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
  <us-gaap:FiniteLivedIntangibleAssetUsefulLife id="F_000974" contextRef="C_0000879407_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapPatentsMember_us-gaapRangeAxis_us-gaapMaximumMember_20131001_20140331">P20Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
  <us-gaap:FiniteLivedIntangibleAssetUsefulLife id="F_000975" contextRef="C_0000879407_20131001_20140331">P12Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
  <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths id="F_000976" contextRef="C_0000879407_20140331" decimals="0" unitRef="U_iso4217USD">55000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
  <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo id="F_000977" contextRef="C_0000879407_20140331" decimals="0" unitRef="U_iso4217USD">55000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
  <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree id="F_000978" contextRef="C_0000879407_20140331" decimals="0" unitRef="U_iso4217USD">13000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
  <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive id="F_000979" contextRef="C_0000879407_20140331" decimals="0" unitRef="U_iso4217USD">0</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
  <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill id="F_000980" xsi:nil="true" contextRef="C_0000879407_20110930" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:IndefinitelivedIntangibleAssetsAcquired id="F_000981" contextRef="C_0000879407_us-gaapBusinessAcquisitionAxis_arwrRocheMadisonMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">944935</us-gaap:IndefinitelivedIntangibleAssetsAcquired>
  <us-gaap:IndefinitelivedIntangibleAssetsAcquired id="F_000982" contextRef="C_0000879407_us-gaapBusinessAcquisitionAxis_arwrAlvosTherapeuticsMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">2172387</us-gaap:IndefinitelivedIntangibleAssetsAcquired>
  <arwr:IndefiniteLivedIntangibleAssetsAccumulatedAmortization id="F_000983" xsi:nil="true" contextRef="C_0000879407_20120930" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill id="F_000984" contextRef="C_0000879407_20120930" decimals="0" unitRef="U_iso4217USD">3117322</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
  <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill id="F_000985" xsi:nil="true" contextRef="C_0000879407_20121001_20130930" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <arwr:IndefiniteLivedIntangibleAssetsAccumulatedAmortization id="F_000986" xsi:nil="true" contextRef="C_0000879407_20130930" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill id="F_000987" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">3117322</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
  <arwr:IndefiniteLivedIntangibleAssetsAccumulatedAmortization id="F_000988" xsi:nil="true" contextRef="C_0000879407_20140331" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill id="F_000989" contextRef="C_0000879407_20140331" decimals="0" unitRef="U_iso4217USD">3117322</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
  <us-gaap:FiniteLivedIntangibleAssetsNet id="F_000990" contextRef="C_0000879407_20110930" decimals="0" unitRef="U_iso4217USD">1731211</us-gaap:FiniteLivedIntangibleAssetsNet>
  <us-gaap:FinitelivedIntangibleAssetsAcquired1 id="F_000991" contextRef="C_0000879407_us-gaapBusinessAcquisitionAxis_arwrRocheMadisonMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">230000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
  <us-gaap:FinitelivedIntangibleAssetsAcquired1 id="F_000992" xsi:nil="true" contextRef="C_0000879407_us-gaapBusinessAcquisitionAxis_arwrAlvosTherapeuticsMember_20111001_20120930" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:AmortizationOfIntangibleAssets id="F_000993" contextRef="C_0000879407_20111001_20120930" decimals="0" unitRef="U_iso4217USD">293964</us-gaap:AmortizationOfIntangibleAssets>
  <us-gaap:FiniteLivedIntangibleAssetsNet id="F_000994" contextRef="C_0000879407_20120930" decimals="0" unitRef="U_iso4217USD">1667247</us-gaap:FiniteLivedIntangibleAssetsNet>
  <us-gaap:ImpairmentOfIntangibleAssetsFinitelived id="F_000995" contextRef="C_0000879407_20121001_20130930" decimals="0" unitRef="U_iso4217USD">1308047</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
  <us-gaap:AmortizationOfIntangibleAssets id="F_000996" contextRef="C_0000879407_20121001_20130930" decimals="0" unitRef="U_iso4217USD">236009</us-gaap:AmortizationOfIntangibleAssets>
  <us-gaap:FiniteLivedIntangibleAssetsNet id="F_000997" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">123191</us-gaap:FiniteLivedIntangibleAssetsNet>
  <us-gaap:AmortizationOfIntangibleAssets id="F_000998" contextRef="C_0000879407_20131001_20140331" decimals="0" unitRef="U_iso4217USD">27327</us-gaap:AmortizationOfIntangibleAssets>
  <us-gaap:FiniteLivedIntangibleAssetsNet id="F_000999" contextRef="C_0000879407_20140331" decimals="0" unitRef="U_iso4217USD">95864</us-gaap:FiniteLivedIntangibleAssetsNet>
  <us-gaap:IntangibleAssetsNetExcludingGoodwill id="F_001000" contextRef="C_0000879407_20110930" decimals="0" unitRef="U_iso4217USD">1731211</us-gaap:IntangibleAssetsNetExcludingGoodwill>
  <arwr:IntangibleAssetsAdditions id="F_001001" contextRef="C_0000879407_us-gaapBusinessAcquisitionAxis_arwrRocheMadisonMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">1174935</arwr:IntangibleAssetsAdditions>
  <arwr:IntangibleAssetsAdditions id="F_001002" contextRef="C_0000879407_us-gaapBusinessAcquisitionAxis_arwrAlvosTherapeuticsMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">2172387</arwr:IntangibleAssetsAdditions>
  <us-gaap:IntangibleAssetsNetExcludingGoodwill id="F_001003" contextRef="C_0000879407_20120930" decimals="0" unitRef="U_iso4217USD">4784569</us-gaap:IntangibleAssetsNetExcludingGoodwill>
  <us-gaap:IntangibleAssetsNetExcludingGoodwill id="F_001004" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">3240513</us-gaap:IntangibleAssetsNetExcludingGoodwill>
  <us-gaap:IntangibleAssetsNetExcludingGoodwill id="F_001005" contextRef="C_0000879407_20140331" decimals="0" unitRef="U_iso4217USD">3213186</us-gaap:IntangibleAssetsNetExcludingGoodwill>
  <arwr:OwnershipPercentageInSubsidiary id="F_001006" contextRef="C_0000879407_20131001_20140331" decimals="INF" unitRef="U_pure">1.00</arwr:OwnershipPercentageInSubsidiary>
  <arwr:OutstandingBalanceOfPromissoryNote id="F_001007" contextRef="C_0000879407_deiLegalEntityAxis_arwrCalandoPharmaceuticalsIncMember_20140331" decimals="0" unitRef="U_iso4217USD">1210000</arwr:OutstandingBalanceOfPromissoryNote>
  <arwr:AmountOwedBySubsidiary id="F_001008" contextRef="C_0000879407_deiLegalEntityAxis_arwrCalandoPharmaceuticalsIncMember_20140331" decimals="-5" unitRef="U_iso4217USD">4600000</arwr:AmountOwedBySubsidiary>
  <arwr:StatedPercentageOfNotesAndAdvances id="F_001009" contextRef="C_0000879407_deiLegalEntityAxis_arwrCalandoPharmaceuticalsIncMember_20140331" decimals="INF" unitRef="U_pure">0.08</arwr:StatedPercentageOfNotesAndAdvances>
  <us-gaap:EquityMethodInvestmentOwnershipPercentage id="F_001010" contextRef="C_0000879407_deiLegalEntityAxis_arwrCalandoPharmaceuticalsIncMember_20140331" decimals="INF" unitRef="U_pure">0.79</us-gaap:EquityMethodInvestmentOwnershipPercentage>
  <arwr:EquityMethodInvestmentOwnershipPercentageOnDilutiveBasis id="F_001011" contextRef="C_0000879407_deiLegalEntityAxis_arwrCalandoPharmaceuticalsIncMember_20140331" decimals="INF" unitRef="U_pure">0.76</arwr:EquityMethodInvestmentOwnershipPercentageOnDilutiveBasis>
  <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock id="F_001012" contextRef="C_0000879407_deiLegalEntityAxis_arwrAblarisTherapeuticsMember_20101001_20110930" decimals="-5" unitRef="U_iso4217USD">2900000</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
  <arwr:InvestmentInPreferredStock id="F_001013" contextRef="C_0000879407_deiLegalEntityAxis_arwrAblarisTherapeuticsMember_20110930" decimals="-5" unitRef="U_iso4217USD">1300000</arwr:InvestmentInPreferredStock>
  <arwr:InvestmentInPreferredStockByOutsider id="F_001014" contextRef="C_0000879407_deiLegalEntityAxis_arwrAblarisTherapeuticsMember_20110930" decimals="-5" unitRef="U_iso4217USD">1600000</arwr:InvestmentInPreferredStockByOutsider>
  <us-gaap:EquityMethodInvestmentOwnershipPercentage id="F_001015" contextRef="C_0000879407_deiLegalEntityAxis_arwrAblarisTherapeuticsMember_20140331" decimals="INF" unitRef="U_pure">0.64</us-gaap:EquityMethodInvestmentOwnershipPercentage>
  <arwr:EquityMethodInvestmentOwnershipPercentageOnDilutiveBasis id="F_001016" contextRef="C_0000879407_deiLegalEntityAxis_arwrAblarisTherapeuticsMember_20140331" decimals="INF" unitRef="U_pure">0.64</arwr:EquityMethodInvestmentOwnershipPercentageOnDilutiveBasis>
  <arwr:UnsecuredConvertiblePromissoryNoteAgreements id="F_001017" contextRef="C_0000879407_20081126" decimals="-5" unitRef="U_iso4217USD">2500000</arwr:UnsecuredConvertiblePromissoryNoteAgreements>
  <arwr:InvestInNotesOffering id="F_001018" contextRef="C_0000879407_20081126" decimals="INF" unitRef="U_iso4217USD">200000</arwr:InvestInNotesOffering>
  <arwr:AdditionalInvestmentInNotesOffering id="F_001019" contextRef="C_0000879407_20081126" decimals="INF" unitRef="U_iso4217USD">600000</arwr:AdditionalInvestmentInNotesOffering>
  <arwr:PrincipalAmountOfNoteNotConvertedInToShares id="F_001020" contextRef="C_0000879407_20081126" decimals="INF" unitRef="U_iso4217USD">500000</arwr:PrincipalAmountOfNoteNotConvertedInToShares>
  <us-gaap:DebtConversionConvertedInstrumentSharesIssued1 id="F_001021" contextRef="C_0000879407_deiLegalEntityAxis_arwrCalandoMember_us-gaapStatementClassOfStockAxis_us-gaapSeriesAPreferredStockMember_20131001_20140331" decimals="INF" unitRef="U_shares">2950</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
  <us-gaap:DebtInstrumentMaturityDate id="F_001022" contextRef="C_0000879407_20131001_20140331">2013-11-26</us-gaap:DebtInstrumentMaturityDate>
  <us-gaap:DebtInstrumentPaymentTerms id="F_001023" contextRef="C_0000879407_20131001_20140331">Two times principal payment at maturity</us-gaap:DebtInstrumentPaymentTerms>
  <us-gaap:DebtInstrumentInterestRateStatedPercentage id="F_001024" contextRef="C_0000879407_20081126" decimals="INF" unitRef="U_pure">0.10</us-gaap:DebtInstrumentInterestRateStatedPercentage>
  <us-gaap:DebtInstrumentInterestRateDuringPeriod id="F_001025" contextRef="C_0000879407_20131001_20140331" decimals="INF" unitRef="U_pure">0.15</us-gaap:DebtInstrumentInterestRateDuringPeriod>
  <us-gaap:DebtInstrumentCarryingAmount id="F_001026" contextRef="C_0000879407_20140331" decimals="-5" unitRef="U_iso4217USD">1000000</us-gaap:DebtInstrumentCarryingAmount>
  <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent id="F_001027" contextRef="C_0000879407_20140331" decimals="INF" unitRef="U_iso4217USD">210000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
  <us-gaap:CapitalUnitsAuthorized id="F_001028" contextRef="C_0000879407_20140331" decimals="INF" unitRef="U_shares">150000000</us-gaap:CapitalUnitsAuthorized>
  <us-gaap:DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance id="F_001029" contextRef="C_0000879407_us-gaapPlanNameAxis_arwrTwoThousandFourEquityIncentivePlanTwoThousandStockOptionPlanAndInducementGrantsMember_20140331" decimals="INF" unitRef="U_shares">3451210</us-gaap:DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance>
  <arwr:ThresholdPercentageOfCommonStockOwnershipUponPreferredStockConversion id="F_001030" contextRef="C_0000879407_20140331" decimals="INF" unitRef="U_pure">0.0999</arwr:ThresholdPercentageOfCommonStockOwnershipUponPreferredStockConversion>
  <arwr:MaximumEquityCommitmentAmountUnderAgreement id="F_001031" contextRef="C_0000879407_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_us-gaapLimitedLiabilityCompanyMember_20140331" decimals="-6" unitRef="U_iso4217USD">15000000</arwr:MaximumEquityCommitmentAmountUnderAgreement>
  <arwr:EquityCommitmentAgreementPeriod id="F_001032" contextRef="C_0000879407_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_us-gaapLimitedLiabilityCompanyMember_20140101_20140331">P3Y</arwr:EquityCommitmentAgreementPeriod>
  <arwr:CashDrawnFromFacility id="F_001033" contextRef="C_0000879407_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_us-gaapLimitedLiabilityCompanyMember_20140331" decimals="-6" unitRef="U_iso4217USD">1000000</arwr:CashDrawnFromFacility>
  <us-gaap:PreferredStockParOrStatedValuePerShare id="F_001034" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_us-gaapSeriesAPreferredStockMember_20120229" decimals="INF" unitRef="U_iso4217USD_shares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockParOrStatedValuePerShare id="F_001035" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_us-gaapSeriesAPreferredStockMember_20111021" decimals="INF" unitRef="U_iso4217USD_shares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:SaleOfStockPricePerShare id="F_001036" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_us-gaapSeriesAPreferredStockMember_20111021" decimals="INF" unitRef="U_iso4217USD_shares">1000</us-gaap:SaleOfStockPricePerShare>
  <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock id="F_001037" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_us-gaapSeriesAPreferredStockMember_20111001_20111031" decimals="0" unitRef="U_iso4217USD">1015000</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_001038" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_us-gaapSeriesAPreferredStockMember_us-gaapStatementScenarioAxis_arwrSubscriptionAgreementMember_20111001_20111031" decimals="INF" unitRef="U_shares">1015</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:ConversionOfStockSharesConverted1 id="F_001039" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_us-gaapSeriesAPreferredStockMember_20111001_20111031" decimals="INF" unitRef="U_shares">1015</us-gaap:ConversionOfStockSharesConverted1>
  <us-gaap:ConversionOfStockSharesConverted1 id="F_001040" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_us-gaapSeriesAPreferredStockMember_20120201_20120229" decimals="INF" unitRef="U_shares">1015</us-gaap:ConversionOfStockSharesConverted1>
  <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities id="F_001041" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_us-gaapSeriesAPreferredStockMember_20120201_20120229" decimals="INF" unitRef="U_shares">275782</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
  <us-gaap:CommonStockParOrStatedValuePerShare id="F_001042" contextRef="C_0000879407_us-gaapStatementScenarioAxis_arwrSubscriptionAgreementMember_20111031" decimals="INF" unitRef="U_iso4217USD_shares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
  <arwr:AggregatePurchasePriceOnIssuanceOfCommonStockToBeReceived id="F_001043" contextRef="C_0000879407_us-gaapStatementScenarioAxis_arwrSubscriptionAgreementMember_20111001_20111031" decimals="0" unitRef="U_iso4217USD">2497500</arwr:AggregatePurchasePriceOnIssuanceOfCommonStockToBeReceived>
  <us-gaap:SaleOfStockPricePerShare id="F_001044" contextRef="C_0000879407_us-gaapStatementScenarioAxis_arwrSubscriptionAgreementMember_20111031" decimals="INF" unitRef="U_iso4217USD_shares">3.70</us-gaap:SaleOfStockPricePerShare>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_001045" contextRef="C_0000879407_us-gaapStatementScenarioAxis_arwrSubscriptionAgreementMember_20111001_20111031" decimals="INF" unitRef="U_shares">675000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_001046" contextRef="C_0000879407_20120809_20120810" decimals="INF" unitRef="U_shares">2260869</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:SaleOfStockPricePerShare id="F_001047" contextRef="C_0000879407_20120810" decimals="INF" unitRef="U_iso4217USD_shares">2.76</us-gaap:SaleOfStockPricePerShare>
  <us-gaap:ProceedsFromIssuanceOfCommonStock id="F_001048" contextRef="C_0000879407_20120809_20120810" decimals="-5" unitRef="U_iso4217USD">6200000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <arwr:UnitSoldDescription id="F_001049" contextRef="C_0000879407_20120809_20120810">Each unit consisted of one share of common stock and a warrant to purchase</arwr:UnitSoldDescription>
  <arwr:WarrantToPurchaseShareOfCommonStock id="F_001050" contextRef="C_0000879407_20120810" decimals="2" unitRef="U_shares">0.75</arwr:WarrantToPurchaseShareOfCommonStock>
  <arwr:CommonStockExercisePrice id="F_001051" contextRef="C_0000879407_20120809_20120810" decimals="INF" unitRef="U_iso4217USD_shares">3.25</arwr:CommonStockExercisePrice>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_001052" contextRef="C_0000879407_20121201_20121231" decimals="INF" unitRef="U_shares">1825079</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:SaleOfStockPricePerShare id="F_001053" contextRef="C_0000879407_20121231" decimals="INF" unitRef="U_iso4217USD_shares">2.26</us-gaap:SaleOfStockPricePerShare>
  <us-gaap:ProceedsFromIssuanceOfCommonStock id="F_001054" contextRef="C_0000879407_20121201_20121231" decimals="-5" unitRef="U_iso4217USD">4100000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <arwr:UnitSoldDescription id="F_001055" contextRef="C_0000879407_20121201_20121231">Each unit consisted of one share of common stock and a warrant to purchase</arwr:UnitSoldDescription>
  <arwr:WarrantToPurchaseShareOfCommonStock id="F_001056" contextRef="C_0000879407_20121231" decimals="INF" unitRef="U_shares">0.5</arwr:WarrantToPurchaseShareOfCommonStock>
  <us-gaap:SaleOfStockPricePerShare id="F_001057" contextRef="C_0000879407_20130131" decimals="INF" unitRef="U_iso4217USD_shares">2.12</us-gaap:SaleOfStockPricePerShare>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_001058" contextRef="C_0000879407_20130101_20130131" decimals="INF" unitRef="U_shares">1667051</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:ProceedsFromIssuanceOfCommonStock id="F_001059" contextRef="C_0000879407_20130101_20130131" decimals="-5" unitRef="U_iso4217USD">3500000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <arwr:UnitSoldDescription id="F_001060" contextRef="C_0000879407_20130101_20130131">Each unit consisted of one share of common stock and a warrant to purchase</arwr:UnitSoldDescription>
  <arwr:WarrantToPurchaseShareOfCommonStock id="F_001061" contextRef="C_0000879407_20130131" decimals="INF" unitRef="U_shares">0.5</arwr:WarrantToPurchaseShareOfCommonStock>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights id="F_001062" contextRef="C_0000879407_20130930" decimals="2" unitRef="U_iso4217USD_arwrWarrant">1.83</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:SaleOfStockPricePerShare id="F_001063" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20130531" decimals="INF" unitRef="U_iso4217USD_shares">1.83</us-gaap:SaleOfStockPricePerShare>
  <us-gaap:SaleOfStockPricePerShare id="F_001064" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrConvertiblePreferredStockSeriesBMember_20130531" decimals="INF" unitRef="U_iso4217USD_shares">1000</us-gaap:SaleOfStockPricePerShare>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_001065" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20130501_20130531" decimals="INF" unitRef="U_shares">14300000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_001066" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrConvertiblePreferredStockSeriesBMember_20130501_20130531" decimals="INF" unitRef="U_shares">9900</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <arwr:ConversionPricePerShare id="F_001067" contextRef="C_0000879407_20130531" decimals="INF" unitRef="U_iso4217USD_shares">1.83</arwr:ConversionPricePerShare>
  <us-gaap:ProceedsFromIssuanceOrSaleOfEquity id="F_001068" contextRef="C_0000879407_20130501_20130531" decimals="-6" unitRef="U_iso4217USD">36000000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
  <us-gaap:SaleOfStockPricePerShare id="F_001069" contextRef="C_0000879407_20131011" decimals="INF" unitRef="U_iso4217USD_shares">5.86</us-gaap:SaleOfStockPricePerShare>
  <us-gaap:SaleOfStockPricePerShare id="F_001070" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_us-gaapSeriesCPreferredStockMember_20131011" decimals="INF" unitRef="U_iso4217USD_shares">1000</us-gaap:SaleOfStockPricePerShare>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_001071" contextRef="C_0000879407_20131010_20131011" decimals="INF" unitRef="U_shares">3071672</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_001072" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_us-gaapSeriesCPreferredStockMember_20131010_20131011" decimals="INF" unitRef="U_shares">46000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <arwr:ConversionPricePerShare id="F_001073" contextRef="C_0000879407_20131011" decimals="INF" unitRef="U_iso4217USD_shares">5.86</arwr:ConversionPricePerShare>
  <us-gaap:ProceedsFromIssuanceOfCommonStock id="F_001074" contextRef="C_0000879407_20131010_20131011" decimals="0" unitRef="U_iso4217USD">60000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <arwr:AggregatePriceOnIssuanceOrSaleOfEquity id="F_001075" contextRef="C_0000879407_20131010_20131011" decimals="0" unitRef="U_iso4217USD">64000000</arwr:AggregatePriceOnIssuanceOrSaleOfEquity>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_001076" contextRef="C_0000879407_20140223_20140224" decimals="INF" unitRef="U_shares">6325000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <arwr:CommonStockExercisePrice id="F_001077" contextRef="C_0000879407_20140223_20140224" decimals="INF" unitRef="U_iso4217USD_shares">18.95</arwr:CommonStockExercisePrice>
  <us-gaap:ProceedsFromIssuanceOfCommonStock id="F_001078" contextRef="C_0000879407_20140223_20140224" decimals="-5" unitRef="U_iso4217USD">112600000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights id="F_001079" contextRef="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantOneMember_20140331" decimals="INF" unitRef="U_iso4217USD_arwrWarrant">70.60</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights id="F_001080" contextRef="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantTwoMember_20140331" decimals="INF" unitRef="U_iso4217USD_arwrWarrant">5.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights id="F_001081" contextRef="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantThreeMember_20140331" decimals="INF" unitRef="U_iso4217USD_arwrWarrant">5.09</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights id="F_001082" contextRef="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantFourMember_20140331" decimals="INF" unitRef="U_iso4217USD_arwrWarrant">1.38</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights id="F_001083" contextRef="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantFiveMember_20140331" decimals="INF" unitRef="U_iso4217USD_arwrWarrant">4.16</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights id="F_001084" contextRef="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantSixMember_20140331" decimals="INF" unitRef="U_iso4217USD_arwrWarrant">3.25</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights id="F_001085" contextRef="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantSevenMember_20140331" decimals="INF" unitRef="U_iso4217USD_arwrWarrant">2.12</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights id="F_001086" contextRef="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantEightMember_20140331" decimals="INF" unitRef="U_iso4217USD_arwrWarrant">1.83</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightOutstanding id="F_001087" contextRef="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantOneMember_20140331" decimals="INF" unitRef="U_shares">94897</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:ClassOfWarrantOrRightOutstanding id="F_001088" contextRef="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantTwoMember_20140331" decimals="INF" unitRef="U_shares">995692</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:ClassOfWarrantOrRightOutstanding id="F_001089" contextRef="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantThreeMember_20140331" decimals="INF" unitRef="U_shares">291204</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:ClassOfWarrantOrRightOutstanding id="F_001090" contextRef="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantFourMember_20140331" decimals="INF" unitRef="U_shares">24324</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:ClassOfWarrantOrRightOutstanding id="F_001091" contextRef="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantFiveMember_20140331" decimals="INF" unitRef="U_shares">1000</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:ClassOfWarrantOrRightOutstanding id="F_001092" contextRef="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantSixMember_20140331" decimals="INF" unitRef="U_shares">746306</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:ClassOfWarrantOrRightOutstanding id="F_001093" contextRef="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantSevenMember_20140331" decimals="INF" unitRef="U_shares">75000</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:ClassOfWarrantOrRightOutstanding id="F_001094" contextRef="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantEightMember_20140331" decimals="INF" unitRef="U_shares">305084</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:ClassOfWarrantOrRightOutstanding id="F_001095" contextRef="C_0000879407_20140331" decimals="INF" unitRef="U_shares">2533507</us-gaap:ClassOfWarrantOrRightOutstanding>
  <arwr:RemainingLifeOfWarrant id="F_001096" contextRef="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantOneMember_20140101_20140331">P3Y1M6D</arwr:RemainingLifeOfWarrant>
  <arwr:RemainingLifeOfWarrant id="F_001097" contextRef="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantTwoMember_20140101_20140331">P8M12D</arwr:RemainingLifeOfWarrant>
  <arwr:RemainingLifeOfWarrant id="F_001098" contextRef="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantThreeMember_20140101_20140331">P8M12D</arwr:RemainingLifeOfWarrant>
  <arwr:RemainingLifeOfWarrant id="F_001099" contextRef="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantFourMember_20140101_20140331">P1Y8M12D</arwr:RemainingLifeOfWarrant>
  <arwr:RemainingLifeOfWarrant id="F_001100" contextRef="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantFiveMember_20140101_20140331">P2Y8M12D</arwr:RemainingLifeOfWarrant>
  <arwr:RemainingLifeOfWarrant id="F_001101" contextRef="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantSixMember_20140101_20140331">P2Y4M24D</arwr:RemainingLifeOfWarrant>
  <arwr:RemainingLifeOfWarrant id="F_001102" contextRef="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantSevenMember_20140101_20140331">P3Y8M12D</arwr:RemainingLifeOfWarrant>
  <arwr:RemainingLifeOfWarrant id="F_001103" contextRef="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantEightMember_20140101_20140331">P3Y8M12D</arwr:RemainingLifeOfWarrant>
  <us-gaap:LeaseExpirationDate1 id="F_001104" contextRef="C_0000879407_us-gaapPropertySubjectToOrAvailableForOperatingLeaseAxis_arwrCorporateHeadquartersInPasadenaMember_20131001_20140331">2018-07-31</us-gaap:LeaseExpirationDate1>
  <us-gaap:LeaseAndRentalExpense id="F_001105" contextRef="C_0000879407_us-gaapPropertySubjectToOrAvailableForOperatingLeaseAxis_arwrCorporateHeadquartersInPasadenaMember_20131001_20140331" decimals="0" unitRef="U_iso4217USD">22000</us-gaap:LeaseAndRentalExpense>
  <arwr:PercentageOfIncreaseInAnnualRentalCost id="F_001106" contextRef="C_0000879407_us-gaapPropertySubjectToOrAvailableForOperatingLeaseAxis_arwrCorporateHeadquartersInPasadenaMember_20131001_20140331" decimals="2" unitRef="U_pure">0.03</arwr:PercentageOfIncreaseInAnnualRentalCost>
  <us-gaap:LeaseExpirationDate1 id="F_001107" contextRef="C_0000879407_us-gaapPropertySubjectToOrAvailableForOperatingLeaseAxis_arwrResearchFacilityInMadisonMember_20131001_20140331">2019-02-28</us-gaap:LeaseExpirationDate1>
  <us-gaap:LeaseAndRentalExpense id="F_001108" contextRef="C_0000879407_us-gaapPropertySubjectToOrAvailableForOperatingLeaseAxis_arwrResearchFacilityInMadisonMember_20131001_20140331" decimals="0" unitRef="U_iso4217USD">23000</us-gaap:LeaseAndRentalExpense>
  <arwr:OtherRentalExpenses id="F_001109" contextRef="C_0000879407_20131001_20140331" decimals="0" unitRef="U_iso4217USD">15000</arwr:OtherRentalExpenses>
  <us-gaap:UtilitiesCosts id="F_001110" contextRef="C_0000879407_20131001_20140331" decimals="0" unitRef="U_iso4217USD">14000</us-gaap:UtilitiesCosts>
  <arwr:PaymentsUnderCapitalLease id="F_001111" contextRef="C_0000879407_us-gaapPropertySubjectToOrAvailableForOperatingLeaseAxis_us-gaapAssetsHeldUnderCapitalLeasesMember_20131001_20140331" decimals="0" unitRef="U_iso4217USD">19000</arwr:PaymentsUnderCapitalLease>
  <arwr:IncreaseInMonthlyExpenditureDueToUtilitiesCosts id="F_001112" contextRef="C_0000879407_20131001_20140331" decimals="0" unitRef="U_iso4217USD">71000</arwr:IncreaseInMonthlyExpenditureDueToUtilitiesCosts>
  <arwr:FacilityAndEquipmentRentExpense id="F_001113" contextRef="C_0000879407_20131001_20140331" decimals="0" unitRef="U_iso4217USD">264000</arwr:FacilityAndEquipmentRentExpense>
  <arwr:FacilityAndEquipmentRentExpense id="F_001114" contextRef="C_0000879407_20121001_20130331" decimals="0" unitRef="U_iso4217USD">281000</arwr:FacilityAndEquipmentRentExpense>
  <us-gaap:LeaseAndRentalExpense id="F_001115" contextRef="C_0000879407_20030501_20140331" decimals="0" unitRef="U_iso4217USD">4924000</us-gaap:LeaseAndRentalExpense>
  <us-gaap:CapitalLeasesFutureMinimumPaymentsDueCurrent id="F_001116" contextRef="C_0000879407_20140331" decimals="0" unitRef="U_iso4217USD">114211</us-gaap:CapitalLeasesFutureMinimumPaymentsDueCurrent>
  <us-gaap:CapitalLeasesFutureMinimumPaymentsDueInTwoYears id="F_001117" contextRef="C_0000879407_20140331" decimals="0" unitRef="U_iso4217USD">228420</us-gaap:CapitalLeasesFutureMinimumPaymentsDueInTwoYears>
  <us-gaap:CapitalLeasesFutureMinimumPaymentsDueInThreeYears id="F_001118" contextRef="C_0000879407_20140331" decimals="0" unitRef="U_iso4217USD">228420</us-gaap:CapitalLeasesFutureMinimumPaymentsDueInThreeYears>
  <us-gaap:CapitalLeasesFutureMinimumPaymentsDueInFourYears id="F_001119" contextRef="C_0000879407_20140331" decimals="0" unitRef="U_iso4217USD">228420</us-gaap:CapitalLeasesFutureMinimumPaymentsDueInFourYears>
  <us-gaap:CapitalLeasesFutureMinimumPaymentsDueInFiveYears id="F_001120" contextRef="C_0000879407_20140331" decimals="0" unitRef="U_iso4217USD">228420</us-gaap:CapitalLeasesFutureMinimumPaymentsDueInFiveYears>
  <us-gaap:CapitalLeasesFutureMinimumPaymentsDueThereafter id="F_001121" contextRef="C_0000879407_20140331" decimals="0" unitRef="U_iso4217USD">95175</us-gaap:CapitalLeasesFutureMinimumPaymentsDueThereafter>
  <us-gaap:CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments id="F_001122" contextRef="C_0000879407_20140331" decimals="0" unitRef="U_iso4217USD">45055</us-gaap:CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments>
  <us-gaap:CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments id="F_001123" contextRef="C_0000879407_20140331" decimals="0" unitRef="U_iso4217USD">1078011</us-gaap:CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent id="F_001124" contextRef="C_0000879407_20140331" decimals="0" unitRef="U_iso4217USD">234692</us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears id="F_001125" contextRef="C_0000879407_20140331" decimals="0" unitRef="U_iso4217USD">552028</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears id="F_001126" contextRef="C_0000879407_20140331" decimals="0" unitRef="U_iso4217USD">567904</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears id="F_001127" contextRef="C_0000879407_20140331" decimals="0" unitRef="U_iso4217USD">583932</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears id="F_001128" contextRef="C_0000879407_20140331" decimals="0" unitRef="U_iso4217USD">607437</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueThereafter id="F_001129" contextRef="C_0000879407_20140331" decimals="0" unitRef="U_iso4217USD">393133</us-gaap:OperatingLeasesFutureMinimumPaymentsDueThereafter>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDue id="F_001130" contextRef="C_0000879407_20140331" decimals="0" unitRef="U_iso4217USD">2939126</us-gaap:OperatingLeasesFutureMinimumPaymentsDue>
  <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance id="F_001131" contextRef="C_0000879407_us-gaapPlanNameAxis_arwrTwoThousandsStockOptionPlanMember_20140331" decimals="INF" unitRef="U_shares">50750</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
  <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance id="F_001132" contextRef="C_0000879407_20140331" decimals="INF" unitRef="U_shares">417406</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
  <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance id="F_001133" contextRef="C_0000879407_us-gaapPlanNameAxis_arwrTwoThousandsFourEquityIncentivePlanMember_20140331" decimals="INF" unitRef="U_shares">2735597</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
  <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance id="F_001134" contextRef="C_0000879407_us-gaapPlanNameAxis_arwrTwoThousandsThirteenIncentivePlanMember_20140331" decimals="INF" unitRef="U_shares">4000000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber id="F_001135" contextRef="C_0000879407_us-gaapPlanNameAxis_arwrTwoThousandsStockOptionPlanMember_20140331" decimals="INF" unitRef="U_shares">50750</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber id="F_001136" contextRef="C_0000879407_us-gaapPlanNameAxis_arwrTwoThousandsFourEquityIncentivePlanMember_20140331" decimals="INF" unitRef="U_shares">2733595</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber id="F_001137" contextRef="C_0000879407_us-gaapPlanNameAxis_arwrTwoThousandsThirteenIncentivePlanMember_20140331" decimals="INF" unitRef="U_shares">615000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross id="F_001138" contextRef="C_0000879407_us-gaapPlanNameAxis_arwrTwoThousandsFourEquityIncentivePlanMember_20131001_20140331" decimals="INF" unitRef="U_shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross id="F_001139" contextRef="C_0000879407_us-gaapPlanNameAxis_arwrTwoThousandsThirteenIncentivePlanMember_20131001_20140331" decimals="INF" unitRef="U_shares">615000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted id="F_001140" contextRef="C_0000879407_20131001_20140331" decimals="INF" unitRef="U_shares">165000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber id="F_001141" contextRef="C_0000879407_20110930" decimals="INF" unitRef="U_shares">729096</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross id="F_001142" contextRef="C_0000879407_20111001_20120930" decimals="INF" unitRef="U_shares">1229500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod id="F_001143" contextRef="C_0000879407_20111001_20120930" decimals="INF" unitRef="U_shares">42919</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised id="F_001144" contextRef="C_0000879407_20111001_20120930" decimals="INF" unitRef="U_shares">4883</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber id="F_001145" contextRef="C_0000879407_20120930" decimals="INF" unitRef="U_shares">1910794</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross id="F_001146" contextRef="C_0000879407_20121001_20130930" decimals="INF" unitRef="U_shares">1509166</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod id="F_001147" xsi:nil="true" contextRef="C_0000879407_20121001_20130930" unitRef="U_shares" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised id="F_001148" contextRef="C_0000879407_20121001_20130930" decimals="INF" unitRef="U_shares">675</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber id="F_001149" contextRef="C_0000879407_20130930" decimals="INF" unitRef="U_shares">3419285</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross id="F_001150" contextRef="C_0000879407_20131001_20140331" decimals="INF" unitRef="U_shares">780000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod id="F_001151" contextRef="C_0000879407_20131001_20140331" decimals="INF" unitRef="U_shares">40196</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised id="F_001152" contextRef="C_0000879407_20131001_20140331" decimals="INF" unitRef="U_shares">342338</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber id="F_001153" contextRef="C_0000879407_20140331" decimals="INF" unitRef="U_shares">3816751</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber id="F_001154" contextRef="C_0000879407_20140331" decimals="INF" unitRef="U_shares">1351974</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice id="F_001155" contextRef="C_0000879407_20110930" decimals="2" unitRef="U_iso4217USD_shares">9.03</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice id="F_001156" contextRef="C_0000879407_20111001_20120930" decimals="2" unitRef="U_iso4217USD_shares">4.40</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice id="F_001157" contextRef="C_0000879407_20111001_20120930" decimals="2" unitRef="U_iso4217USD_shares">11.77</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice id="F_001158" contextRef="C_0000879407_20111001_20120930" decimals="2" unitRef="U_iso4217USD_shares">5.20</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice id="F_001159" contextRef="C_0000879407_20120930" decimals="2" unitRef="U_iso4217USD_shares">6.10</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice id="F_001160" contextRef="C_0000879407_20121001_20130930" decimals="2" unitRef="U_iso4217USD_shares">2.03</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice id="F_001161" xsi:nil="true" contextRef="C_0000879407_20121001_20130930" unitRef="U_iso4217USD_shares" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice id="F_001162" contextRef="C_0000879407_20121001_20130930" decimals="2" unitRef="U_iso4217USD_shares">3.93</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice id="F_001163" contextRef="C_0000879407_20130930" decimals="2" unitRef="U_iso4217USD_shares">4.68</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice id="F_001164" contextRef="C_0000879407_20131001_20140331" decimals="2" unitRef="U_iso4217USD_shares">13.51</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice id="F_001165" contextRef="C_0000879407_20131001_20140331" decimals="2" unitRef="U_iso4217USD_shares">4.68</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice id="F_001166" contextRef="C_0000879407_20131001_20140331" decimals="2" unitRef="U_iso4217USD_shares">6.54</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice id="F_001167" contextRef="C_0000879407_20140331" decimals="2" unitRef="U_iso4217USD_shares">5.81</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice id="F_001168" contextRef="C_0000879407_20140331" decimals="2" unitRef="U_iso4217USD_shares">5.91</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 id="F_001169" contextRef="C_0000879407_20131001_20140331">P7Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 id="F_001170" contextRef="C_0000879407_20131001_20140331">P7Y2M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue id="F_001171" contextRef="C_0000879407_20140331" decimals="0" unitRef="U_iso4217USD">38622771</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 id="F_001172" contextRef="C_0000879407_20140331" decimals="0" unitRef="U_iso4217USD">14710062</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
  <us-gaap:AllocatedShareBasedCompensationExpense id="F_001173" contextRef="C_0000879407_20131001_20140331" decimals="0" unitRef="U_iso4217USD">1719582</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="F_001174" contextRef="C_0000879407_20121001_20130331" decimals="0" unitRef="U_iso4217USD">750782</us-gaap:AllocatedShareBasedCompensationExpense>
  <arwr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue id="F_001175" contextRef="C_0000879407_20140101_20140331" decimals="0" unitRef="U_iso4217USD">7085656</arwr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue>
  <arwr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue id="F_001176" contextRef="C_0000879407_20130101_20130331" decimals="0" unitRef="U_iso4217USD">103293</arwr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue id="F_001177" contextRef="C_0000879407_20131001_20140331" decimals="0" unitRef="U_iso4217USD">3115175</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue id="F_001178" contextRef="C_0000879407_20121001_20130331" decimals="0" unitRef="U_iso4217USD">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
  <arwr:PreTaxCompensationExpense id="F_001179" contextRef="C_0000879407_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_arwrArrowheadMember_20140331" decimals="0" unitRef="U_iso4217USD">17294117</arwr:PreTaxCompensationExpense>
  <arwr:WeightedAveragePeriodToRecognizePreTaxCompensationExpense id="F_001180" contextRef="C_0000879407_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_arwrArrowheadMember_20140101_20140331">P3Y6M</arwr:WeightedAveragePeriodToRecognizePreTaxCompensationExpense>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate id="F_001181" contextRef="C_0000879407_20131001_20140331" decimals="2" unitRef="U_pure">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate id="F_001182" contextRef="C_0000879407_20121001_20130331" decimals="2" unitRef="U_pure">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum id="F_001183" contextRef="C_0000879407_20131001_20140331" decimals="3" unitRef="U_pure">0.019</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum id="F_001184" contextRef="C_0000879407_20121001_20130331" decimals="3" unitRef="U_pure">0.007</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum id="F_001185" contextRef="C_0000879407_20131001_20140331" decimals="4" unitRef="U_pure">0.0226</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum id="F_001186" contextRef="C_0000879407_20121001_20130331" decimals="3" unitRef="U_pure">0.010</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate id="F_001187" xsi:nil="true" contextRef="C_0000879407_us-gaapRangeAxis_us-gaapMinimumMember_20131001_20140331" unitRef="U_pure" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate id="F_001188" xsi:nil="true" contextRef="C_0000879407_us-gaapRangeAxis_us-gaapMaximumMember_20131001_20140331" unitRef="U_pure" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate id="F_001189" xsi:nil="true" contextRef="C_0000879407_us-gaapRangeAxis_us-gaapMinimumMember_20121001_20130331" unitRef="U_pure" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate id="F_001190" xsi:nil="true" contextRef="C_0000879407_us-gaapRangeAxis_us-gaapMaximumMember_20121001_20130331" unitRef="U_pure" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate id="F_001191" xsi:nil="true" contextRef="C_0000879407_20121001_20130331" unitRef="U_pure" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate id="F_001192" contextRef="C_0000879407_20131001_20140331" decimals="2" unitRef="U_pure">0.69</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate id="F_001193" contextRef="C_0000879407_20121001_20130331" decimals="2" unitRef="U_pure">0.69</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 id="F_001194" contextRef="C_0000879407_us-gaapRangeAxis_us-gaapMinimumMember_20131001_20140331">P5Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 id="F_001195" contextRef="C_0000879407_us-gaapRangeAxis_us-gaapMaximumMember_20131001_20140331">P6Y3M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 id="F_001196" contextRef="C_0000879407_us-gaapRangeAxis_us-gaapMinimumMember_20121001_20130331">P5Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 id="F_001197" contextRef="C_0000879407_us-gaapRangeAxis_us-gaapMaximumMember_20121001_20130331">P6Y3M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue id="F_001198" contextRef="C_0000879407_20131001_20140331" decimals="2" unitRef="U_iso4217USD_shares">9.08</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue id="F_001199" contextRef="C_0000879407_20121001_20130331" decimals="2" unitRef="U_iso4217USD_shares">1.31</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber id="F_001200" contextRef="C_0000879407_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20140331" decimals="INF" unitRef="U_shares">470000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber id="F_001201" xsi:nil="true" contextRef="C_0000879407_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20130930" unitRef="U_shares" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod id="F_001202" contextRef="C_0000879407_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20131001_20140331" decimals="INF" unitRef="U_shares">470000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod id="F_001203" xsi:nil="true" contextRef="C_0000879407_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20131001_20140331" unitRef="U_shares" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod id="F_001204" xsi:nil="true" contextRef="C_0000879407_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20131001_20140331" unitRef="U_shares" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue id="F_001205" xsi:nil="true" contextRef="C_0000879407_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20130930" unitRef="U_iso4217USD_shares" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue id="F_001206" contextRef="C_0000879407_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20131001_20140331" decimals="2" unitRef="U_iso4217USD_shares">14.54</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue id="F_001207" xsi:nil="true" contextRef="C_0000879407_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20131001_20140331" unitRef="U_iso4217USD_shares" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue id="F_001208" xsi:nil="true" contextRef="C_0000879407_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20131001_20140331" unitRef="U_iso4217USD_shares" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue id="F_001209" contextRef="C_0000879407_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20140331" decimals="2" unitRef="U_iso4217USD_shares">14.54</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
  <us-gaap:AllocatedShareBasedCompensationExpense id="F_001210" contextRef="C_0000879407_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20131001_20140331" decimals="0" unitRef="U_iso4217USD">570707</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="F_001211" contextRef="C_0000879407_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20121001_20130331" decimals="0" unitRef="U_iso4217USD">0</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:CashAndCashEquivalentsFairValueDisclosure id="F_001212" contextRef="C_0000879407_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20140331" decimals="0" unitRef="U_iso4217USD">142847860</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
  <us-gaap:CashAndCashEquivalentsFairValueDisclosure id="F_001213" contextRef="C_0000879407_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20140331" decimals="0" unitRef="U_iso4217USD">142847860</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
  <us-gaap:DerivativeAssetsNoncurrent id="F_001214" xsi:nil="true" contextRef="C_0000879407_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20140331" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:DerivativeAssetsNoncurrent id="F_001215" xsi:nil="true" contextRef="C_0000879407_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20140331" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:DerivativeAssetsNoncurrent id="F_001216" xsi:nil="true" contextRef="C_0000879407_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20140331" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:DerivativeAssetsNoncurrent id="F_001217" xsi:nil="true" contextRef="C_0000879407_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20140331" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:DerivativeLiabilities id="F_001218" contextRef="C_0000879407_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20140331" decimals="0" unitRef="U_iso4217USD">4936530</us-gaap:DerivativeLiabilities>
  <us-gaap:DerivativeLiabilities id="F_001219" contextRef="C_0000879407_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20140331" decimals="0" unitRef="U_iso4217USD">4936530</us-gaap:DerivativeLiabilities>
  <us-gaap:BusinessCombinationContingentConsiderationLiability id="F_001220" contextRef="C_0000879407_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20140331" decimals="0" unitRef="U_iso4217USD">1595273</us-gaap:BusinessCombinationContingentConsiderationLiability>
  <us-gaap:BusinessCombinationContingentConsiderationLiability id="F_001221" contextRef="C_0000879407_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20140331" decimals="0" unitRef="U_iso4217USD">1595273</us-gaap:BusinessCombinationContingentConsiderationLiability>
  <us-gaap:CashAndCashEquivalentsFairValueDisclosure id="F_001222" contextRef="C_0000879407_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20130930" decimals="0" unitRef="U_iso4217USD">19114444</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
  <us-gaap:CashAndCashEquivalentsFairValueDisclosure id="F_001223" contextRef="C_0000879407_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20130930" decimals="0" unitRef="U_iso4217USD">19114444</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
  <us-gaap:DerivativeAssetsNoncurrent id="F_001224" xsi:nil="true" contextRef="C_0000879407_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20130930" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:DerivativeAssetsNoncurrent id="F_001225" xsi:nil="true" contextRef="C_0000879407_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20130930" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:DerivativeAssetsNoncurrent id="F_001226" xsi:nil="true" contextRef="C_0000879407_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20130930" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:DerivativeAssetsNoncurrent id="F_001227" xsi:nil="true" contextRef="C_0000879407_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20130930" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:DerivativeLiabilities id="F_001228" contextRef="C_0000879407_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20130930" decimals="0" unitRef="U_iso4217USD">4096363</us-gaap:DerivativeLiabilities>
  <us-gaap:DerivativeLiabilities id="F_001229" contextRef="C_0000879407_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20130930" decimals="0" unitRef="U_iso4217USD">4096363</us-gaap:DerivativeLiabilities>
  <us-gaap:BusinessCombinationContingentConsiderationLiability id="F_001230" contextRef="C_0000879407_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20130930" decimals="0" unitRef="U_iso4217USD">1595273</us-gaap:BusinessCombinationContingentConsiderationLiability>
  <us-gaap:BusinessCombinationContingentConsiderationLiability id="F_001231" contextRef="C_0000879407_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20130930" decimals="0" unitRef="U_iso4217USD">1595273</us-gaap:BusinessCombinationContingentConsiderationLiability>
  <arwr:NonCashConsiderationReceivedInSaleOfInterestInSubsidiaryBonds id="F_001232" contextRef="C_0000879407_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_arwrUnidymIncMember_20110101_20110131" decimals="-5" unitRef="U_iso4217USD">2500000</arwr:NonCashConsiderationReceivedInSaleOfInterestInSubsidiaryBonds>
  <us-gaap:DebtInstrumentConvertibleConversionPrice1 id="F_001233" contextRef="C_0000879407_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_arwrUnidymIncMember_20110131" decimals="INF" unitRef="U_iso4217USD_shares">2.00</us-gaap:DebtInstrumentConvertibleConversionPrice1>
  <us-gaap:FairValueAssumptionsRiskFreeInterestRate id="F_001234" xsi:nil="true" contextRef="C_0000879407_us-gaapFairValueByAssetClassAxis_us-gaapDerivativeFinancialInstrumentsAssetsMember_20131001_20140331" unitRef="U_pure" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:FairValueAssumptionsRiskFreeInterestRate id="F_001235" xsi:nil="true" contextRef="C_0000879407_us-gaapFairValueByAssetClassAxis_us-gaapDerivativeFinancialInstrumentsAssetsMember_20121001_20130930" unitRef="U_pure" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:FairValueAssumptionsExpectedTerm id="F_001236" xsi:nil="true" contextRef="C_0000879407_us-gaapFairValueByAssetClassAxis_us-gaapDerivativeFinancialInstrumentsAssetsMember_20131001_20140331" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:FairValueAssumptionsExpectedTerm id="F_001237" xsi:nil="true" contextRef="C_0000879407_us-gaapFairValueByAssetClassAxis_us-gaapDerivativeFinancialInstrumentsAssetsMember_20121001_20130930" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:FairValueAssumptionsExpectedDividendRate id="F_001238" xsi:nil="true" contextRef="C_0000879407_us-gaapFairValueByAssetClassAxis_us-gaapDerivativeFinancialInstrumentsAssetsMember_20131001_20140331" unitRef="U_pure" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:FairValueAssumptionsExpectedDividendRate id="F_001239" xsi:nil="true" contextRef="C_0000879407_us-gaapFairValueByAssetClassAxis_us-gaapDerivativeFinancialInstrumentsAssetsMember_20121001_20130930" unitRef="U_pure" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:FairValueAssumptionsExpectedVolatilityRate id="F_001240" xsi:nil="true" contextRef="C_0000879407_us-gaapFairValueByAssetClassAxis_us-gaapDerivativeFinancialInstrumentsAssetsMember_20131001_20140331" unitRef="U_pure" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:FairValueAssumptionsExpectedVolatilityRate id="F_001241" xsi:nil="true" contextRef="C_0000879407_us-gaapFairValueByAssetClassAxis_us-gaapDerivativeFinancialInstrumentsAssetsMember_20121001_20130930" unitRef="U_pure" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue id="F_001242" contextRef="C_0000879407_us-gaapFairValueByAssetClassAxis_us-gaapDerivativeFinancialInstrumentsAssetsMember_20120930" decimals="0" unitRef="U_iso4217USD">250250</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases id="F_001243" xsi:nil="true" contextRef="C_0000879407_us-gaapFairValueByAssetClassAxis_us-gaapDerivativeFinancialInstrumentsAssetsMember_20121001_20130930" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1 id="F_001244" contextRef="C_0000879407_us-gaapFairValueByAssetClassAxis_us-gaapDerivativeFinancialInstrumentsAssetsMember_20121001_20130930" decimals="0" unitRef="U_iso4217USD">-250250</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements id="F_001245" xsi:nil="true" contextRef="C_0000879407_us-gaapFairValueByAssetClassAxis_us-gaapDerivativeFinancialInstrumentsAssetsMember_20121001_20130930" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue id="F_001246" xsi:nil="true" contextRef="C_0000879407_us-gaapFairValueByAssetClassAxis_us-gaapDerivativeFinancialInstrumentsAssetsMember_20130930" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases id="F_001247" xsi:nil="true" contextRef="C_0000879407_us-gaapFairValueByAssetClassAxis_us-gaapDerivativeFinancialInstrumentsAssetsMember_20131001_20140331" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1 id="F_001248" xsi:nil="true" contextRef="C_0000879407_us-gaapFairValueByAssetClassAxis_us-gaapDerivativeFinancialInstrumentsAssetsMember_20131001_20140331" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements id="F_001249" xsi:nil="true" contextRef="C_0000879407_us-gaapFairValueByAssetClassAxis_us-gaapDerivativeFinancialInstrumentsAssetsMember_20131001_20140331" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue id="F_001250" xsi:nil="true" contextRef="C_0000879407_us-gaapFairValueByAssetClassAxis_us-gaapDerivativeFinancialInstrumentsAssetsMember_20140331" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <arwr:WarrantsIssuedToAcquireCommonStock id="F_001251" contextRef="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrTwoThousandTenWarrantsMember_20140331" decimals="INF" unitRef="U_shares">329649</arwr:WarrantsIssuedToAcquireCommonStock>
  <arwr:WarrantsIssuedToAcquireCommonStock id="F_001252" contextRef="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrTwoThousandsTwelveWarrantsMember_20140331" decimals="INF" unitRef="U_shares">912543</arwr:WarrantsIssuedToAcquireCommonStock>
  <arwr:WarrantsIssuedToAcquireCommonStock id="F_001253" contextRef="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrTwoThousandThirteenWarrantsMember_20140331" decimals="INF" unitRef="U_shares">833530</arwr:WarrantsIssuedToAcquireCommonStock>
  <us-gaap:ClassOfWarrantOrRightOutstanding id="F_001254" contextRef="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrTwoThousandTenWarrantsMember_20140331" decimals="INF" unitRef="U_shares">24324</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:ClassOfWarrantOrRightOutstanding id="F_001255" contextRef="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrTwoThousandsTwelveWarrantsMember_20140331" decimals="INF" unitRef="U_shares">265461</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:ClassOfWarrantOrRightOutstanding id="F_001256" contextRef="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrTwoThousandThirteenWarrantsMember_20140331" decimals="INF" unitRef="U_shares">39623</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings id="F_001257" contextRef="C_0000879407_20131001_20140331" decimals="0" unitRef="U_iso4217USD">9234419</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
  <us-gaap:FairValueAssumptionsRiskFreeInterestRate id="F_001258" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrTwoThousandTenWarrantsMember_20131001_20140331" decimals="4" unitRef="U_pure">0.0044</us-gaap:FairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:FairValueAssumptionsRiskFreeInterestRate id="F_001259" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrTwoThousandTenWarrantsMember_20121001_20130930" decimals="4" unitRef="U_pure">0.0033</us-gaap:FairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:FairValueAssumptionsExpectedTerm id="F_001260" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrTwoThousandTenWarrantsMember_20131001_20140331">P2Y</us-gaap:FairValueAssumptionsExpectedTerm>
  <us-gaap:FairValueAssumptionsExpectedTerm id="F_001261" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrTwoThousandTenWarrantsMember_20121001_20130930">P2Y2M12D</us-gaap:FairValueAssumptionsExpectedTerm>
  <us-gaap:FairValueAssumptionsExpectedDividendRate id="F_001262" xsi:nil="true" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrTwoThousandTenWarrantsMember_20131001_20140331" unitRef="U_pure" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:FairValueAssumptionsExpectedDividendRate id="F_001263" xsi:nil="true" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrTwoThousandTenWarrantsMember_20121001_20130930" unitRef="U_pure" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:FairValueAssumptionsExpectedVolatilityRate id="F_001264" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrTwoThousandTenWarrantsMember_20131001_20140331" decimals="2" unitRef="U_pure">0.69</us-gaap:FairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:FairValueAssumptionsExpectedVolatilityRate id="F_001265" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrTwoThousandTenWarrantsMember_20121001_20130930" decimals="2" unitRef="U_pure">0.69</us-gaap:FairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:FairValueAssumptionsRiskFreeInterestRate id="F_001266" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrTwoThousandsTwelveWarrantsMember_20131001_20140331" decimals="4" unitRef="U_pure">0.0131</us-gaap:FairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:FairValueAssumptionsRiskFreeInterestRate id="F_001267" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrTwoThousandsTwelveWarrantsMember_20121001_20130930" decimals="4" unitRef="U_pure">0.0139</us-gaap:FairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:FairValueAssumptionsExpectedTerm id="F_001268" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrTwoThousandsTwelveWarrantsMember_20131001_20140331">P3Y8M12D</us-gaap:FairValueAssumptionsExpectedTerm>
  <us-gaap:FairValueAssumptionsExpectedTerm id="F_001269" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrTwoThousandsTwelveWarrantsMember_20121001_20130930">P4Y2M12D</us-gaap:FairValueAssumptionsExpectedTerm>
  <us-gaap:FairValueAssumptionsExpectedDividendRate id="F_001270" xsi:nil="true" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrTwoThousandsTwelveWarrantsMember_20131001_20140331" unitRef="U_pure" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:FairValueAssumptionsExpectedDividendRate id="F_001271" xsi:nil="true" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrTwoThousandsTwelveWarrantsMember_20121001_20130930" unitRef="U_pure" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:FairValueAssumptionsExpectedVolatilityRate id="F_001272" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrTwoThousandsTwelveWarrantsMember_20131001_20140331" decimals="2" unitRef="U_pure">0.69</us-gaap:FairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:FairValueAssumptionsExpectedVolatilityRate id="F_001273" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrTwoThousandsTwelveWarrantsMember_20121001_20130930" decimals="2" unitRef="U_pure">0.69</us-gaap:FairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:FairValueAssumptionsRiskFreeInterestRate id="F_001274" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrTwoThousandThirteenWarrantsMember_20131001_20140331" decimals="4" unitRef="U_pure">0.0131</us-gaap:FairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:FairValueAssumptionsRiskFreeInterestRate id="F_001275" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrTwoThousandThirteenWarrantsMember_20121001_20130930" decimals="4" unitRef="U_pure">0.0139</us-gaap:FairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:FairValueAssumptionsExpectedTerm id="F_001276" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrTwoThousandThirteenWarrantsMember_20131001_20140331">P3Y9M18D</us-gaap:FairValueAssumptionsExpectedTerm>
  <us-gaap:FairValueAssumptionsExpectedTerm id="F_001277" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrTwoThousandThirteenWarrantsMember_20121001_20130930">P4Y3M18D</us-gaap:FairValueAssumptionsExpectedTerm>
  <us-gaap:FairValueAssumptionsExpectedDividendRate id="F_001278" xsi:nil="true" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrTwoThousandThirteenWarrantsMember_20131001_20140331" unitRef="U_pure" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:FairValueAssumptionsExpectedDividendRate id="F_001279" xsi:nil="true" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrTwoThousandThirteenWarrantsMember_20121001_20130930" unitRef="U_pure" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:FairValueAssumptionsExpectedVolatilityRate id="F_001280" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrTwoThousandThirteenWarrantsMember_20131001_20140331" decimals="2" unitRef="U_pure">0.69</us-gaap:FairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:FairValueAssumptionsExpectedVolatilityRate id="F_001281" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrTwoThousandThirteenWarrantsMember_20121001_20130930" decimals="2" unitRef="U_pure">0.69</us-gaap:FairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue id="F_001282" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_us-gaapWarrantMember_20120930" decimals="0" unitRef="U_iso4217USD">626195</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues id="F_001283" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_us-gaapWarrantMember_20121001_20130930" decimals="0" unitRef="U_iso4217USD">2153819</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings id="F_001284" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_us-gaapWarrantMember_20121001_20130930" decimals="0" unitRef="U_iso4217USD">5066591</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements id="F_001285" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_us-gaapWarrantMember_20121001_20130930" decimals="0" unitRef="U_iso4217USD">3754808</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue id="F_001286" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_us-gaapWarrantMember_20130930" decimals="0" unitRef="U_iso4217USD">4091797</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues id="F_001287" xsi:nil="true" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_us-gaapWarrantMember_20131001_20140331" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings id="F_001288" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_us-gaapWarrantMember_20131001_20140331" decimals="0" unitRef="U_iso4217USD">9234419</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements id="F_001289" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_us-gaapWarrantMember_20131001_20140331" decimals="0" unitRef="U_iso4217USD">8447443</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue id="F_001290" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_us-gaapWarrantMember_20140331" decimals="0" unitRef="U_iso4217USD">4878773</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings id="F_001291" contextRef="C_0000879407_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_arwrAblarisTherapeuticsMember_20131001_20140331" decimals="0" unitRef="U_iso4217USD">53190</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
  <arwr:TermOfExchangeRights id="F_001292" contextRef="C_0000879407_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_arwrAblarisTherapeuticsMember_20131001_20140331">P7Y</arwr:TermOfExchangeRights>
  <arwr:ExchangeRightConvertibleConversionRatioForFirstYear id="F_001293" contextRef="C_0000879407_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_arwrAblarisTherapeuticsMember_20131001_20140331" decimals="2" unitRef="U_pure">0.06</arwr:ExchangeRightConvertibleConversionRatioForFirstYear>
  <arwr:ExchangeRightConvertibleConversionRatioForTwoYear id="F_001294" contextRef="C_0000879407_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_arwrAblarisTherapeuticsMember_20131001_20140331" decimals="2" unitRef="U_pure">0.04</arwr:ExchangeRightConvertibleConversionRatioForTwoYear>
  <arwr:ExchangeRightConvertibleConversionRatioForThreeYear id="F_001295" contextRef="C_0000879407_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_arwrAblarisTherapeuticsMember_20131001_20140331" decimals="2" unitRef="U_pure">0.03</arwr:ExchangeRightConvertibleConversionRatioForThreeYear>
  <arwr:ExchangeRightConvertibleConversionRatioForFourYear id="F_001296" contextRef="C_0000879407_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_arwrAblarisTherapeuticsMember_20131001_20140331" decimals="2" unitRef="U_pure">0.02</arwr:ExchangeRightConvertibleConversionRatioForFourYear>
  <arwr:ExchangeRightConvertibleConversionRatioForFiveYear id="F_001297" contextRef="C_0000879407_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_arwrAblarisTherapeuticsMember_20131001_20140331" decimals="2" unitRef="U_pure">0.01</arwr:ExchangeRightConvertibleConversionRatioForFiveYear>
  <arwr:NumberOfExchangeRightAreSold id="F_001298" contextRef="C_0000879407_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_arwrAblarisTherapeuticsMember_20131001_20140331" decimals="INF" unitRef="U_shares">675000</arwr:NumberOfExchangeRightAreSold>
  <us-gaap:FairValueAssumptionsRiskFreeInterestRate id="F_001299" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrExchangeRightsMember_20140101_20140331" decimals="4" unitRef="U_pure">0.0131</us-gaap:FairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:FairValueAssumptionsRiskFreeInterestRate id="F_001300" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrExchangeRightsMember_20121001_20130930" decimals="4" unitRef="U_pure">0.0139</us-gaap:FairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:FairValueAssumptionsExpectedTerm id="F_001301" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrExchangeRightsMember_20140101_20140331">P3Y9M18D</us-gaap:FairValueAssumptionsExpectedTerm>
  <us-gaap:FairValueAssumptionsExpectedTerm id="F_001302" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrExchangeRightsMember_20121001_20130930">P4Y3M18D</us-gaap:FairValueAssumptionsExpectedTerm>
  <us-gaap:FairValueAssumptionsExpectedDividendRate id="F_001303" xsi:nil="true" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrExchangeRightsMember_20140101_20140331" unitRef="U_pure" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:FairValueAssumptionsExpectedDividendRate id="F_001304" xsi:nil="true" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrExchangeRightsMember_20121001_20130930" unitRef="U_pure" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:FairValueAssumptionsExpectedVolatilityRate id="F_001305" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrExchangeRightsMember_20140101_20140331" decimals="2" unitRef="U_pure">0.69</us-gaap:FairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:FairValueAssumptionsExpectedVolatilityRate id="F_001306" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrExchangeRightsMember_20121001_20130930" decimals="2" unitRef="U_pure">0.69</us-gaap:FairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue id="F_001307" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrExchangeRightsMember_20120930" decimals="0" unitRef="U_iso4217USD">10375</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues id="F_001308" xsi:nil="true" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrExchangeRightsMember_20121001_20130930" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings id="F_001309" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrExchangeRightsMember_20121001_20130930" decimals="0" unitRef="U_iso4217USD">-5806</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements id="F_001310" xsi:nil="true" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrExchangeRightsMember_20121001_20130930" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue id="F_001311" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrExchangeRightsMember_20130930" decimals="0" unitRef="U_iso4217USD">4569</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues id="F_001312" xsi:nil="true" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrExchangeRightsMember_20131001_20140331" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings id="F_001313" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrExchangeRightsMember_20131001_20140331" decimals="0" unitRef="U_iso4217USD">53190</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements id="F_001314" xsi:nil="true" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrExchangeRightsMember_20131001_20140331" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue id="F_001315" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrExchangeRightsMember_20140331" decimals="0" unitRef="U_iso4217USD">57759</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
  <us-gaap:BusinessCombinationContingentConsiderationLiability id="F_001316" contextRef="C_0000879407_20120930" decimals="0" unitRef="U_iso4217USD">173621</us-gaap:BusinessCombinationContingentConsiderationLiability>
  <arwr:BusinessCombinationPurchasePriceContingentConsiderationFairValue id="F_001317" xsi:nil="true" contextRef="C_0000879407_20120930" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <arwr:BusinessCombinationContingentConsiderationPayments id="F_001318" xsi:nil="true" contextRef="C_0000879407_20120930" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <arwr:BusinessCombinationFairValueOfChangeInContingentConsideration id="F_001319" contextRef="C_0000879407_20120930" decimals="0" unitRef="U_iso4217USD">1421652</arwr:BusinessCombinationFairValueOfChangeInContingentConsideration>
  <us-gaap:BusinessCombinationContingentConsiderationLiability id="F_001320" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">1595273</us-gaap:BusinessCombinationContingentConsiderationLiability>
  <arwr:BusinessCombinationPurchasePriceContingentConsiderationFairValue id="F_001321" xsi:nil="true" contextRef="C_0000879407_20140331" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <arwr:BusinessCombinationContingentConsiderationPayments id="F_001322" xsi:nil="true" contextRef="C_0000879407_20140331" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <arwr:BusinessCombinationFairValueOfChangeInContingentConsideration id="F_001323" xsi:nil="true" contextRef="C_0000879407_20140331" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:BusinessCombinationContingentConsiderationLiability id="F_001324" contextRef="C_0000879407_20140331" decimals="0" unitRef="U_iso4217USD">1595273</us-gaap:BusinessCombinationContingentConsiderationLiability>
</xbrl>
